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Abstract

Large fluid shifts and oedema are features of burn injuries. Oedema hampers burn
wound healing and is directly related to the size and depth of the burn. The degree of
oedema in burns covers a broad spectrum: Minor burns cause localised or peripheral
oedema, whilst major burns may result in a systemic inflammatory response which
can be life threatening and necessitates formal fluid resuscitation. Acute burn fluid
resuscitation is paramount in decreasing patient morbidity and mortality but can
contribute to already large amounts of oedema.

There is currently no single

clinically applicable, non-invasive and accurate outcome measure to titrate fluid
volumes in acute burns or monitor the effect of treatments on oedema (in minor and
major burns). Bioimpedance spectroscopy (BIS) has emerged as a possible solution
to these challenges. It can measure body fluid compartments and thus fluid volume
changes over time providing a sensitive non-invasive device to estimate resuscitation
requirements and oedema change and is emerging as a measure of wound healing.
This series of studies therefore aimed to 1) address the potential barriers to use of
BIS in the burns population, 2) determine if BIS provides an accurate measure of
whole body/systemic fluid volume change and 3) localised burn wound oedema
changes, as applied across the spectrum of burn severity, and 4) determine if BIS can
monitor wound healing in minor burns.
The studies therefore investigated novel whole body and localised electrode positions
in the presence of open and dressed wounds, using repeated measures over time in
minor and major burns.
The key novel findings arising from the research series include: 1) alternate electrode
placements are interchangeable with standardised placement for the measurement of
whole body resistance, extracellular and total body fluid volumes in specified
dressing conditions. Therefore BIS can be utilised to monitor changes in fluid shifts
when wounds preclude the manufacturer’s standard placement of electrodes in the
presence of burn wounds, 2) BIS is a reliable method of monitoring fluid in any
dressing condition and electrode position with no systematic bias indicated in both
major and minor burns, 3) In both minor and major burns, BIS is a valid indicator of
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net fluid shifts and oedema change, if dressing condition is adjusted for using the
developed algorithms or calculator and 4) BIS resistance variables, R0 and Rinf, can
be used to monitor wound healing in minor limb burns as an adjunct to standard
practice.
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Publications And Abstracts

The following is a list of peer reviewed publications I have contributed to during the
course of candidature. A total of six co-authored papers were prepared, submitted or
published during the candidacy. The first four of these contribute directly to the
thesis (in the order they appear).

Peer Reviewed Publications
1. Kenworthy P, Grisbrook TL, Phillips M, Wood FM, Gibson W, Edgar DW.
Addressing the barriers to bioimpendance spectroscopy in major burns: alternate
electrode placements. J Burn Care Res. 2017 Mar 15.
2. Kenworthy P, Grisbrook TL, Phillips M, Wood FM, Gibson W, Edgar DW.
An objective measure for the assessment and management of fluid shifts in acute
major burns. Accepted to Burns and Trauma, November 2017.
3. Kenworthy P, Grisbrook TL, Gittings P, Phillips M, Wood FM, Gibson W,
Edgar DW. Bioimpedance spectroscopy: A technique to monitor interventions for
swelling in minor burns. Burns. 2017 August 3. DOI: 10.1016/j.burns. 2017.
04.022
4. Kenworthy P, Grisbrook TL, Phillips M, Wood FM, Gibson W, Edgar DW.
Monitoring wound healing in minor burns – a novel approach. Burns. 2017
August 4. DOI: http://dx.doi.org/10.1016/j.burns.2017.06.007
5. Grisbrook TL, Kenworthy P, Phillips M, Wood FM, Edgar DW.
Nanaocrystalline silver dressings influence Bioimpedance Spectroscopy
measurements in burns patients. Burns. 2016; 42 (7): 1548-1555
6. Grisbrook TL, Kenworthy P, Phillips M, Gittings PM, Wood FM, Edgar DW.
Alternate electrode placement for whole body and segmental bioimpedance
spectroscopy. Physiological measurement. 2015; 36 (10):2189-201.

Abstracts and Presentations
1. Kenworthy P, Grisbrook TL, Gittings P, Phillips M, Wood FM, Gibson W, Edgar
DW. A technique to monitor interventions for swelling in minor burns: A pilot

12

study. Bullet poster presentation. Proceedings of the Australian and New Zealand
Burns Association, October 2015, Melbourne, Australia.
2. Grisbrook TL, Kenworthy P, Phillips M, Wood FM, Edgar DW.
Nanaocrystalline silver dressings influence Bioimpedance Spectroscopy
measurements in burns patients. Proceedings of the Australian and New Zealand
Burns Association, October 2015, Melbourne, Australia
3. Kenworthy P, Grisbrook TL, Phillips M , Gittings P, Wood FM, Gibson W,
Edgar DW. Confirmation of a novel localised measure for swelling in patients
with acute burn wounds. Proceedings of IHR Health Research Symposium,
December 2016, Perth, Australia.
4. Kenworthy P, Grisbrook TL, Phillips M, Gittings P, Wood FM, Gibson W,
Edgar DW. Bioimpedance spectroscopy: A technique to monitor interventions for
swelling in minor burns. Poster presentation. Proceedings of the British Burns
Association, May 2017, London, United Kingdom

13

List Of Figures

Figure 1.1: Current distribution in cell suspensions (37) .......................................... 23
Figure 2.1: Cross section of burn depth and skin layers (reproduced with
permission F. Wood)............................................................................ 34
Figure 2.2: Diagrammatic representation of the zones of injury (reproduced
with permission, D.Edgar) ................................................................... 37
Figure 2.3: Demonstration of burn wound conversion in a scald injury. Mid
dermal (A) to full thickness (B). .......................................................... 37
Figure 2.4: Rule of nines for estimation of burn severity in adults (33) ................... 41
Figure 2.5: Impedimed SFB7 bioimpedance spectroscopy instrument
(Impedimed Limited, Brisbane, Australia) .......................................... 52
Figure 2.6: Body fluid compartments ....................................................................... 54
Figure 2.7: Bioimpedance spectroscopy: whole body electrode positions ............... 56
Figure 2.8: Localised (sense) electrode placement either side of a wound ............... 57
Figure 3.1: Electrode placement sites used for whole body, upper limb and
lower limb BIS. .................................................................................... 82
Figure 4.1: Bioimpedance spectroscopy: standard whole body electrode
positions ............................................................................................... 99
Figure 4.2: Consort Diagram-Flow diagram of data collection process ................. 101
Figure 4.3: Predicted margin plots of BIS variable (Ri, ICF) and net fluid shift
relationship......................................................................................... 110
Figure 5.1: Flow diagram of data collection process. * Occurs at time point 1
and 2. ................................................................................................. 124
Figure 5.2: Position of distal localised electrode on a thigh, 3 cm from wound
edge. Day 4 post burn. ....................................................................... 125
Figure 5.3: Schematic representation of the BIS whole body and limb segment
electrode positioning: measurement (sense) electrode sites (solid
circles) and drive (current injecting) electrode sites (open circles). .. 126
Figure 5.4: The interaction between dressing condition and mean localised
segment volume (logarithmic scale) for R0 (A), Ri (B) and Rinf
(C). ..................................................................................................... 135
Figure 5.5: The interaction between dressing condition and localised interelectrode distance (logarithmic scale) for R0 (A), Ri (B) and Rinf
(C). ..................................................................................................... 136
Figure 6.1: Burn of volar forearm two days after surgery. Sense electrodes in
place either side of wound ................................................................. 151
Figure 6.2: ImpediMed SFB7 instrument (ImpediMed, Brisbane, Queensland,
Australia) ........................................................................................... 153
Figure 7.1: Summary flow chart for the use of BIS in major acute burns .............. 167
14

List Of Tables

Table 2.1: Burn depth characteristics. ....................................................................... 40
Table 3.1: Patient data. Presented as means (standard deviations) ± range .............. 84
Table 3.2: Estimated BIS variable values for each electrode placement and
dressing condition. Values presented as means (95% confidence
intervals). ............................................................................................. 85
Table 3.3: Difference in means comparison of standard and alternate electrode
placement, in different dressing conditions for each of the BIS
variables. Data presented as χ2 (p-value). ............................................ 86
Table 3.4: BIS measures in standard and alternate electrode placements in the
healthy population................................................................................ 86
Table 4.1: Patient data (n=21). ................................................................................ 103
Table 4.2: BIS Reliability ....................................................................................... 104
Table 4.3: BIS variable values for the standard whole body electrode
placement and time point. Values presented as means (confidence
intervals). ........................................................................................... 105
Table 4.4: Predictor variable effects on whole body BIS variables for
determining the effect of ActicoatTM ................................................. 107
Table 4.5: Univariate analysis of variable correlation on whole body BIS
measures............................................................................................. 109
Table 5.1: Geometric means of unaffected CLM (cm) at time point 1 and time
point 2 ................................................................................................ 130
Table 5.2: BIS reliability results ............................................................................. 130
Table 5.3: Change in BIS resistance variables with the interactions between
time point and electrode position (in reference to time point 1 and
EP1) ................................................................................................... 131
Table 5.4: BIS resistance measures relationships with covariates at electrode
position ‘local’ only ........................................................................... 133
Table 6.1: Patient injury details (n=28). Values presented as means and
(standard deviations) or number, where appropriate. ........................ 154
Table 6.2: Relationship of wound healing with localised BIS variables ................ 156

15

List And Definitions Of Key Terms

Acticoat TM

Ionic silver antimicrobial burn and wound dressing (Smith &
Nephew) (1)

Bioimpedance

BIS

A method used to assess body composition and allows for evaluation
of specific body compartments and cell health such as fat free mass

spectroscopy

(FFM), inter-compartmental fluid volumes (extra and intra cellular
fluid and total body fluid) and cell mass (2, 3). It uses a range of
frequencies from 4-1000 kHz.
Bioimpedance

BIA

Like BIS it is a method used to assess body composition and allows
for evaluation of specific body compartments and cell health. It is

Analysis

either a single frequency or multi-frequency method.
Body Cell Mass

BCM

Reflects the actively metabolizing cellular compartment. Indicated by
ICF.

Burn Service of

BSWA

Includes Fiona Stanley Hospital (FSH)

ECF

Fluid outside the cell consists of interstitial fluid (~13L) (dense

Western
Australia
Extracellular

connective tissue and bone), plasma (~3L) and transcellular fluid

fluid.

(~1L) (4).
Fluid

Intravenous ± oral fluid given in the first 24-48 hours of moderate to

resuscitation

large burn injury to maintain intravascular volumes (5)

Intracellular

ICF

as Mg+, phosphates and protein (4)

fluid
Lean Body Mass

Fluid contained within the cell, has a high K+ content (95%) as well

LBM

Body weight – fat mass
The difference between the input and output of fluids over a specified

Net Fluid Shift

timeframe
The fluid which traverses from the intravascular space into the

Oedema

extravascular space in response to tissue injury (6, 7). Otherwise
known as swelling
Phase angle

PA

A measure of cell membrane vitality and prognostic indicator of
malnutrition and disease. Calculated as the arc tangent of Xc/R and
expressed in degrees (8).

Resistance at

Rinf

An index of TBF and used in the calculation of estimates of TBF (9).

R0

An index of ECF and used in the calculation of estimates of ECF (9).

infinite
frequency
Resistance at
zero frequency
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Resistance of

Ri

An index of ICF and used in the calculation of estimates of ICF (9).

TBF

ECF + ICF. 56%-70% of the body consist of fluid, equivalent to 35-

intracellular
fluid
Total body fluid

45 L in an average sized human being (4)
Total body

TBSA

Expressed as a percentage

surface area
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Chapter 1 Introduction

Burns are one of the most traumatic injuries a patient can sustain often having a
lifelong impact on a person’s quality of function, both physically and mentally. Burn
injury causes tissue damage, and a unique inflammatory response, which results in
marked oedema. The inflammatory mediators released, such as prostaglandins,
histamine and bradykinin, increase intravascular permeability and promote the
passage of fluid into interstitial spaces causing local and systemic fluid shifts (1, 2).
Excess oedema inhibits blood flow and reduces oxygen perfusion in vulnerable
tissue, resulting in worsening of the burn wound (3). Immediate management and
ongoing monitoring of oedema is therefore essential in limiting the severity of burn
injury, especially in the first 48 – 72 hours (4).
Optimising emergency treatment of burns is paramount to achieve the best possible
outcome. Fluid resuscitation is an important aspect of acute burns management in
burns greater than 15-20% total body surface area (TBSA) and may be thought of as
the cornerstone of burns early management and patient survival (5). Despite this,
there has been limited innovation or progress in interventions in the area over the last
30 years (6). Initial fluid resuscitation volumes delivered are determined using
formulas based on the patients weight and %TBSA (7, 8). Fluid volumes are
monitored closely and titrated, most commonly, according to urine output (30 –
50ml/hour) (9). Administering acute fluid resuscitation volumes as closely aligned to
those initially calculated and closely monitoring urine output is essential in the
prevention of burn shock and other complications such as abdominal and peripheral
compartment syndromes, kidney failure, pulmonary oedema and peripheral tissue
oedema (10). Fluid resuscitation in the first twenty four hours post burns remains a
complex task as the patient must receive sufficient fluid to prevent hypovolemia and
ensure adequate tissue perfusion and blood supply to vital organs but it will also
accentuate the oedema process (1, 11, 12). Both peripheral and systemic oedema can
contribute to burn wound complications and delay wound healing. It therefore needs
to be optimally managed (10, 13). To optimally manage oedema a reliable and
accurate measurement device is firstly required.
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Current methods of oedema or fluid shift assessment in burns are either invasive,
time consuming, require an open wound or are an indirect measure. Fluid
resuscitation volumes in moderate to large burns are initially determined using
accepted formulas as guidelines e.g. Parkland formula (14, 15) and are then titrated
using most commonly, urine output and haemodynamic observations such as oxygen
saturation and blood pressure. Other objective measures used to guide fluid volume
titration are: pulmonary artery catheterisation and transpulmonary thermodilution
(provide right heart diagnostic information to rapidly determine hemodynamic
pressures, cardiac output, and mixed venous blood sampling) and base deficit and
lactate (16, 17). These are all indirect (and invasive) methods of measuring fluid
volumes and attempts to normalise cardiac output and haematocrit in the first 48
hours of injury does not improve patient outcomes and may lead to over resuscitation
(18). Fluid creep, the tendency to administer too much intravenous fluid is not
uncommon (6).
The widely accepted methods for clinical monitoring of peripheral oedema are
circumferential limb measures (CLM) and water displacement volumetry (WDV)
(19). These are both confounded when wounds are dressed; pose a potential infection
risk and WDV can be cumbersome. Limited progress in identification of clinically
applicable oedema measures has contributed to the lack of emergent interventions for
more proactive oedema removal (20). Thus, to guide improvements in fluid
resuscitation and oedema management in the burn population, a non-invasive, easy
to use, accurate assessment of oedema is required.
Bioimpedance spectroscopy (BIS) is a technique used to assess and monitor an
individual’s body composition, such as inter-compartmental fluid volumes, fat free
mass and cell health (21, 22). It is an instrument frequently utilised in healthy
populations, lymphoedema and more recently in other clinical populations such as
dialysis patients (23, 24). There are many studies investigating its use as a method of
assessing and monitoring malnutrition, fluid shifts in the critically ill and after
surgery and as a prognostic tool in cancer (25-28). Bioimpedance spectroscopy is
gaining popularity as method of assessment in the aforementioned areas as it is
practical, rapid and has demonstrated sensitivity and reliability (29, 30).
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The bioimpedance spectroscopy instrument applies a small alternating current into
the body over a range of frequencies (4-1000 kHz), via electrodes, providing
instantaneous measures of resistance (R) and reactance (capacitive resistance (Xc)).
Resistance is the opposition to flow of an electric current and capacitance is the delay
in the passage of current through the cell membranes and tissue interfaces. The flow
and path of the electrical current is frequency (Hz) dependent (Figure 1.1).
Resistances at zero and infinite frequencies (considered ideal measurement
frequencies) are estimated utilising the Cole-Cole plot embedded in the BIS
software, due the constraints of using a direct or very high frequency alternating
current in humans (31). The resistance at zero (R0) and infinite (Rinf) frequencies (32)
are representative of extracellular fluid (ECF) and total body fluid (TBF)
respectively. Resistance (Ri) of the intracellular fluid (ICF) is extrapolated using the
other raw variable data. At low frequencies, the current cannot traverse the cell
membrane and will only pass through the ECF, which surrounds the cells. At high
frequencies (>50 kHz) the current will pass through the ECF and the cell membrane
or intracellular compartment thus estimating TBF (33) (Figure 1.1). When these raw
resistance variables are incorporated into predictive mixture theory equations (e.g.
Hanai equation) embedded in the BIS software, fluid volumes (ECF, ICF, TBF) can
be calculated (32). The raw resistance variables can also be utilised to monitor intercompartmental fluid volume changes as body fluid behaves as resistive components
and resistance is inversely proportional to fluid volume and therefore oedema (34,
35). Reactance is caused by the capacitance of the cell membrane and represents cell
membrane mass and function. Another variable, phase angle (PA), is a measurement
calculated from the relationship between R and Xc (36). It is a predictor of cell
health, and has been shown to have potential in the ability to monitor wound healing
and as a prognostic indicator of malnutrition and disease (30).
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Figure 1.1: Current distribution in cell suspensions (37)
Bioimpedance can measure fluid shifts at a whole body level, with electrodes placed
on the hands and feet (38). Fluid volume change and cell health of limbs or wounds
can be measured simply by placing the electrodes either side of the segment to be
measured. This is termed segmental or localised bioimpedance. It brings the field of
measurement closer to the site of interest and is more sensitive to fluid volume
changes compared to whole body measures (35).
To date there is limited literature investigating the use of bioimpedance in burns.
Zdolsek (1998) found whole body bioimpedance analysis (BIA) was sensitive
enough to determine the development of oedema (using TBF) and the effects of fluid
resuscitation following burn injury (15-63% TBSA) (39). This was however a small
and underpowered study (n=9). Another study by Miller et al (1999) found there was
a significant positive correlation (r=0.958) between single frequency whole body
BIA and the titrated water method of determining TBF in patients with severe burns
(<23% TBSA range 23-65%). More recently, Edgar et al (2009) used whole body
BIS to measure acute oedema shifts in human burn survivors in different dressing
conditions (29). They concluded that BIS analysis is clinically applicable for the real
time monitoring of whole body fluid shifts in patients with injuries less than 30%
TBSA regardless of dressing conditions, but it was more reliable with no dressings
than when dressings were in place. They did not however, explore the reason
dressings affected the reliability of BIS variables. These researchers demonstrated
BIS has the ability to monitor fluid changes in acute burns, however they did not
confirm whether it is a valid measure of fluid shift to be able to clinically titrate fluid
resuscitation volumes.
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There are no studies in the literature, exploring BIS as a measure of localised limb
oedema or wound healing in burn injured patients. However in muscle injuries,
single frequency bioimpedance analysis (BIA) with localised electrode placement
(sense and drive either side of the injury) was able to detect changes in oedema and
cellular injury consistent with MRI imaging over time in the individual (41). In
patients with wounds of varying aetiologies, localised single frequency
bioimpedance variables R, Xc and PA were found to increase with reepithelialisation of a wound, with modest decreases after wound debridement and
greater decreases with methicillin-resistant staphylococcus aureus (MRSA) infection
of a wound (30). The rate of change in the raw variables signalled the presence of
infection before detection with laboratory methods (30). Measuring local wound and
peripheral oedema practically and with ease in a clinical setting will guide
improvements in pro-active oedema management and thus aid wound healing.
There are potential barriers to the use of BIS in burns such as open wounds and
dressings. These may prevent the placement of standardised electrode positions and
influence the BIS variable output. There is conflicting evidence regarding movement
of standardised electrode positions and repeatability of BIS variables. The theory of
equi-potentials, which are loci of points with the same electrical potential and
perpendicular to the flow of the current, suggest movement of electrodes at points
circumferentially will yield the same results as standard electrode placements (42).
Movement proximally however, by one and two centimetres has been reported to
change mean resistance values by 2% and 4% respectively, indicating BIS is a highly
sensitive measure (43). Thus, the standardisation and accuracy of electrode
placement is important to minimise BIS reproducibility errors between measures.
Acute burn wounds, minor and major, will have a dressing in place at all times
except at the time of dressing change. Further, commonly burn dressings are
impregnated with silver ions or are water based (hydrocolloid). Considering
resistance (opposition by a conductor; a type of material that allows the flow of
electrical current in one or more directions) is proportional to the amount of fluid and
ionic content of the fluid, it is not unrealistic to expect burn dressings may alter the
BIS variable measures (resistance and calculated fluid volumes). Silver is a highly
conductive material and will therefore likely decrease the measured BIS resistance.
Hydrocolloid dressings will also be expected to affect the resistance measured due to
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it being an ionic dressing. Edgar et al (2009), as previously mentioned, demonstrated
BIS measurements were less sensitive in older dressings (>8 hours old) compared to
when no dressings were in place (29). Moving forward, being able to utilise BIS
when dressings are in place and/or when wounds prevent standardised electrode
positioning would enhance the applicability of BIS clinically in burns and other
clinical environments.

1.1 Statement Of The Problem
All burn injuries result in a cascade of inflammatory mediators and oedema. Oedema
is detrimental to wound healing. However, minimal advance is observed in the
interventions to control or reduce oedema volume in wounded tissue. The lack of
advances may be attributed to a lack of accurate, clinically viable assessment of new
methods. Whether it is a localised wound or systemic oedema there is no single noninvasive, real time, bedside measure of monitoring oedema change. It is evident in
both the literature and clinical setting that oedema can lead to conversion of an acute
burn wound, limb and abdominal compartment syndromes and slow healing. These
negative sequelae of oedema can significantly impact an individual’s physical
function, scar quality, psychological recovery and even morbidity outcome. These
adverse outcomes lead to increased medical costs, increased length of stay and an
increased burden on the patient and family. There has been little advance in 1) the
assessment and monitoring of burns resuscitation fluid monitoring and titration in the
last forty years and 2) in the assessment and treatment of peripheral limb oedema. A
major reason for this is due to the lack of user friendly, sensitive outcome measures.
Bioimpedance spectroscopy is a method of oedema measurement and wound
healing, which has merit in burns. It is worth investigating BIS in this challenging
unique population where dressings and open wounds often hinder the use of the gold
standard measures of oedema volume (WDV and CLM) (4, 19).

1.1.1

Aims Of Study Series

This research aims to assess whether BIS is a reliable and valid measure of fluid
volume change, across the spectrum of burn severity. Secondly, it aims to address the
barriers, such as wounds and dressings that may impede the use of BIS in this
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environment. It will attempt to provide solutions to overcome these potential
barriers, through investigation of i) novel electrode placements and ii) the effect of
dressings on BIS variable outputs. Thirdly, the study aims to establish whether BIS
can be used to monitor local wound healing.

1.1.2

Significance Of Study Series

This series of studies will aim to provide a solution for real time, practical
assessment and monitoring of fluid volume change and wound healing in burn
patients, providing solutions to real clinical problems and therefore help guide
improved clinical care of the patient.
The basis of this research is to provide a reliable and valid measure of oedema
change so it can i) guide future intervention studies to progress proactive oedema
management and ii) improve oedema assessment clinically to allow application and
adjustment of the current best practice management strategies in the burn population.
Thus significantly impacting patient outcome and recovery following a burn, as
“every intervention from the point of injury influences the outcome after burn” (4).
It is anticipated the findings of this research will be applicable to all staff responsible
for the wound care in burn patients, from nursing and medical staff to allied health
professionals. All of these team members will benefit from the findings of this
research, as all members are involved in aspects of oedema control, prevention and
wound healing management. The findings hope to drive clinician behavioural change
with respect to positive changes in proactive oedema management and care, through
the use of BIS in standard clinical practice. By delivering the outcomes of the study
to burns clinicians and translating the use of BIS into clinical practice, it will reiterate and reinforce the importance of oedema management in the care of the burn
patient. It also has the potential to reduce the cost to the health system.

1.2 Thesis Outline
The context for the study, the research problem and its significance are presented in
the introduction and literature review and they communicate the steps taken to
address the questions posed. This is followed by a series of studies exploring the
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challenges to the use of BIS in burns and establishment of its methodological utility
and concluding with a synthesis of the results and discussion. Both studies
investigate the use of BIS in acute burns, across the spectrum of severity as major
burns cause a systemic inflammatory response and minor a localised inflammatory
response. Each class of burn also have their own, similar but unique, potential
barriers to the use of BIS.
The first study relates to the assessment of whole body fluid shifts, using BIS, in
acute burns requiring fluid resuscitation. It is disclosed as two papers; (i) addresses
the issue of wounds to the placement of BIS electrodes and (ii) presents the
reliability and validity of BIS and factors that influence BIS variables.
The second study is also presented as two papers. The first of these addresses the
barriers to the application of BIS and the reliability and validity of novel localised
BIS in the assessment of minor limb burn oedema. The second presents localised BIS
as a method of monitoring wound healing. The thesis therefore consists of four
separate inter-related papers.
There are aspects of each of the studies that are similar due to the nature of the burn
environment and the similar aims addressed across the burns spectrum. The
references are presented at the end of each studies manuscript. A synthesis of the
results and discussion concludes the thesis.
This series of studies was conducted at Fiona Stanley Hospital (FSH), the tertiary
hospital for the Burn Service of Western Australia (BSWA), a state-wide service.
Understanding the current clinical practices and model of care of the service will
provide context and insight to the research methodology for the study series. The
BSWA utilises the modified Parkland formula to instigate initial intravenous fluid
resuscitation (2 ml/kg/hr) in burns greater than 15% TBSA, or as deemed clinically
necessary. Fluid volumes are monitored and titrated according to urine output (0.5
ml/kg/hr) and haemodynamic monitoring. Limb oedema is most commonly assessed
subjectively and with CLM. Oedema management is integral to clinical practice and
a priority of all treatments. The BSWA employs a multi-disciplinary approach in
ongoing oedema management practices. The most common oedema management
principles applied are: education; elevation using positioning devices such as lower
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limb wedge cushions and axilla arm boards; low stretch compression using - Coban
3MTM (Critical & Chronic Care Solutions, New South Wales, Australia) self
adherent wrap, tubular-form (Sutherland Medical Pty.Ltd., Victoria, Australia) and
oedema gloves; cardiovascular fitness exercise such as walking, exercise bike and
arm ergometer; active range of motion to enhance lymph flow and strength/resisted
exercise. Wounds in the first 48 hours of injury are managed with an antimicrobial,
silver impregnated dressing (ActicoatTM) as it has been shown to be effective against
most common strains of wound pathogens; decreases pain levels; reduces infection
rates; and is cost effective (44). Dressing choice after this period is dependent on the
status of the wound as decided by the clinical specialist.

1.2.1

Study One: Addressing The Barriers To Bioimpedance
Spectroscopy In Major Burns: Alternate Electrode
Placements

The aim of this study was to:


Determine whether alternate electrode configurations for whole body and
limb segmental BIS outputs were comparable to standardised electrode
configurations in moderate to large size burns across different dressing
conditions

It was hypothesised that:


Whole body and limb segmental alternate electrode positions will provide
comparable BIS variable output, raw and predicted, to standard electrode
positions

Conclusion: Whole body resistance variables and extracellular fluid can monitor
changes in fluid shifts with alternate electrode placements where wounds preclude
standardised placement in both an open wound and ActicoatTM dressing. It was also
apparent the ActicoatTM dressing exaggerated the differences between the standard
and alternate electrode positions but also between the open wound and ActicoatTM
dressing condition.

28

1.2.2

Study Two: An Objective Measure For The Assessment
And Management Of Fluid Shifts In Acute Major Burns

The aims of this study were to:


Examine the reliability of BIS with respect to dressing condition and
electrode position.



Establish the effect of ActicoatTM dressings on BIS variable outputs



Determine the validity of whole body BIS in the presence of major burns

It was hypothesised that:


BIS will be reliable in any dressing and electrode position



ActicoatTM dressings used in the first 48 hours of burn injury in the Burn
Service of Western Australia (BSWA) will reduce BIS variable outputs



BIS raw resistance variables will decrease and predicted fluid volumes will
increase with increasing fluid shift

Conclusion: Whole body bioimpedance is a valid indicator of net fluid shifts, if
dressing condition is adjusted for.

1.2.3

Study Three: Bioimpedance Spectroscopy: A Technique
To Monitor Interventions For Swelling In Minor Burns

The aims of this study were to:


Examine the reliability and validity of the BIS technique for the measurement
of localised burn wound oedema with respect to electrode position and
dressing condition.

It was hypothesised that:


Bioimpedance resistance variables, R0, Ri, Rinf will increase as limb volumes
decrease.

Conclusion: BIS is a sensitive, reliable and valid technique that may be used
clinically to monitor localised changes in burn wound oedema.
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1.2.4

Study Four: Monitoring Wound Healing In Minor Burns –
A Novel Approach

The aim of this study was to:


Determine whether the BIS technique is a valid measure of wound healing

It was hypothesised that:


BIS resistance and phase angle will increase with burn wound healing

Conclusion: BIS is a technique, which has the potential to monitor the wound healing
process of a minor acute burn.

1.2.5

Synthesis Of Results And Conclusions

This final chapter draws the results of the individual studies together, providing an
integrated discussion of the major findings, study limitations and future research and
gives an encompassing conclusion of the entire research.
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Chapter 2 Review Of The Literature

This literature review provides an overview of oedema production after a burn
injury, its potential impacts in the burn wound environment and why it is important
to have a reliable and valid bedside oedema assessment tool. The pathophysiology of
burn wound healing and oedema is firstly discussed. It then outlines factors
contributing to burn severity and oedema volumes. Followed then by a discussion of
current burn oedema or fluid monitoring outcome measures and their limitations.
Bioimpedance spectroscopy is subsequently introduced. A brief overview of BIS
properties and its potential uses in the burns environment is provided.

2.1 Wound Healing
Inflammation is the body’s normal response to injury. It is a complex process of
vascular and cellular responses protecting the body against infection. Normal healing
of an acute wound occurs in a timely and orderly sequential manner (1). Factors
impacting the normal pathway to healing include injury severity, age, co-morbidities
and ethnicity (2). The longer a wound takes to heal the greater the risk of infection
and hypertrophic scarring.
The ability for the skin to heal largely depends on the extent of the injury (2). Skin
can be simply divided into three layers (Figure 2.1) (3). Understanding the structure
of these three layers and the burn depth can provide invaluable information on
expected wound healing times and necessary medical interventions.
i. Epidermis: outer most superficial layer of skin. It is composed of epithelial
tissue. The dermal epidermal junction, the interface between the epidermis
and dermis, attach the two layers to each other and is a key to epithelial
repair. The epidermis also influences the dermis with regards to structural
remodelling, re-innervation and vascularisation (3).
ii. Dermis: has two layers, the papillary and reticular layers. The upper, papillary
layer, contains a thin arrangement of collagen fibres and the lower, reticular
layer, is thicker and made of thick collagen fibres arranged parallel to the
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surface of the skin. The dermis consists of oil and sweat glands and hair
follicles. The types of tissue are: collagen, elastic tissue and reticular fibres.
iii. Subcutaneous tissue: a layer of fat and connective tissue that houses larger
blood vessels and nerves. This layer is important in the regulation of skin and
body temperature.

Figure 2.1: Cross section of burn depth and skin layers (reproduced
with permission F. Wood)
Superficial burns (involving epidermis and papillary dermis) will regenerate
epithelium from sufficient unburned epithelial appendages, allowing spontaneous
healing with minimal scarring. Deep partial and full thickness burns (deep dermis to
subcutaneous tissue) are slow to heal with resultant unstable skin and hypertrophic
scarring (4, 5).

2.1.1

Factors Affecting Wound Healing

Multiple factors can impair healing and they exist at a local wound and systemic
level. The following are a common but not exhaustive list of patient factors affecting
healing:


Pre-existing disease (e.g. peripheral vascular disease, diabetes) and increasing
age. Both result in an altered inflammatory response compared to normal and
are predisposing factors to oedema formation (6).
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Alcoholism, obesity and smoking increase the risk of vascular, heart and lung
disease. These diseases commonly cause affect the structure and function of
the vessels which can interfere with oxygen supply (2).



Ethnicity, pre-existing nutrition and stress also impact wound healing (2).

Additionally, injury severity, presence of infection and oedema all contribute to the
healing capacity of a wound (7).
A burn injury results in a hypermetabolic response and increased catabolism of
protein. In severe injuries the body can be catabolic during wound healing greater
than 12 months after injury (8, 9). The body requires sufficient and generally extra
nutrients to promote healing and sustain hypermetabolism. A high caloric and
nutritious diet is therefore needed. Further detail here is beyond the scope of this
project but it is necessary to understand factors influencing a healing wound.
Burn injuries are highly susceptible to infections due to loss of skin integrity and
reduced cell mediated immunity (10). The presence of infection will slow wound
healing and leads to altered fluid dynamics and extravasation of oedema (6). Burn
patients are susceptible to infection due to the removal of skin, the protective barrier;
general immunosuppression; surgical intervention; prolonged hospital impatient stay;
and the environment of injury (11). It is the main cause of mortality and morbidity
for burn injured patients (10). Wound colonisation with microorganisms delay
wound healing, increase graft loss and increase risk of systemic infection (1, 12). It is
vital that wound management is optimum and infection control procedures (e.g.
sterilisation and/or cleaning of equipment, hand hygiene) are adhered to (13).
Burn wound dressings are therefore important and provide a variety of benefits. They
protect the wound from further trauma or infection by providing a barrier to
infection, provide comfort and pain relief, and promote healing (14). There are
number of different dressings and choice is dependent on various factors: the extent
of injury, stage of healing, amount of exudate, patients intact skin integrity, presence
of infection, position of injury, surgical intervention. The BSWA protocol is to apply
ActicoatTM dressings to all burns for the first forty-eight hours of injury, then change
as appropriate according to the wound condition.
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2.2 Burn Wound Response
Oedema, a natural inflammatory response to trauma, is a normal part of the healing
process. This response however is exaggerated in a burn injury causing excessive
tissue fluid deposition, both locally and systemically (15, 16).

2.2.1

Zones Of Injury

The burn wound is described in three zones of tissue injury (Figure 2.2). 1) The
irreversible zone of necrosis – the extent of which is directly related to the
temperature and duration of exposure and is irreversible due to coagulation of
constituent proteins (16). 2) The zone of stasis - characterized by decreased tissue
perfusion. In the first 48-72 hours it can be salvaged through timely and appropriate
intervention. In this area, excess oedema can further decrease tissue perfusion
converting salvageable to necrotic tissue, a process known as burn wound conversion
(17). 3) The outermost zone of hyperaemia – an area of tissue with increased
perfusion, which surrounds the zone of stasis. It is invariably oedematous
recoverable tissue (17). Oedema, a natural response to trauma through inflammation,
is a normal part of the healing process. However, excessive oedema can result in
increased tissue losses, slow wound healing, exacerbate tissue scarring, limit
function and at worst increase mortality (15, 18).

2.2.2

Burn Wound Conversion

Burn wound conversion is an important phenomenon in the treatment of thermal
injury as burn wound depth may be a significant determinant of morbidity and
mortality. It is also clinically significant because as the degree of burn advances it
increases the likelihood of hypertrophic scarring, contractures, need for surgical
excision and grafting, wound infection, sepsis and shock (19).
Burn wound conversion is a term for the dynamic process resulting in increased
tissue losses and wound deepening. It is caused by many factors both local and
systemic such as excess oedema, changes in blood flow, excess inflammation and
inflammatory mediators, infection and chronic medical illnesses (e.g. diabetes,
vascular disease) (20). Excess oedema limits the exchange of vital nutrients
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Figure 2.2: Diagrammatic representation of the zones of injury
(reproduced with permission, D.Edgar)

A

B

Figure 2.3: Demonstration of burn wound conversion in a scald injury.
Mid dermal (A) to full thickness (B).
(including oxygen), between the circulation and the damaged areas compromising
vulnerable tissues (21). Conversion is commonly seen in the subacute phase (threefive days) where burns initially assessed as superficial-mid dermal thickness progress
to deep partial or full thickness burns (Figure 2.3). Thus, timely removal of oedema
is paramount in limiting the risk of burn wound conversion. Also, as the TBSA of the
burn increases so too does the risk of wound progression (17). Limiting the degree of
both local and systemic oedema through optimal control of fluid resuscitation in
major burns, elevation, movement, compression where appropriate and using
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appropriate wound dressings, maintaining nutritional status and timely surgery can
reduce the risk of burn wound depth.

2.2.3

Burn Pathophysiology

The pathophysiology of the microvascular changes post-burn is quite complex. It is
known that when burnt the damaged tissues release chemical mediators, such as
histamine, prostaglandins and oxidants (all cells altered from the burn injury are
capable of releasing oxidants), which can damage the capillary membrane and
increase capillary permeability (22). This allows leakage of fluids, plasma proteins
and electrolytes from the intravascular space into the extravascular space (or tissues)
causing immediate localised oedema, and in burns greater than 15-20% TBSA,
systemic oedema (swelling in non-injured tissues and the lungs) (23). This is known
as the ‘vascular leakage syndrome’ noted to last for ~24 hours after burn. The
syndrome is life threatening and immediate medical attention is recommended as it
can lead to burn shock, a unique phenomenon, which is a combination of
distributive, hypovolemic and cardiogenic shock (22). Fluid resuscitation is
necessary to maintain circulating blood volume and blood supply to vital organs, but
it also contributes to oedema in the tissues, particularly during the ‘leaky blood
vessel’ period.
Unavoidable local oedema and large scale fluid shifts are caused by disruption of
collagen cross linking destroying the integrity of the osmotic and hydrostatic
pressure gradients (24). There is also worsening fluid regulation and systemic
inflammatory responses due to cell membrane damage from the influx of
inflammatory mediators exacerbating abnormal cell to cell permeability.
These fluid shifts and resultant micro-thrombi in vessels can exacerbate
hypoperfusion (or inhibition of blood flow) in vulnerable tissue, specifically in the
zone of stasis and hyperaemia i.e. inadequate oxygen perfusion can increase the zone
of necrosis thus worsening the burn wound (25). Limiting excess oedema is therefore
important as it can reduce healing time via optimal blood flow and oxygen to the
wound thus positively benefiting burn survivors.
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2.3 Contributing Factors To Acute Burn Oedema
Acute burn oedema formation and resolution is related to the severity of the injury
including factors such as the depth and size of burn, immediate first aid management
and fluid resuscitation.

2.3.1

Burn Depth

Burn depth is defined according to the layer of skin damaged i.e. epidermis, dermis,
subcutaneous fat and can be divided into five categories of increasing depth:
epidermal, superficial dermal, mid dermal, deep dermal and full thickness (Table
2.1) (26).
Burn depth affects the volume and location of oedema. Superficial and mid dermal
burns have a greater local, immediate oedematous response than full thickness burns
(22, 27). Excess ECF (oedema) can be persistent in deeper burns due to the disrupted
integrity of capillaries and increased capillary leak. The capacity for oedema to be
reabsorbed into the vascular system and be carried away by the lymphatics in a
timely fashion as it is in normal wound healing, is therefore reduced (28).
In partial thickness burns, oedema located mainly in the dermis, increases in the first
few hours and then gradually reabsorbs over three-four days due to the preserved
lymphatic system (17, 22). Oedema in deep or full thickness burns increases at a
slower rate and over a longer period due to damaged dermal vascular and lymphatic
channels with reports of peak levels at 18 hours after-injury (29). Twenty five
percent of oedema in deep burns is still present at one week.
In pigs inflicted with minor burns, Papp et al (2006) found superficial burns had
increased water content of the whole dermis and subcutaneous fat at eight hours after
burn; partial thickness burns had a greater water content in the whole dermis still at
24 and 72 hours after burn; Full thickness burns presented with significantly less
water content in the upper dermis at 24 hours and was associated with necrosis of the
tissue layer (30). All burns had higher tissue water content in the subcutaneous fat
compared to non burned areas. In sheep inflicted with burns, oedema was located in
the surrounding dermis and subfascial tissue for all burn depths and in underlying
adipose and muscle in full thickness burns of sheep (31). It has been demonstrated
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the distribution and the rate of occurrence of oedema and the capacity of the body to
reabsorb oedema is related to burn depth. It is just one component of burn injury
supporting the importance of early oedema management and monitoring.
Table 2.1: Burn depth characteristics.
Depth

Colour

Blisters

Capillary

Sensation

Healing

Refill
Epidermal

Red

No

Present

Present

Yes (3-7 days)

Superficial

Pale pink

Small

Present

Painful

Yes (7-10 days

Dermal

with minimal
dressings)

Mid-dermal

Dark pink

Present

Sluggish

+/-

Usually (should
heal within 14
days)

Deep

Blotchy

Dermal

red

+/-

Absent

Absent

No (generally
needs surgical
intervention)

Full

White

No

Absent

thickness

Absent

No (generally
needs surgical
intervention)

[Table adjusted from the Emergency management of Severe Burns course manual
2013] (26).

2.3.2

Total Body Surface Area

Total body surface area influences the volume of oedema production due to
increased tissue damage increasing the rate or volume of vascular permeability (22).
Increasing TBSA is also associated with an increased risk of burn wound conversion
and is an indication of overall burn severity (16, 17). Generally minor burns < 1015% TBSA result in localised burn wound oedema and major burns > 20-25% TBSA
induce a systemic reaction with significant ‘vascular-leak’ or hyper-permeability of
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the capillaries in the first 24-48 hours after surgery (32). Research has estimated that
in large burns up to 50% of oedema volume is in non-burn areas (22). Total body
surface area is one of the main considerations in the determining fluid resuscitation
volumes in large burns and is determined most commonly using the ‘rule of nines’
(Figure 2.4).

Figure 2.4: Rule of nines for estimation of burn severity in adults (33)

2.3.3

Inhalation Injury

As the size of the burn increases so does the risk of inhalation injury and it will occur
in two-thirds of patients with greater than 70% TBSA burn injury (5). Upper airway
oedema can occur rapidly in patients with smoke inhalation and a sizable burn.
Intubation should not be delayed. Patients considered at risk of inhalation injury
should be assessed and monitored with arterial blood gases, chest x-rays and pulse
oximetry. If the equipment is available, monitoring of end tidal carbon dioxide using
capnometry or capnography can provide useful respiratory status information.
Fiberoptic laryngoscopy and bronchoscopy can assess the extent of airway injury
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(34). These are indirect measures of oedema but contribute to the overall picture of
injury severity.
The scope of this thesis is investigation of whole body and localised limb wound
oedema and not distinguishing airway oedema. However, it is known major burns are
at risk of pulmonary oedema due to vascular leak in the initial stage of injury (16).
After reviewing the literature, Saffle et al (2007) reported fluid resuscitation
requirements of patients with an inhalation injury was greater than those patients
without an inhalation injury (from 35% to 65% greater) (35). This was independent
of the type of resuscitation fluid delivered.

2.3.4

First Aid

Recommended immediate first aid management is 20 minutes of cool running water
(15° - 18°C), occurring up to three hours after the injury has occurred at the burn site
whilst keeping the patient warm (36). It significantly lessens the impact of the injury
through reducing scar and infection and the need for surgery (37).

2.3.5

Fluid Resuscitation

A major goal of the initial management of burn injuries is to replace ECF loss
proportional to %TBSA of the burn. This is in the form of intravenous fluids in large
burns. Optimal fluid resuscitation is important to: maintain the circulating blood
volume; supply blood to vital organs; help prevent local impaired wound perfusion
through maintenance of perfusion pressures to maximally oxygenate the injured and
non-injured tissues; and systemically to restore intracellular and intravascular fluid
volumes thus improving cellular respiration and increasing tissue perfusion (17, 20,
22).
Resuscitation itself is a source of fluid that leaks into the tissues and contributes to
the oedema (38). It is therefore important to be as precise as possible, giving the
minimal volumes of fluid required to achieve vital organ perfusion and limiting
contribution to oedema. There are a number of formulas used to guide initial
volumes of fluid required for adequate resuscitation in partial to full thickness burns
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exceeding 15-20% TBSA (39-41) but the Parkland formula developed by Baxter and
Shires’s over 40 years ago is most widely used (23, 24, 38).
The Parkland formula calculates total fluid requirements using lactate ringer’s
(crystalloid) solution in the first 24 hours from injury as 4mL/kg/%TBSA and the
current Emergency Management of Severe Burns formula is 3-4mL/kg/%TBSA (42,
43). The total volume is divided in half and half the fluid given intravenously over
the first eight hours following the burn and the remaining volume over the next 16
hours. In addition, two litres of background fluid is administered. For a 70 kg person,
with a 20% TBSA burn, this can equate to a total of 6200 – 7600 ml of resuscitation
fluid delivered in 24 hours. The host of formulas utilised in the literature are almost
all based on weight and burn size and use various combinations of fluids.
2.3.5.1

Fluid Creep

It has been demonstrated in recent times that over-resuscitation or delivery of fluid
volumes in excess of those predicted is a frequent occurrence, a phenomenon known
as ‘fluid creep’ (43-45). It can negatively impact a patient’s outcome and contributes
to the volume of oedema caused by the acute burn injury. The reasons for this fluid
creep remain unclear. Saffle et al (2007) post review of the literature suggested
clinicians are instinctively adopting a ‘more is better’ approach with less stringent
adherence to guideline formulas as a decrease in mortality is being seen with
aggressive fluid resuscitation (35). In 2000, Engrav et al conducted a survey of 28
burn centres in the USA and found 58% of patients received greater than
4ml/kg/%TBSA of fluid (46).
The use of opioid drugs is another primary cause thought to contribute to this
phenomenon. Opioids given in high doses for pain relief are known to cause
hypovolemia, as they have significant effects on the cardiovascular system
(contribute to vasodilation) thus increasing fluid requirements (46, 47). Current pain
control interventions have improved and more opioids are given now than in the
1970’s (24) contributing to the higher incidence of over resuscitation. In 2004 a
study by Friedrich et al compared a group of patients treated at a Washington burn
centre from 1975-1978 to a similar group of patients (%TBSA, sex, age) treated in
2000 and found the latter group received significantly more fluid per %TBSA and
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significantly more opioid agonists than the 1970’s group. They concluded that opioid
dosage correlated positively with fluid requirements (48).
Other proposed reasons behind ‘fluid creep’ have been identified and may include:
patients with inhalation injuries, electrical burns, delayed resuscitation, other
traumatic injuries, pre-existing disease and nutritional status and previous alcohol or
drug abuse. These patients are most likely seen to require additional fluid to maintain
end organ perfusion (24, 35, 49).
Inexperienced clinicians may also contribute to increased resuscitation volumes by
making substantial errors in estimating burn area and depth, which can result in
significant under or over calculation of fluid requirements. Despite these known
influences the accuracy of Parkland formula has not been challenged by these
reports, rather it has emphasized the necessity of monitoring patients carefully and
adjusting fluid infusions based on patients’ response (35, 44). It has proposed the
need for valid and sensitive monitoring devices (22, 35).
Fluid creep and its prevention are imperative due to the increase risk of adverse
outcomes. Well documented side effects of over resuscitation are pulmonary
oedema, acute respiratory distress syndrome, abdominal compartment syndrome,
peripheral compartment syndromes, elevated intraocular pressure, increase gut
permeability and burn wound conversion (24, 35, 50). It also hampers burn wound
healing contributing to worsening scar formation and potentially decreased physical
function.
2.3.5.2

Resuscitation Fluid Choices

Fluid resuscitation is fundamental in the management of acute major burns. The two
most common fluids administered during the resuscitation period are either
crystalloid or lactate ringer solution (23). However there is ongoing debate regarding
the use of and timely delivery of colloid (protein based) solutions.
Colloids are used to increase the intravascular osmolality and to stop the
extravasation (leakage into the extracellular space) of the crystalloid or lactate ringer
solution (23). There is conflicting evidence as to whether colloids decrease fluid
volumes delivered in the initial resuscitation phase or add to already existing tissue
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oedema. Goodwin et al (1983) and Jelenko et al (1978) supported the use of colloids
suggesting they reduced fluid resuscitation volumes infused, however mortality and
pulmonary complications were increased. There was also no significant reduction in
systemic sepsis or need for escharotomy (15, 51, 52). Pham et al (2008) reviewed the
literature and found several studies indicating colloids provide little clinical benefit
to burn patients especially in the first 12 hours of resuscitation. Further its use has
been shown to increase lung water content (pulmonary oedema) after the
resuscitation phase even in the absence of an inhalation injury (51, 53).
Further experimental investigation is required to determine the most appropriate fluid
resuscitation regime in order to limit tissue and lung oedema and the negative impact
to the patient.

2.4 Impact Of Acute Oedema
There are numerous factors contributing to the magnitude of oedema in burn
patients, both directly related to the extent or severity of the injury and the medical,
nursing and allied health interventions or lack thereof (dressings, fluid resuscitation,
oedema management procedures). Burn wound oedema can alter wound severity
through increasing the oxygen diffusion distance to the wound, forming a physical
barrier to healing (54). Consequently increasing the risk of hypertrophic scarring
with associated functional, psychological and aesthetic sequelae (55). In children, a
wound taking greater than ten days to heal had an eight percent chance of
hypertrophic scarring (7). Finlay et al (2017) demonstrated reduced burn scar quality
in adults as the time to healing increased, with the effect being significantly greater
within 21 days after injury (56). Oedema affects the outcome of the wound (size,
depth, healing). It also affects an individual’s immediate physical function. Oedema
can limit the range of motion of joints, cause pain with movement and mobilisation,
increase the effort required to move and affect the cardio respiratory system if the
lungs are involved. The changes in the composition of oedema in subacute or chronic
states, may increase the resistance to movement (57). In addition, prolonged oedema
has been associated with deposition of calcium in the tissues, fat in the muscles and
peri muscular fascia thickening (58). To limit the negative impacts of oedema, time
is of the essence and oedema management strategies should be instigated straight
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away. Oedema assessment techniques are imperative to successful oedema reduction
and prevention.

2.4.1

Summary

Many factors contribute to the degree and extent of oedema in this unique population
and if it is not managed optimally the results can be devastating. Timely management
of acute burn oedema can positively impact burn survivors’ bio-psycho-social
outcomes. Reducing wound healing time will also decrease the cost to the health
system through decrease hospital inpatient length of stay, decreased services as an
outpatient, decrease surgery cost and decreased risk of infections. Thus to improve
acute and long term management of oedema an appropriate clinical tool for
measuring and monitoring fluid shifts will help guide best practice.

2.5 Outcome Measures To Monitor Post Burn Oedema
The literature presents several options or current practices for quantifying oedema in
both major and minor burns but they are not without limitations. The most common
measures of burn fluid shift or oedema change are discussed below and it is evident a
true gold standard outcome measure for burn oedema is still a goal worth pursuing.

2.5.1

Major Burns: Monitoring Of Resuscitation

Burns >15-20% TBSA require fluid replacement therapy to maintain circulating
blood volumes. Initial volumes are determined by formulas including TBSA and
patient weight variables. The fluid volume has to then be titrated according to the
individual’s response to therapy.
Endpoints of resuscitation include primarily urine output, and secondarily
haemodynamic parameters such as blood pressure and oxygen saturation (44). Fluid
is titrated based on maintaining a urine output of 30-50ml per hour (or 0.5-0.8
ml/kg/hr). The accuracy and validity of these endpoints of fluid resuscitation as a
measure of whole body perfusion and fluid balance have been questioned (29). Burn
centres are allowing urine output to exceed accepted values, contributing to over
resuscitation (22, 41). Cartotto and Zhou (2010) carried out a retrospective review of
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196 patients at a single centre over eight years and found the mean urine output was
1.2ml/kg/hr (SD 0.7) in the first 24 hours and 76% of patients received
>4.3ml/kg/%TBSA of fluid (recommended 4ml/kg/%TBSA with Parkland formula)
(41). Despite knowing the phenomenon of fluid creep, the burns centre did not adjust
the resuscitation volumes to maintain urine output within the accepted range. Urine
output has also been suggested to lag behind the actual events of hypoperfusion by
up to two hours (21, 59).
Other options of endpoint fluid monitoring have been explored, but many of these
are invasive and require expensive or specialist equipment (e.g. central venous
catheters and pulmonary artery catheters) (45, 49, 60, 61). Burn patients requiring
formal fluid resuscitation admitted to Fiona Stanley Hospital (FSH) may be treated
on the burns unit and not the intensive care unit, so invasive monitoring such as
Swan-Ganz (pulmonary artery) catheters are not available.
An American Burns Association survey of burn centres showed rates of different
objective measures used to guide fluid volume titration are: pulmonary artery
catheterisation eight percent, transpulmonary thermodilution three percent (44).
These provide right heart diagnostic information to rapidly determine hemodynamic
pressures, cardiac output, and mixed venous blood sampling; base deficit seven
percent and lactate five percent (indicative of respiratory or metabolic
compensations), lithium indicator dilution five percent (cardiac output measure), and
haematocrit one percent. These are all used as indirect measures of the body’s fluid
volume, haemodynamic state or tissue perfusion.
These recommendations may need to be treated with caution in the first 24 hours as
attempts to normalise the values can lead to over resuscitation and compartment
syndromes (44). Abnormal arterial lactate and base excess values have been shown
to correlate with the magnitude of injury and their failure to correct over time
predicts mortality but there are no prospective studies to support their use to guide
fluid resuscitation (53). The pathophysiology of burn shock creates a persistent
hypovolemic state that gradually subsides, attempts at rapidly clearing anaerobic by
products with aggressive volume replacement (attempting to normalise blood lactate
and haematocrit) may be unsuccessful and exacerbate oedema formation.
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Holm et al (2004) completed the only well designed prospective randomised trial
comparing burn shock therapy guided by invasive haemodynamic monitoring to
restore preload and cardiac output with standard therapy according to Parkland’s
formula (in the first 24 hours after burn) (60). In the pre-load driven intervention
group intrathoracic blood volume or cardiac index (to within normal range) was
unable to be achieved and they received 68% more fluid (above the predicted
volumes) compared to the Parkland driven strategy. No association between
increased fluid administration and more effective resuscitation was shown and the
patients in the treatment group also showed much more pronounced subcutaneous
oedema. This demonstrates attempts to normalise invasive haemodynamic properties
may not lead to improved outcomes in the first 48 hours of major burns. It also has
increase risks due do its invasive procedure and injection of contrast dye. Invasive
procedures in acute burn care also increase the risk of septicaemia and wound
infection (44).
Patient’s weight can also be used to monitor changes in total body fluid although
clinical validity is controversial (62). Reliable and valid body weight measurements
are difficult to ascertain in the acute burns environment due to reduced patient
mobility; resuscitation fluid retention and the added weight of burn dressings and
wound ooze. All these factors introduce confounding and variability in the weight
measurement and make interpretation of weight changes difficult.
Current techniques to guide fluid therapy are blunt and do not measure volumes of
the body fluid compartments, most importantly extracellular and intracellular fluid.
These give an indication of the extent of oedema (primarily in the ECF) and
reabsorption of fluid into the capillaries and/or cellular oedema (23). If the volume of
ECF could be measured easily and regularly over time, then re-hydration volumes
could be adjusted to maintain normal (13-17L or ~25% of total body water) or
clinically acceptable values, in turn limiting oedema and potentially catastrophic side
effects (63).

2.5.2

Minor Burns: Localised Oedema Outcome Measures

Burn oedema volume and location (e.g. lungs, limbs) relates to the spectrum of
severity of burn. In minor burns, complex, formal fluid resuscitation is not required
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and oedema is generally localised to the vicinity of the burn site. The ability to track
changes in localised oedema volumes at the site of injury can provide information on
the efficacy of oedema management and treatment (e.g. medical management,
physiotherapy input) and thus help guide best practice. An understanding of effective
interventions is determined through appropriate assessment. There are few sensitive
and accurate measures of localised oedema that are easy and quick to perform,
however they are not without limitations in the burn trauma environment.
The ‘gold standard’ measures of peripheral oedema (limb volume change) include
WVD and CLM (57). These can be difficult to perform with the nature of burn injury
and can be logistically and mechanically challenging. For example, WVD may
require large volumes of water to submerge a whole limb, depending on the location
of burn and thus is not practical in large %TBSA burns. In addition, the vessel must
be cleaned appropriately between subjects to prevent potential cross-infection. Limb
circumference measures have limitations in the burn population due to dressings and
open wounds. Infection prevention and management protocols of individual burn
facilities, may prevent the use of CLM, otherwise require single use tape measures
thus increasing patient contact consumables (64). In lymphoedema and hand therapy,
however, CLM has been shown to have a significant correlation with WVD and thus
can be used with confidence in detecting volume change (65, 66).
Limb oedema can also be objectively measured using clinical assessment, magnetic
resonance imaging (MRI), computed topography scans, near-infrared spectroscopy
(NIR), perometry and ultrasound. However, they lack clinical utility and validation
(18, 67). An easy to use, rapid outcome measure for more localised oedema will
provide immediate feedback of the effectiveness of oedema and wound management
interventions.

2.5.3

Wound Healing Assessment

Wound healing is a significant component in recovery from burn injury and it is also
influenced by oedema change. Time to wound healing is directly related to the
severity of scarring (56). Monitoring of healing is essential to ensure the most
appropriate intervention to promote healing is carried out. This includes the choice of
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dressing, surgical intervention, use of pharmaceutical agents (e.g. antibiotics), other
indicated medical management (e.g. vascular optimisation), and oedema control.
Current monitoring of wound healing assesses wound size, wound bed
characteristics, type of tissue, colour and wound bed depth. Various methods
including

clinical

assessment,

photographs,

visitrak

wound

area

tracing,

circumference measures, computer software packages such as digital planimetry and
image J may be used in isolation or combination (68, 69). None of these methods
provide cellular level information of the wound, have low sensitivity to changes or
are expensive and require an undressed wound.
Laser Doppler perfusion imaging (LDPI) is another method utilised to determine
burn wound depth. It operates by scanning a burned area with laser light and the light
frequency changes with the amount of perfusion of the tissues. A color-coded
perfusion map is generated, which corresponds to varying burn depths. It is a highly
valid and accurate (> 95%) measure of burn wound depth (70, 71). Wound infection,
tissue curvature, topical substances and ambient light significantly affect the
accuracy of LDPI, major limitations to its use in burns. (20). Other optical techniques
such as optical coherence tomography, reflection-optical multispectral imaging and
orthogonal polarization spectral imaging are non invasive, rapid methods of burn
wound depth assessment (20). Their application and use are still in the research
phase. Thermographic imagery is another emergent burn wound evaluation tool,
however it is limited to use in temperature controlled rooms with a constant humidity
(72).
The literature transcribes, ‘no method of measurement is perfect’ and results need to
be interpreted in conjunction with the clinical picture (69). An instrument that
provides insights into the cell health and processes of healing over time would
facilitate successful clinical decision making.

2.5.4

Summary

There is a lack of user friendly, valid, reliable and non-invasive outcome measures to
determine real time fluid changes after an injury and during wound healing in an

50

acute setting. Bioimpedance spectroscopy (BIS) may be a solution. It is a tool
capable of oedema assessment and emerging as an indicator of wound healing.

2.6 Bioimpedance Spectroscopy
There have been few studies investigating bioimpedance and measurement of intercompartmental fluid levels in major burns, and the current outcome measures of fluid
management in this challenging population in the acute and subacute phase have
questionable accuracy. Due to the rapid acute change and shift of fluid into tissues
secondary to the body’s response to injury, the potential ability of BIS to provide
‘real time’ measurements of volume change is promising. The first studies exploring
bioimpedance as a method of oedema assessment in major burns was in the late
nineties (73, 74). Bioimpedance analysis was determined to be a reliable and
sensitive measure of TBF volumes. However, further investigation of BIA, as a
method of monitoring fluid resuscitation, did not occur until ten years later (75). Was
this potentially due to the difficulties in clinical application of BIA in the burns
environment? The current literature explores the utility of BIS in a range of clinical
areas, with novel concepts that may be applied in the burns patients. Following on,
BIS and its potential application in the burns environment is described.

2.6.1

Use And Significance Of Bioimpedance Spectroscopy In
Burns

Bioimpedance Spectroscopy is a method used commonly to assess body composition
and allows for evaluation of specific body compartments and cell health such as fat
free mass (FFM), inter-compartmental fluid volumes (ECF, ICF, TBF) and cell mass
(76, 77). It is used commonly in the areas of nutrition and physical health and has
gained popularity as a clinical tool in the last two decades. It is routinely used to
monitor and assess lymphoedema (78, 79) and has also been used extensively in
studies investigating fluid shifts in haemodialysis, as a prognostic tool in human
immune-deficiency virus (HIV) and cancer, and as a screening tool for malnutrition
in the elderly (80-82). The method has been validated in healthy and clinical
populations against MRI and bromide and potassium dilution techniques, which are
considered gold standard in the assessment of fluid compartment volumes and lean
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body mass (LBM) (83-86). Bioimpedance spectroscopy is a popular tool for
monitoring and assessing clinical changes as it is easy to use, processes information
rapidly at the bedside, is relatively inexpensive and is portable (Figure 2.5) (87). It
has demonstrated sensitivity, repeatability and high reliability of measures all
deemed essential when investigating a new method of measurement (79).

Figure 2.5: Impedimed SFB7 bioimpedance spectroscopy instrument
(Impedimed Limited, Brisbane, Australia)
Bioimpedance has demonstrated its application and usefulness as an assessment tool
in fluid monitoring, wound healing and nutritional assessment in various clinical
settings (88-91). Investigation into the possible uses of BIS in burns is therefore
warranted. The burn wound journey can be arduous and long. The injury itself
causes, whole body and local fluid shift alterations, increased metabolic rate and
protein catabolism (affecting LBM) and open wounds (92). There is no real time,
clinically available tool in the burns environment that objectively measure changes in
wound healing, fluid distribution and LBM. The following provides an overview of
BIS and discusses the possible applications and limitations of BIS in the burns
populations.
The term bioimpedance describes the response of a living organism to an externally
applied alternating electrical current and is a measure of the opposition to the flow of
that electrical current through the various tissues (93). It works on the principle that
human tissues have different resistive and conductive properties. Electrically, a cell
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can be represented as an “ion-rich conductive centre (cytoplasm) embedded in an
ion-rich conductive medium (extracellular fluid), separated by a relatively nonconductive barrier (cell membrane)”(94). Because the conductivity of the body is
directly proportional to the amount of electrolyte-rich fluid that is present, BIS can
be used to measure fluid components such as TBF and the condition of the tissue
(85).
There are a number of bioimpedance instruments on the market and they differ in the
type of and array of electrodes used, range of frequencies applied and mathematical
formulas (regression derived or biophysical curve fitted modelling) that are used to
determine the body composition values (95, 96). They are single frequency, multiplefrequency and spectroscopy devices. Irrespective of the device, bioimpedance works
by applying electrodes to intact skin and then a small, painless alternating current
across one or more frequencies is passed through the body. The current flows
depending on the composition of the body. The resistance (opposition of flow to an
alternating current) and capacitance (delay in the passage of current through the cell
membranes and tissue interfaces) of the tissues and bodily fluids also vary with the
frequency of the applied electrical current (76). This necessitates an understanding
Ohm’s law which states that the flow of an electrical current (I) passing through two
points of a conductor is equal to the voltage drop (V) divided by the electrical
resistance (R) between these 2 points (97).
I

= V/R

Or

R

= V/I

This is based on a direct current into a simple conductor. Generalisation of Ohm’s
law to alternating current yields the concept of electrical impedance (Z).
𝑍=

𝑉
𝐼

At low frequencies (<30-50 kHz) the current passes through only the ionic
environment surrounding or outside the cells and therefore is indicative of ECF. At
high frequencies the current passes through the ionic extracellular environment, the
cell membranes and intracellular environment and is indicative of TBF. Intracellular
fluid can be determined by subtracting ECF from TBF and is also reflective of body
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cell mass (BCM) (89). The components of the individual fluid compartments are as
follows (Figure 2.6). ECF (13-17L): Fluid outside the cell consists of interstitial fluid
(~13L) (dense connective tissue and bone), plasma (~3L) and transcellular fluid
(~1L). It has a high electrolyte content of which 90% is Na+, then Cl- and HCO3 and
traces of others. It will expand in conditions of hyper-hydration and decrease in
hypo-hydration states; ICF (21-25L): Fluid contained within the cell, has a high K+
content (95%) as well as Mg+, phosphates and protein; TBF = ECF + ICF. 56%-70%
of the body consist of fluid, equivalent to 35-45L (97, 98).

Total body Fluid 35 – 45 L
Intracellular fluid Volume = 21 – 25 L
Mg+

phosphates

Cell membrane

(K+

Extracellular Fluid Volume = 13-17 L

protein)

(Na+

Interstitial fluid
~ 13 L

Cl- HCO3)

Transcellular
fluid ~1 L+
Plasma ~ 3 L

Figure 2.6: Body fluid compartments
The raw bioimpedance variables of resistance (R), reactance (Xc) and phase angle
(PA) provide information about tissue hydration and integrity. Resistance is
reflective of the body’s water compartments and is inversely proportional to fluid
volume and therefore oedema i.e. the greater the fluid the lower the R (85, 89).
Reactance indicates cell mass and function. Phase angle is the arc tangent of the ratio
Xc/R (99) and is a result of the capacitance (a factor in determining Xc), due to the
structure of the cell membrane. Capacitance causes the current to lag behind the
voltage creating a phase shift (100, 101). If tissue health (integrity of the cytoplasm,
cell membrane and/or cellular fluid) is disturbed in any way (e.g. inflammation,
disease) the electrical properties of those tissues are altered, therefore directly
affecting PA (100). Tissue or cell damage results in a loss of cell membrane
structure, which allows ions and the BIS current to pass through the cell. Damaged
cells therefore behave more like a resistor than a capacitor. Phase angle therefore
relates to the health of the cell/s (a lower PA is indicative of poorer health) (89).
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These raw variables can either be interpreted alone or are used to calculate the fluid
volumes through empirical predictive equations (76, 102).
The different bioimpedance devices use different prediction equations but the
impedimed SFB7 BIS instrument, uses a model which has been reported as being the
superior model under conditions in which body water compartmentalisation is altered
from normal state (103, 104). It also does not require the use of population specific
prediction equations like single frequency bioimpedance analysis (BIA) does (105).
The raw impedimed SFB7 BIS resistance values indicative of ECF, ICF and TBF are
obtained on the basis of the Cole-Cole model and from here on BIS refers to
measures obtained from this model (106). For further insight into the different
models refer to Kyle et al (2004) and Mulasai et al (2014) (76, 107). Bioimpedance
spectroscopy and multi-frequency BIA feed seven or more (4-1000kHz) and two or
more frequencies (4-100khz) respectively into the tissue allowing for measurement
of ECF, ICF and TBF (108). At low frequencies the current can penetrate the ECF
only, due to the high capacitance of the cell membrane and at high frequencies it
passes through both the ECF and ICF measuring TBF. The ICF is then determined
by subtracting ECF from TBF. Single frequency BIA feeds one current, most
commonly 50 kHz, which penetrates both the ECF and ICF (102). It is therefore
more suitable for TBF and fat free mass (FFM) estimates only (107, 109).
Body composition analysis can be performed via whole body or segmental BIS,
differing in the placement of electrodes. Whole body BIS involves four electrodes
(two current sensing and two current drives), which are placed on intact skin in a
standard tetrapolar configuration on the dorsal surface of the hand and feet (104). It
is standardised and has been widely used in assessment of physiological changes at a
whole body level in normal and specific clinical populations (Figure 2.7) (83, 110).
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Figure 2.7: Bioimpedance spectroscopy: whole body electrode
positions
Segmental BIA measures arm, leg or trunk segments and requires drive electrodes to
be placed on the dorsum of the ipsilateral hand and foot (as per whole body BIS) and
sense electrodes placed on either the 1) the dorsum of the feet at the talo-crural joint
or 2) the dorsum of the hands at the radio-ulnar joint, depending on which segment is
being measured (76). To produce interpretable data, this method relies on theory of
equi-potentials, which are loci of points with the same potential and are
perpendicular to the flow of current (111).For further explanation please refer to
Cornish et al (1999) (112). Segmental BIS is described as being insensitive to
oedema of the contra-lateral limb (113). It has been used in the assessment of
unilateral lymphoedema to generate ECW/ICW ratios, using the unaffected arm as a
control (114).
Localised BIS is a relatively new concept and involves the electrodes being placed
close to the site of injury (e.g. pressure sore, muscle tear, fracture site), zoning in on
the field of assessment (87, 115, 116). Electrode positions have not been
standardised, i.e. sense electrodes are placed as close to the injury as possible with
the drive electrode remaining in the standard positions (hand and feet), or moved
alongside the sense electrodes, or either side of a sub-limb segment e.g. calf (Figure
2.8) (117). When the distance between the sense electrodes is reduced the sensitivity
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close to the electrodes increases but the measurement depth is reduced (118). In
muscle injuries, single frequency BIA with localised novel electrode placement
(sense and drive either side of the injury) was able to detect changes in oedema and
cellular injury consistent with MRI imaging over time in the individual (115). Other
BIS studies assessing single limb oedema use segmental or localised electrode
placement as whole body electrode placement has been shown to be insensitive to
decreases in volumetric measures such as during the treatment of lymphedema (113,
119). The reason for this is suggested to be due to the electric current path through
soft tissues being largely determined by body geometry and the relative contribution
of body segments to the whole body BIS measures.
Impedance measurements of a sublimb (localised) segment, the calf, have become
the method of choice to monitor fluid status during dialysis and are more sensitive
and precise than whole body or limb measurements (95, 117).

Figure 2.8: Localised (sense) electrode placement either side of a
wound
In the burn environment, the choice of electrode placements would depend on the
desired assessment, such as whole body fluid shifts or local wound oedema. The
standardised electrode positions may pose a barrier to clinical use in burn injured
patients. This will be discussed in more detail later.
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2.6.2

Application Of Bioimpedance Spectroscopy To Clinical
Practice In Burns

2.6.2.1

Monitoring And Assessing Fluid Shifts

In a major burn, fluid resuscitation is instigated to maintain circulating blood
volume, prevent hypovolemia and ensure adequate tissue perfusion and blood supply
to vital organs (22, 40, 120). Fluid volumes resuscitated need to be monitored closely
and administered as close to predicted as possible to prevent burn shock, renal
failure, compartment syndromes, burn wound conversion, respiratory compromise
and even death (29). Too much fluid will add to the already significant oedema
volume.
Currently fluid resuscitation volumes in major acute burns are initially determined
using formulas as guidelines and then titrated primarily according to hourly urine
output (38). Urine output is a quasi- measure of fluid shift and is not in real time.
Other observations utilised as indirect measures of fluid management and titration
are blood serum levels, standard nursing observations (blood pressure, tissue
oxygenation) and measurement of cardiac output with pulmonary artery catheters
(44, 45, 49, 60). Some of these are invasive and attempts to normalise bloods and
cardiac output in first 24-48hrs often leads to increased fluid volumes delivered, thus
increased oedema, but not improved patient outcomes (60). Where invasive
monitoring is not available, the clinician’s ability to respond quickly is compromised
by the insensitive measures available.
Only a few studies have utilised BIA in the assessment of fluid shifts in burns
patients (73-75). It has however, been investigated in goal directed therapy to guide
intraoperative fluid administration in surgical and intensive care unit patients with
promising results (89, 121). Both Ernstbrunner et al (2014) and Malbrain et al (2014)
believe BIS can help guide fluid resuscitation but suggest more research is needed in
the critically ill population (89, 122). Ernstbrunner et al (2014) assessed volume
status in patient’s before and after surgery using BIS and believe it could become a
useful guide to intraoperative fluid therapy (122). They found ECF (p<0.05)
increased significantly from before to after surgery with administration of
intraoperative fluid (mean 1.9L) with no significant change in ICF (p=0.15). In
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contrast, Plank et al (1998) found BIS underestimated absolute volumes of ECF
when compared to dilution techniques in the critically ill from day 0 to 10. However,
the ECF change from day 0 to 10 was not significantly different between BIS and the
dilution method (123).
A study by Slotwenski et al (2013) of critically ill patients found those with sepsis
had significantly higher impedance (566 ± 98.66 ohms, P=0.0003) than those with
severe sepsis (423.86 ± 149.7 ohms), and a lower % ECF (45.95± 2.97% vs. 49.2 ±
6.11% P=0.026) (124). Summarising, those with increasing sepsis severity had
decreasing impedance and a greater percentage of ECF. This may be explained by
damage of the cell membrane and loss of cell wall integrity in the critically ill (89).
Assessment and monitoring of dry weight (targeted optimal body weight of the
patient, achieved through the removal of excess water) in dialysis is important and
BIS can provide real time continuous measurements of compartmental fluid volume
changes and calculate over-hydration within 1-2 L (considered a clinically
appropriate range) (125). Others have found development of their own bioimpedance
algorithms improves accuracy of fluid volume changes in dialysis patients (90).
Raimann et al (2013) recently compared single frequency BIA and BIS to direct
estimation methods (DEMs) (i.e. deuteriumoxide-dilution, bromide-dilution and total
potassium) in haemodialysis patients (126). They found BIS ECF was closer to DEM
ECF than single frequency BIA based on root mean squared error analysis. Both BIS
and single frequency BIA were equally precise in determining ICF and TBF, when
compared to DEMs.
Close monitoring of net fluid shifts in large burns is essential, especially in the first
24-48 hours, when a complex inflammatory process is in place and fluid shifts are
great with ebbs and flows. Using BIS to ensure adequate intravascular blood volume
may be achieved through titrating fluid volumes to achieve a stable and ‘normal
range’ ICF volume. Once the target ICF is reached and maintained the resuscitation
fluid volumes may be titrated with the aim of reducing ECF volumes. This is one
potential way BIS may be utilised for, real time monitoring to optimise fluid
resuscitation and therefore improve patient outcomes.
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2.6.2.2

Monitoring Peripheral Oedema

As well as fluid shifts in large burns, monitoring smaller fluid shifts, or oedema, in
minor burns is just as important. The standard measures of peripheral oedema
include

clinical

assessment,

water

displacement

volumetry

(WDV)

and

circumference limb measures (CLM). These can be difficult to perform with the
nature of burn injury and can be logistically and mechanically challenging. In a proof
of concept study, Edgar et al (2013) demonstrated BIS is a sensitive measure of
small changes in fluid locally and thus ideal for monitoring and determining best
practice for oedema management (75). Bioimpedance spectroscopy is used routinely
to monitor and assess lymphoedema (78, 127, 128). Multiple frequency BIA was
100% sensitive in detecting limb volume changes as compared to CLM in upper limb
lymphoedema (81) and it is now being considered as gold standard of measurement
in lymphoedema (97).
Segmental BIS was able to detect changes in oedema post-traumatic ankle fracture
with a strong inverse linear relationship between impedance at 5kHz (representative
of ECF) and WDV (r=-0.92) (67). Localised electrode placement BIS was also able
to detect changes in oedema and cellular injury consistent with MRI imaging over
time after muscle injury (115). Pichonnaz et al (2015) propose the raw BIS variable
R0 had greater diagnostic sensitivity and responsive, and is a valid method for
measuring oedema post total knee replacement, as compared to CLM and volume
measures (129).
An accurate and sensitive assessment technique of oedema can guide best practice in
the treatment of oedema, thus contributing to optimum healing conditions in most
injuries. Bioimpedance spectroscopy has been identified as a method of oedema
assessment that has merit after burns (75).
2.6.2.3

Wound Assessment And Monitoring

Optimal management of the acute burn wound aims to: cool the wound immediately
for 20 minutes; reduce oedema in the first three to four days; and prevent burn
wound conversion in order to aid in reduced healing times (4, 17). This is important
because the severity of scarring is directly related to time to healing (25). Current
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wound assessment techniques can be time consuming, require specialist equipment,
software or clinicians and many do not provide outcomes that are indicative of the
wound at a cellular level. The most common techniques are photographs, laser
Doppler and wound area measures, all reliant on a degree of clinician experience and
subjectivity. Objective assessment of wound healing is essential to evaluate
nutritional and therapeutic interventions and detect complications. Bioimpedance
analysis is an emergent concept in the assessment of wound healing but shows
promising results.
Lukaski et al (2012) discovered in several case studies in wounds of varying
aetiologies, localised single frequency raw bioimpedance variables, resistance (R),
reactance (Xc) and phase angle (PA) increased with re- epithelialisation of the
wound and could detect the presence of infection prior to laboratory methods (130).
This is supported by Moore et al (2011) who found PA measurements mirrored the
health of the wound and provided an accurate tool for assessing the regional tissue
health, in diabetic, surgical, neurotrophic, venous, traumatic and infectious chronic
wounds (88).
Wagner et al (1996) found localised BIA (frequency 50kHz) was able to predict
patients at risk of pressure ulcers (116). Phase sensitive measures were taken and
patients at risk had significantly decreased Xc, R and PA values suggesting
malnutrition, ECF accumulation and decreased cellular vitality. In rats, local BIA
was found to be a highly reliable measure with low within subject variability and
high retest reliability for describing cellular changes that occur during and signal
complications to wound healing. In these rats, tissue health was highly correlated
with impedance (94). Rats were subject to a one and three hour ischaemic injury with
weighted magnets and fluorescence angiography was utilized to image real-time
blood flow in the tissue. Wounded areas showed a decrease in impedance magnitude
and PA closer to zero, suggesting BIS could identify tissue damage that is not
visible. Swisher et al (2015) reported that many researchers are actively exploring
this area, with a number of clinical trials underway and impedance-based wound
monitoring devices have been patented (94).
Bioimpedance assessment decreases the degree of subjective error in wound
assessment and may allow for earlier detection of infections and more timely
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treatment as opposed to waiting for clinical signs and laboratory tests in the burn
population. The ability to track wound healing with an instrument, which is
indicative of wound changes at a cellular level could positively affect treatment
choices. Major burns patients are a high risk for pressure injuries, especially in the
intensive care setting. Regular assessment of at risk areas such as the heels and the
sacrum with BIS could lead to earlier pressure care intervention, such as more
frequent patient turns, thus minimising the impact on patient care and morbidity. In
the series of the following studies, one explores the novel concept of wound
assessment in minor limb burns.
2.6.2.4

Assessment Of Nourishment And Health

It is known that a burn injury causes an increase in metabolic rate and catabolism of
protein, hence the need for increased nutritional and energy requirements (8). This
response is characterised by decreases in lean body and total body mass, liver
dysfunction, proteolysis and insulin resistance amongst other things (131). Newsome
et al (1973) stated severely burned patients in the acute setting can lose up to 25%
total body mass (132), as skeletal muscle is a major source of fuel for the burned
patient (133). Accurate assessment of cellular level body components such as body
cell mass (BCM which is equivalent to ICF) and fluid compartment volumes can
indicate malnourishment and cell health. Malnutrition has been associated with
increased infections, longer length of hospital stay and higher mortality (134-136).
Therefore optimising nutrition is essential to promote and provide best conditions for
wound healing, help prevent infection and limit functional decline (137). Measuring
BCM can provide an estimate of protein balance and an aspect of metabolic
improvement (138). Protein is the main component of muscle mass and protein is
directly related to ICF. Therefore, an improvement in BCM or ICF may indicate the
effectiveness of nutritional support (139, 140).
Initial nutritional support assessment of burns patients includes consideration of
resting energy expenditure, burn depth, %TBSA, time post burn, pre-existing
nutrition and their level of activity. These factors are then incorporated into
equations such as the Toronto formula and modified Harris-Benedict equation to
determine the caloric requirements (141). These assessments are used in the BSWA.
Ongoing monitoring and assessment are required to adjust nutritional support as
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necessary. Other methods of nutrition and LBM assessment may include:
questionnaires (e.g. Subjective global assessment) however these can be time
consuming and tedious for the patient to complete and clinician to assess,
biochemical indicators such as serum albumin, total lymphocyte count and serum
pre-albumin but there have been recent objections raised against these as they are
influenced by acute inflammation (142, 143). Computerised tomography (CT) and
MRI can also assess LBM but these are costly, time consuming, not always readily
available and may not be appropriate for acute burns patients, particularly the
critically ill. Ongoing monitoring of nutritional status is by body weight, aiming for a
stable positive change. Factors such as maintenance fluids, fluid shifts associated
with infection and hypoproteinemia however can mask LBM losses as fluid can
increase their weight (131).
Bioimpedance spectroscopy has the ability to assess components of nutrition with
variables BCM and PA. Phase angle indicates cell viability and health.
Bioimpedance analysis, using a predictive regression equation, has been shown to
provide valid estimates of skeletal muscle mass (SMM) (r2 = 0.86, SEE 9%), across
multiple ethnicities, when compared to SMM determined by MRI (85). In disease
such as HIV and cancer, a loss of ICF (reflecting BCM) is frequently accompanied
by an increase in ECF. This can cause body weight to remain constant or increase,
masking malnutrition (144), indicating BIS may be useful in the assessment and
monitoring of burn patient caloric intake or nutrition.
In studies particularly in the elderly a lower PA is associated with malnourishment
and has been found to be a determinant of those nutritionally at risk in hospital (137).
Zdolsek et al. (1998) proposed that PA was able to detect the effects of a burn and
sepsis in cellular membranes, because it significantly decreased in the post-burn
period, with the lowest values being found in two patients who died (74). This was
however a small sample (n=10). In critically ill patients in intensive care units, Lee et
al (2015) found a PA <4.1 (+-1.1, P=0.01) degrees indicates negative nutritional
issues (145). In another study, lung cancer patients with a PA <4.5 degrees had
significantly (P=0.01) shorter survival rates (median 3.7 months) compared to those
with PA >4.5 degrees (median 12.1 months) (146). The PA of healthy white
populations has been reported as >7 degrees for males and >6 degrees for females
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(101, 147). Others state the average range of PA for healthy humans is 5-9 degrees
(148). Multiple frequency BIA was used to assess Xc and PA in response to refeeding treatments for anorexia nervosa patients (n=21) (149). Reactance and PA
improved significantly in patients who were receiving the treatment and these values
no longer differed from age matched healthy females at 15 weeks, even though their
body mass index remained significantly lower than the controls. This suggests cell
health can improve without an increase body weight. However, this was a small
sample size.
In burns it is essential patients have optimal feeding to promote and provide best
conditions for wound healing, help prevent infection and limit functional decline
(137). It is difficult to determine an individual’s nutritional needs and absorption of
their dietary intake, especially in major burns, due to other medical issues.
Assessment of BIS variables could theoretically guide nutritional support
prescription and aid in optimising their management (150). Investigation of
nutritional assessment in burns is out of the scope of this study but is an area worth
pursuing in future research.
2.6.2.5

Assessment And Monitoring Of Body Composition

Part of the standard care of patients with a burn injury is exercise to maintain
movement, function and strength. It is essential to patient recovery, for optimal
outcomes, in both the acute and long term rehabilitation phase (151). There is limited
literature in acute burns, assessing the impact of exercise on the individual’s rate of
protein catabolism and lean body mass (LBM), especially in the acute care phase.
A burn injury causes an increase in metabolic rate and catabolism of protein. This
response may last up to or greater than 12 months after injury (152, 153). The loss of
protein leads to a loss of LBM and muscle wasting and therefore strength. The lean
tissue compartment (BCM) is vitally important in the body’s ability to respond to
acute and chronic illness. A decline in BCM is associated with a decrease in strength,
functional decline, and immune function, as seen in HIV patients for example (144,
154, 155). The addition of exercise will enhance an individual’s energy requirements
but is essential in building or maintaining lean muscle mass. It is however unknown
whether a resistance and strength building exercise program in the acute burn phase
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is beneficial or detrimental to the healing process. Also for a patient to be able to
participate fully in physical rehabilitation they need enough caloric energy to do so.
Bioimpedance spectroscopy provides an opportunity to objectively measure the
effects of exercise on LBM and more specifically BCM.
Current and traditional methods of monitoring the effects of exercise training on
muscle and LBM are, anthropometric measures (girths and skin folds), muscle
strength (by e.g. dynamometry), dual X-ray absorptiometry, MRI and CT. Only MRI
and CT can provide muscle anatomical and physiological cross sectional area but
these aren’t always readily available for use and are expensive (91). Dual X-ray
absorptiometry is not real time and involves the injection of tracer dyes; skin folds
are challenging, if not invalid, with open wounds or scarred tissue; and muscle
strength dynamometry is a valid measure, but may at times be limited due to pain
with open wounds in the acute burn environment.
Bioimpedance spectroscopy has been used to assess both body composition and the
effects of exercise training on body composition in healthy and clinical populations
in numerous studies (110, 156, 157). Weber-Lang (2009) showed improved BCM
over time when comparing two different exercise training types in end stage lung
disease (158). Intracellular fluid and SMM, assessed by BIA, increased significantly
(P = <0.05) in both men (8.2% and 4.2% respectively) and women (11% and 3.9%
respectively) after 16 weeks of resistance training (159). A significant correlation
(Pearson r= 0.66-0.8, 95% CI, p<0.01) was found between upper extremity strength
and SMM measured by segmental BIA in healthy individuals (91). Burn injured
patients more than 2 years after injury, after a 12 week interval training program,
displayed the same training effects, in strength measured by dynamometry and LBM
measured by DEXA, as healthy matched controls (160). Immediate assessment of
LBM by BIA would be far more convenient and would have less impact on patient’s
time than methods such as dual X-ray absorptiometry and MRI’s.
Bioimpedance spectroscopy may provide an additional and complementary outcome
measure for measuring the training effect of muscle. Some traditional anthropometric
measures such as skin fold and girth measurements may not be suitable in large
burns due to open wounds, extensive scarring, oedema and the loss of skin elasticity.
Monitoring training effects of LBM and BCM with bioimpedance can be frequent
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and easily achieved. It may therefore help guide best practice for exercise training.
Additionally it may help determine how exercise affects BCM and therefore its
potential impacts on nutrition and wound healing. The scope of this study however,
does not include exploration of BIS in monitoring exercise training. It is important to
understand though, the possible applications of BIS in the burns environment and
how valuable it may be.

2.6.3

Limitations Of The BIS Technique And Its Use In Burns

The bioimpedance technique recommends the use of standardised electrode
placement, correct positioning and preparation of the patient. Acute burn injuries will
often preclude the use of standardised whole body and segmental electrode
placements, due to a high percentage of injuries, hence open wounds, to certain areas
on the hands and feet. Alternate placements need to be considered, deciphered and
interpreted in this population. Stahn et al (2008) and Grisbrook et al (2015) report
alternate electrode positions used on the upper limb are valid substitute however
further research is needed for valid alternate positions on the lower limb (160, 161).
The effect of mature scar tissue and the skin area of non standard electrode positions
on tissue impedance and skin resistivity is also unknown. It has been shown that
impedance is affected by the thickness of the stratum corneum of glabrous skin
(162), which likely indicates there will be impedance differences in scar tissue.
Acute burns require dressings to assist wound healing and protect against infection.
Common dressings used are nanocrystalline silver impregnated (a conductive
material) and hydrocolloid (water based) dressings. Both of these dressings have the
potential to alter the BIS variable measures as the technology is based on the
conduction of a small alternating electrical current delivered through the body and is
directly related to the ionic fluid in the field of measure. Grisbrook et al (2016) found
ActicoatTM, a silver dressing, significantly affected BIS fluid volumes (ECF, ICF and
TBF, p<0.01) compared to no dressing in burns patients with a median total body
surface area (TBSA) of 15% (163). However they did not include fluid resuscitation
in their analysis. To account for the ActicoatTM they developed an algorithm to adjust
BIS variables for clinical interpretation. As previously mentioned, Edgar et al (2009)
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determined whole body BIS was more sensitive and reliable in new dressings (<8
hour after application) compared to old dressings (>8 hours after application) (75).
Further understanding of the effect of various dressings on BIS variable outputs,
across the spectrum of burns severity and phases of healing is required to enhance its
clinical utility in this environment.

2.7 Summary
There is currently no single use, rapid measure of fluid volume change in the burns
environment that can be utilised with dressings in place. Bioimpedance spectroscopy
is a promising and novel measure of fluid shifts, wound healing, nutrition and
training effects in burns and is worth the further investigation given in this particular
research. The current research explores whether BIS is a reliable and valid tool in the
assessment of fluid change and wound healing across the spectrum of acute burns,
and addresses potential barriers to the use of BIS in this population. Bedside, userfriendly outcome measures of oedema will aid in management and limitation of the
negative sequelae of burn injuries.

2.8 References
1.
Fong J, Wood F. Nanocrystalline Silver Dressings in Wound Management: A
Review. Int J Nanomedicine. 2006;1(4):441-9.
2.
Guo S, Dipietro LA. Factors Affecting Wound Healing. J Dent Res.
2010;89(3):219-29.
3.
Johnstone CC, Farley A. The Physiological Basics of Wound Healing. Nurs
Stand. 2005;19(43):59-65; quiz 6.
4.
Tiwari VK. Burn Wound: How It Differs from Other Wounds? Indian Journal
of Plastic Surgery. 2012;45(2):364-73.
5.
Monafo WW. Initial Management of Burns. N Engl J Med.
1996;335(21):1581-6.
6.
Sherwood ER, Traber DL. The Systemic Inﬂammatory Response Syndrome.
Total burn care. 2007:292.
7.
Cubison TC, Pape SA, Parkhouse N. Evidence for the Link between Healing
Time and the Development of Hypertrophic Scars (Hts) in Paediatric Burns Due to
Scald Injury. Burns. 2006;32(8):992-9.
8.
Porter C, Hurren NM, Herndon DN, Borsheim E. Whole Body and Skeletal
Muscle Protein Turnover in Recovery from Burns. Int J Burns Trauma. 2013;3(1):917.

67

9.
Hart DW, Wolf SE, Chinkes DL, Gore DC, Mlcak RP, Beauford RB, et al.
Determinants of Skeletal Muscle Catabolism after Severe Burn. Ann Surg.
2000;232(4):455-65.
10.
Fong J. The Use of Silver Products in the Management of Burn Wounds:
Change in Practice for the Burn Unit at Royal Perth Hospital. Primary Intention: The
Australian Journal of Wound Management. 2005;13(4):S16-S22.
11.
Hajská M, Slobodníková L, Hupková H, Koller J. In Vitro Efficacy of
Various Topical Antimicrobial Agents in Different Time Periods from
Contamination to Application against 6 Multidrug-Resistant Bacterial Strains
Isolated from Burn Patients. Burns. 2014;40(4):713-8.
12.
Halstead FD, Rauf M, Bamford A, Wearn CM, Bishop JR, Burt R, et al.
Antimicrobial Dressings: Comparison of the Ability of a Panel of Dressings to
Prevent Biofilm Formation by Key Burn Wound Pathogens. Burns. 2015.
13.
Merchant N, Smith K, Jeschke MG. An Ounce of Prevention Saves Tons of
Lives: Infection in Burns. Surgical Infections. 2015;16(4):380-7.
14.
Rice PL, Orgill DP. Emergency Care of Moderate and Severe Thermal Burns
in Adults 2015. Available from: http://www.uptodate.com/contents/emergency-careof-moderate-and-severe-thermal-burns-in-adults.
15.
Edgar D, Fish JS, Gomez M, Wood FM. Local and Systemic Treatments for
Acute Edema after Burn Injury: A Systematic Review of the Literature. J Burn Care
Res. 2011;32:334-47.
16.
Kao CC, Garner WL. Acute Burns. Plast. Reconstr. Surg. 2000;105:2482-92.
17.
Singh V, Devgan L, Bhat S, Milner SM. The Pathogenesis of Burn Wound
Conversion. Ann Plast Surg. 2007;59(1):109-15.
18.
Cross KM, Leonardi L, Gomez M, Freisen JR, Levasseur MA, Schattka BJ,
et al. Noninvasive Measurement of Edema in Partial Thickness Burn Wounds.
Journal of Burn Care & Research. 2009;30(5):807-17
19.
Latenser BA. Critical Care of the Burn Patient: The First 48 Hours. Critical
Care Medicine. 2009;37(10):2819-26.
20.
Devgan L, Bhat S, Aylward S, Spence R. Modalities for the Assessment of
Burn Wound Depth. Journal of Burns and Wounds. 2006;5:7-15.
21.
Jaskille AD, Jeng JC, Sokolich JC, Lunsford P, Jordan MH. Repetitive
Ischemia-Reperfusion Injury: A Plausible Mechanism for Documented Clinical
Burn-Depth Progression after Thermal Injury. J Burn Care Res. 2007;28(1):13-20.
22.
Demling RH. The Burn Edema Process: Current Concepts. J Burn Care
Rehabil. 2005;26:207-27.
23.
Fodor L, Ramon Y, Shoshani O, Rissin Y, Ullmann Y. Controversies in Fluid
Resuscitation for Burn Management: Literature Review and Our Experience. Injury,
Int. J. Care Injured. 2006;37:374-9.
24.
Tricklebank S. Modern Trends in Fluid Therapy for Burns. Burns.
2009;35:757-67.
25.
Brown TL, Muller MJ. Damage Limitation in Burn Surgery. Injury.
2004;35(7):697-707.
26.
National Burn Service NZ. National Burn Service Initial Assessment 2011
[updated 17/6/2013; cited 2015 March]. Available from:
(http://www.nationalburnservice.co.nz/pdf/NBS-initial-assessment-guideline.pdf).
27.
Hamar J, Jonsson CE, Kovach AG. Acute Effect of Scalding Injury on Blood
Flow in Muscle and Subcutaneous Tissue in the Paw of the Anaesthetized Dog.
Scand J Plast Reconstr Surg. 1979;13(1):39-43.

68

28.
Klabunde RE. Cardiovascular Physiology Concepts: Lippincott Williams and
Wilkins; 2011. Available from:
http://www.cvphysiology.com/Microcirculation/M010.htm
29.
Hayek S, Ibrahim A, Sittah A, Atiyeh B. Burn Resuscitation: Is It
Straightforward or a Challenge? Annals of Burns and Fire Disasters. 2011;24(1):1721.
30.
Papp A, Romppanen E, Lahtinen T, Uusaro A, Härmä M, Alhava E. Red
Blood Cell and Tissue Water Content in Experimental Thermal Injury. Burns.
2005;31(8):1003-6.
31.
Sakurai H, Nozaki M, Traber L, Hawkins H, Traber D. Microvascular
Changes in Large Flame Burn Wound in Sheep. Burns. 2002;28(1):3-9.
32.
Atiyeh BS, Dibo SA, Ibrahim AE, Zgheib ER. Acute Burn Resuscitation and
Fluid Creep: It Is Time for Colloid Rehabilitation. Ann Burns Fire Disasters.
2012;25(2):59-65.
33.
PenWell. My Firefighter Nation USA: PennWell; 2017. Available from:
http://my.firefighternation.com/.
34.
Miller K, Chang A. Acute Inhalation Injury. Emerg Med Clin North Am.
2003;21(2):533-57.
35.
Saffle JR. The Phenomenon of “Fluid Creep” in Acute Burn Resuscitation. J
Burn Care Res. 2007;28:382-95.
36.
http://anzba.org.au/. First Aid [cited 2017 12 January].
37.
Wood F, Phillips M, Jovic T, Cassidy J, Cameron P. Water First Aid Is
Beneficial in Humans Post-Burn: Evidence from a Bi-National Cohort Study. PLOS
One. 2016;11(1):e0147259.
38.
Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn Resuscitation. Burns.
2009;35:4-14.
39.
Dulhunty JM, Boots RJ, Rudd MJ, Muller MJ, Lipman J. Increased Fluid
Resuscitation Can Lead to Adverse Outcomes in Major-Burn Injured Patients, but
Low Mortality Is Achievable. Burns. 2008;34:1090–7.
40.
Zaletel CL. Factors Affecting Fluid Resuscitation in the Burn Patient- the
Collaborative Role of the Apn. Advanced Emergency Nursing Journal.
2009;31(4):309-20.
41.
Cartotto R, Zhou A. Fluid Creep: The Pendulum Hasn’t Swung Back Yet!
Journal of Burn Care Research. 2010;31:551-8.
42.
Service ASBI. Clinical Practice Guidelines: Burn Patient Management Aci
Statewide Burn Injury Service. Sydney, Australia: ACI; 2014. p. 1-25.
43.
Pruitt B. Protection from Excessive Resuscitation: “Pushing the Pendulum
Back” The Journal of Trauma: Injury, Infection, and Critical Care. 2000;49(3):567-8.
44.
Cancio L, Lundy JB, Sheridan RL. Evolving Changes in the Management of
Burns and Environmental Injuries. Surg Clin N Am. 2012;92:959-86.
45.
Chung K, Blackbourne LH, Wolf SE, White CE, Renz E, Cancio L, et al.
Evolution of Burn Resuscitation in Operation Iraqi Freedom. Journal of Burn Care &
Research. 2006;27(5):1-6.
46.
Engrav LH, Colescott PL, Kemalyan N, Heimbach DM, Gibran NS, Solem
LD, et al. A Biopsy of the Use of the Baxter Formula to Resuscitate Burns or Do We
Do It Like Charlie Did It? J Burn Care Rehabil. 2000;21(2):91-5.
47.
Greenhalgh D. Burn Resuscitation. Journal of Burn Care & Research.
2007;28(4):1-11.

69

48.
Friedrich JB, Sullivan SR, Engrav LH, Round KA, Blayney CB, Carrougher
G, et al. Is Supra-Baxter Resuscitation in Burn Patients a New Phenomenon? Burns
30 (2004) 464–466
2004;30:464-6.
49.
Mitchell KB, Khalil E, Brennan A, Shao H, Arne L, Yurt RW, et al. New
Management Strategy for Fluid Resuscitation: Quantifying Volume in the First 48
Hours after Burn Injury. Journal of Burn Care Research. 2013;34:196-202.
50.
Klein MB, Hayden D, Elson C, Nathens AB, Gamelli RL, Gibran NS, et al.
The Association between Fluid Administration and Outcome Following Major Burn.
Annals of Surgery. 2007;245:622-8.
51.
Goodwin CW, Dorethy J, Lam V, Pruitt BA, Jr. Randomized Trial of
Efficacy of Crystalloid and Colloid Resuscitation on Hemodynamic Response and
Lung Water Following Thermal Injury. Ann Surg. 1983;197(5):520-31.
52.
Jelenko C, 3rd, Wheeler ML, Callaway BD, Divilio LT, Bucklen KR,
Holdredge TD. Shock and Resuscitation. Ii: Volume Repletion with Minimal Edema
Using the "Halfd"(Hypertonic Albuminated Fluid Demand) Regimen. Jacep.
1978;7(9):326-33.
53.
Pham TN, Cancio LC, Gibran NS. American Burn Association Practice
Guidelines Burn Shock Resuuscitation. Journal of Burn Care & Research.
2008;29(1):257-66.
54.
Gosling P, Bascom J, Zikria B. Capillary Leak, Oedema and Organ Failure:
Breaking the Triad. Care of the critically ill. 1996;12:191-7.
55.
Mahajan AL, Tenorio X, Pepper MS, Baetens D, Montandon D, Schlaudraff
K-U, et al. Progressive Tissue Injury in Burns Is Reduced by Rnapc2. Burns.
2006;32(8):957-63.
56.
Finlay V, Burrows S, Burmaz M, Yawary H, Lee J, Edgar DW, et al.
Increased Burn Healing Time Is Associated with Higher Vancouver Scar Scale
Score. Scars, Burns & Healing. 2017;3:2059513117696324.
57.
Casley-Smith JR. Measuring and Representing Peripheral Oedema and Its
Alterations. Lymphology. 1994;27(2):56-70.
58.
Marotel M, Cluzan R, Ghabboun S, Pascot M, Alliot F, Lasry JL. Transaxial
Computer Tomography of Lower Extremity Lymphedema. Lymphology.
1998;31(4):180-5.
59.
Jeng JC, Jaskille AD, Lunsford PM, Jordan MH. Improved Markers for Burn
Wound Perfusion in the Severely Burned Patient: The Role for Tissue and Gastric
Pco2. J Burn Care Res. 2008;29:49-55.
60.
Holm C, Mayra M, Tegelera J, Ho ̈rbranda F, Henckel von Donnersmarcka
G, Mu ̈hlbauera W, et al. A Clinical Randomized Study on the Effects of Invasive
Monitoring on Burn Shock Resuscitation. Burns. 2004;30:798-807.
61.
Peacock F, Soto KM. Current Technique of Fluid Status Assessment.
Congest Heart Failure. 2010;16(4):S45-S51.
62.
Kataoka H. Clinical Significance of Bilateral Leg Edema and Added Value of
Monitoring Weight Gain During Follow-up of Patients with Established Heart
Failure. ESC Heart Failure. 2015;2:106-15.
63.
Boron W, Boulpaep E. Medical Physiology, 2nd Edition Published by
Elsevie, Ch 5. 2008.
64.
Cameron MH, Monroe L. Physical Rehabilitation for the Physical Therapist
Assistant St Louis, Missouri: Elsevier Saunders Health Sciences; 2014. Available
from:
https://books.google.com.au/books?id=B8rsAwAAQBAJ&pg=PA495&lpg=PA495

70

&dq=burns+and+circumference+limb+measures&source=bl&ots=h4qO_hSqWT&si
g=B0Bl0tjEAISYDDHl3XnmshUD7Qw&hl=en&sa=X&ved=0ahUKEwiEmZaI5IfT
AhUCVZQKHVJOCTUQ6AEIPzAI#v=onepage&q=burns%20and%20circumferen
ce%20limb%20measures&f=false.
65.
Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J. Reliability and
Validity of Arm Volume Measurements for Assessment of Lymphedema. Physical
Therapy. 2006;86(2):205-14.
66.
Pani SP, Vanamail P, Yuvaraj J. Limb Circumference Measurement for
Recording Edema Volume in Patients with Filarial Lymphedema. Lymphology.
1995;28(2):57-63.
67.
King RJ, Clamp JA, Hutchinson JW, Moran CG. Bioelectrical Impedance: A
New Method for Measuring Post-Traumatic Swelling. J Orthop Trauma.
2007;21(7):462-8.
68.
Shetty R, Sreekar H, Lamba S, Gupta AK. A Novel and Accurate Technique
of Photographic Wound Measurement. Indian J Plast Surg. 2012;45(2):425-9.
69.
Flanagan M. Wound Measurement: Can It Help Us to Monitor Progression to
Healing? Journal of wound care. 2003;12(5):189-94.
70.
Monstrey S, Hoeksema H, Verbelen J, Pirayesh A, Blondeel P. Assessment
of Burn Depth and Burn Wound Healing Potential. Burns. 2008;34(6):761-9.
71.
Jeng JC, Bridgeman A, Shivnan L, Thornton PM, Alam H, Clarke TJ, et al.
Laser Doppler Imaging Determines Need for Excision and Grafting in Advance of
Clinical Judgment: A Prospective Blinded Trial. Burns. 2003;29(7):665-70.
72.
Serrano C, Boloix-Tortosa R, Gomez-Cia T, Acha B. Features Identification
for Automatic Burn Classification. Burns. 2015;41(8):1883-90.
73.
Miller S, Carlson R, Fegelman E, Quinones J, Finley R. Comparison of Total
Body Water Analysis: Bioelectrical Impedance Analysis Versus the Titrated Method.
journal of burn care rehabilitation. 1999;20:363-6.
74.
Zdolsek HJ, Lindahl OA, Angquist KA, Sjoberg F. Non-Invasive Assessment
of Intercompartmental Fluid Shifts in Burn Victims. Burns. 1998;24(3):233-40.
75.
Edgar D, Briffa K, Cole J, Tan MH, Khoo B, Goh J, et al. Measurement of
Acute Edema Shifts in Human Burn Survivors—the Reliability and Sensitivity of
Bioimpedence Spectroscopy as an Objective Clinical Measure. Journal of Burn Care
and Research. 2009;30(5):818-23.
76.
Kyle UG, Bosaeus I, De Lorenzo A, Deurenberg P, Elia M, Gome JM, et al.
Bioelectrical Impedance Analysis-Part I: Review of Principles and Methods. Clinical
Nutrition. 2004;23:1226-43.
77.
Mialich MS, Sicchieri JMF, Jordao Junior AA. Analysis of Body
Composition- a Critical Review of the Use of Bioelectrical Impedance Analysis. .
International Journal of Clinical Nutrition. 2014;2(1):1-10.
78.
Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, et al.
Early Diagnosis of Lymphodema Using Mulitple Frequency Bioimpedance
Lymphology. 2001;34:2-11.
79.
Ward L. Is Bis Ready for Prime Time as the Gold Standard Measure? 2009.
80.
O’Lone EL, Visser A, Finney H, L S. Clinical Significance of MultiFrequency Bioimpedance Spectroscopy in Peritoneal Dialysis Patients: Independent
Predictor of Patient Survival. Nephrology Dialysis Transplant. 2014(0):1-8.
81.
Cornish BH, Bunce IH, Ward LC, Jones, Thomas BJ. Bioelectrical
Impedance for Monitoring the Efficacy of Lymphoedema Treatment Programmes.
Breast Cancer Research and Treatment. 1996;38:169-76.

71

82.
Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, et al.
Bioelectrical Impedance Phase Angle as a Prognostic Indicator in Breast Cancer.
BMC Cancer 2008, 8:249. 2008(8):249-56.
83.
Anderson L, Erceg D, Schroeder E. Utility of Multi-Frequency Bioelectrical
Impedance Compared to Deuterium Dilution for Assessment of Total Body Water.
Nutrition & Dietetics. 2015;72(2):183-9.
84.
Lichtenbelt WVM, Westerterp K, Wouters L, Luijendzjk S. Validation of
Bioelectrical-Impedance Measurements as a Method to Estimate Body-Water
Compartments. Am J Clin Nutrition. 1994:159-66.
85.
Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of Skeletal
Muscle Mass by Bioelectrical Impedance Analysis. J Appl Physiol. 2000;89:461-71.
86.
Armstrong LE, Kenefick RW, Castellani JW, Riebe D, Kavouras SA,
Kuznicki JT, et al. Bioimpedance Spectroscopy Technique: Intra-, Extracellular, and
Total Body Water. Med Sci Sports Exerc. 1997;29(12):1657-63.
87.
Ward L, Sharpe K, Edgar D, Finlay V, Wood F. Measurement of Localised
Tissue Water - Clinical Application of Bioimpedance Spectroscopy in Wound
Management. Journal of Physics: Conference Series 434 012043. 2013.
88.
Moore MF, Dobson N, Castelllino L, Kapp S. Phase Angle, an Alternative
Physiological Tool to Assess Wound Treatment in Chronic Nonhealing Wounds.
Journal of the American College of Certified Wound Specialists. 2011;3:2-7.
89.
Malbrain ML, Huygh J, Dabrowski W, De Waele JJ, Staelens A, Wauters J.
The Use of Bio-Electrical Impedance Analysis (Bia) to Guide Fluid Management,
Resuscitation and Deresuscitation in Critically Ill Patients: A Bench-to-Bedside
Review. Anaesthesiol Intensive Ther. 2014;46(5):381-91.
90.
Montgomery LD, Gerth WA, Montgomery RW, Lew SQ, Klein MM, Stewart
JM, et al. Monitoring Intracellular, Interstitial, and Intravascular Volume Changes
During Fluid Management Procedures. Med Biol Eng Comput. 2013;51(10):116775.
91.
Alizadehkhaiyat O, Hawkes DH, Kemp GJ, Howard A, Frostick SP. Muscle
Strength and Its Relationship with Skeletal Muscle Mass Indices as Determined by
Segmental Bio-Impedance Analysis. Eur J Appl Physiol. 2014;114:177–85.
92.
Shizgal H. Nutritional Assessment with Body Composition Measurements by
Multiple Isotpoe Dilution. Infusions Therapie. 1990;17(3):9-17.
93.
Coffman FD, Cohen S. Impedance Measurements in the Biomedical
Sciences. Stud Health Technol Inform. 2013;185:185-205.
94.
Swisher SL, Lin MC, Liao A, Leeflang EJ, Khan Y, Pavinatto FJ, et al.
Impedance Sensing Device Enables Early Detection of Pressure Ulcers in Vivo. Nat
Commun. 2015;6:6575.
95.
Kotanko P, Levin NW, Zhu F. Current State of Bioimpedance Technologies
in Dialysis. Nephrol Dial Transplant. 2008;23(3):808-12.
96.
Kyle U, Bosaues I, De Lorenzo A, Durenberg P, Elia M, Gomez JM, et al.
Bioelectrical Impedance Analysis-Part I: Review of Principles and Methods. Clinical
Nutrition. 2004;23:1226-43.
97.
Lukaski H. Evolution of Bioimpedance: A Circuitous Journey from
Estimation of Physiological Function to Assessment of Body Composition and a
Return to Clinical Research. Eur J Clin Nutr. 2013;67:S2-S9.
98.
Boron W, Boulpaep E. Medical Physiology. 2 ed. Sciences EH, editor:
Elsevie; 2008.

72

99.
Cox-Reijven P, Soeters P. Validation of Bio-Impedance Spectroscopy:
Effects of Degree of Obesity and Ways of Calculating Volumes from Measured
Resistance Values. International Journal of Obesity. 2000;24:271-80.
100. Lukaski HC, Singer MG. Phase Angle as a Prognostic Indicator in Cancer.
Computational Physiology. 2011;SS-11-04:37-9.
101. Kumar S, Dutt A, Hemraj S, Bhat S, Manipadybhima B. Phase Angle
Measurement in Healthy Human Subjects through Bio-Impedance Analysis. Iran J
Basic Med Sci. 2012;15(6):1180-4.
102. Matthie JR. Bioimpedance Measurements of Human Body Composition:
Critical Analysis and Outlook. Expert Rev Med Devices. 2008;5(2):239-61.
103. Gudivaka R, Schoeller DA, Kushner RF, Bolt MJG. Single and
Multifrequency Models for Bioelectrical Impedance Analysis of Body Water
Compartments. J. Appl. Physiol. 1999;87(3):1087-96.
104. Kyle U, Bosaues I, De Lorenzo A, Durenberg P, Elia M, Gomez JM, et al.
Bioelectrical Impedance Analysis - Part Ii: Review of Principles and Methods.
Clinical Nutrition. 2004a;23:1226-43.
105. Earthman CP, Matthie JR, Reid PM, Harper IT, Ravussin E, WH. H.
Bioimpedance Spectroscopy for Clinical Assessment of Fluid Distribution and Body
Cell Mass. Nutrition in clinical practice. 2007;22(4):389-405.
106. Cole K, Li C, Bak A. Electrical Analogues for Tissues. Exp Neuro.
1969;24:459-73.
107. Mulasi U, Kuchnia A, Cole A, Earthman C. Bioimpedance at the Bedside:
Current Applications, Limitations, and Opportunities. Nutrition in clinical practice.
2015;20(10):1-14.
108. Mialich MS, Sicchieri JMF, Junior AAJ. Analysis of Body Composition- a
Critical Review of the Use of Bioelectrical Impedance Analysis. International
Journal of Clinical Nutrition. 2014;2(1):1-10.
109. Cox-Reijven, M. PL, Bernard van K, Soeters PB. Accuracy in Bioelectrical
Impedance Spectroscopy in Measuring Changes in Body Composition During Severe
Weight Loss. JPEN, Journal of Parenteral and Enteral Nutrition. 2002;26(2):120-7.
110. Janssen I, Heymsfield SB, Ross R. Low Relative Skeletal Muscle Mass
(Sarcopenia) in Older Persons Is Associated with Functional Impairment and
Physical Disability. J Am Geriatr Soc. 2002;50(5):889-96.
111. Cornish BH, Jacobs A, Thomas BJ, Ward LC. Optimizing Electrode Sites for
Segmental Bioimpedance Measurements. Physiol Meas. 1999;20(3):241-50.
112. Cornish BH, Jacobs A, Thomas BJ, Ward LC. Optimizing Electrode Sites for
Segmental Bioimpedance Measurements. Physiological Measures. 1999;20(3):24150.
113. Codognotto M, Piazza M, Frigatti P, Piccoli A. Influence of Localized Edema
on Whole-Body and Segmental Bioelectrical Impedance. Nutrition. 2008;24(6):56974.
114. Ward L, Winall A, Isenring E, Hills A, Czerniec S, Dylke E, et al.
Assessment of Bilateral Limb Lymphedema by Bioelectrical Impedance
Spectroscopy. Int J Gynecol Cancer. 2011;21:409-18.
115. Nescolarde L, Yanguas J, Lukaski H, Alomar X, Rosell-Ferrer J, Rodas G.
Localized Bioimpedance to Assess Muscle Injury. Physiological Measures.
2013;34:237-45.
116. Wagner DR, Jeter KF, Tintle T, Martin MS, Long JM, 3rd. Bioelectrical
Impedance as a Discriminator of Pressure Ulcer Risk. Adv Wound Care.
1996;9(2):30-7.

73

117. Zhu F, Sarkar S, Kaitwatcharachai C, Greenwood R, Ronco C, Levin NW.
Methods and Reproducibility of Measurement of Resistivity in the Calf Using
Regional Bioimpedance Analysis. Blood Purif. 2003;21(1):131-6.
118. Grimnes S, Martinsen O. Bioimpedence and Bioelectricity Basics2008. 190
p.
119. Gaw R, Box R, Cornish BH. Bioimpedance in the Assessment of Unilateral
Lymphedema of a Limb: The Optimal Frequency. Lymphatic Research And Biology.
2011;9(2):93-9.
120. Azzopardi EA, McWilliams B, Iyer S, Whitaker IS. Fluid Resuscitation in
Adults with Severe Burns at Risk of Secondary Abdominal Compartment Syndrome-an Evidence Based Systematic Review. Burns. 2009;35(7):911-20.
121. Thiele RH, Bartels K, Gan TJ. Inter-Device Differences in Monitoring for
Goal-Directed Fluid Therapy. Can J Anaesth. 2015;62(2):169-81.
122. Ernstbrunner M, Kostner L, Kimberger O, Wabel P, M S, Markstallar K, et
al. Bioimpedance Spectroscopy for Assessment of Volume Status in Patients before
and after General Anaesthesia. PLOS One. 2014;9(10).
123. Plank L, Monk D, Woollard G, Hill G. Evaluation of Multifrequency
Bioimpedance Spectroscopy for Measurement of the Extracellular Water Space in
Critically Ill Patients. . Appl Radiat Isot. 1998;49:481-83.
124. Slotwinski R, Saragat B, Cabras S, Rinaldi A, Marini E. Raw Impedance
Data Analysis in Severe Ill Patients with Sepsis. Fluids. 2013;2:168-70.
125. Tattersall J. Bioimpedance Analysis in Dialysis: State of the Art and What
We Can Expect. Blood Purif. 2009;27(1):70-4.
126. Raimann JG, Zhu F, Wang J, Thijssen S, Kuhlmann MK, Kotanko P, et al.
Comparison of Fluid Volume Estimates in Chronic Hemodialysis Patients by
Bioimpedance, Direct Isotopic, and Dilution Methods. Kidney Int. 2014;85(4):898908.
127. Leigh Ward, Ann Winall, Elizabeth Isenring, Andrew Hills, Sharon Czerniec,
Elizabeth Dylke, et al. Assessment of Bilateral Limb Lymphedema by Bioelectrical
Impedance Spectroscopy. Int J Gynecol Cancer. 2011;21:409-18.
128. Ward LC. Bioelectrical Impedance Analysis: Proven Utility in Lymphedema
Risk Assessment and Therapeutic Monitoring. LYMPHATIC RESEARCH AND
BIOLOGY. 2006;4(1):51-6.
129. Pichonnaz C, Bassin J-P, Lécureux E, Currat D, Jolles BM. Bioimpedance
Spectroscopy for Swelling Evaluation Following Total Knee Arthroplasty: A
Validation Study. BMC Musculoskeletal Disorders. 2015;16(100):1-8.
130. Lukaski H, Moore M. Bioelectrical Impedance Assessment of Wound
Healing. Journal of Diabetes Science and Technology. 2012;6(1):209-12.
131. Williams FN, Branski LK, Jeschke MG, Herndon DN. What, How, and How
Much Should Patients with Burns Be Fed? Surg Clin North Am. 2011;91(3):609-29.
132. Newsome TW, Mason AD J, Pruitt BA. J. Weight Loss Following Thermal
Injury. Ann Surg.;178(2):215-17.
133. Herndon D, Tompkins R. Support of the Metabolic Response to Burn Injury.
Lancet. 2004;June 5, 363(9424):1895-902.
134. Pichard C, Kyle UG, Morabia A, Perrier A, Vermeulen B, Unger P.
Nutritional Assessment: Lean Body Mass Depletion at Hospital Admission Is
Associated with an Increased Length of Stay. Am J Clin Nutr. 2004;79(4):613-8.
135. Moisey LL, Mourtzakis M, Cotton BA, Premji T, Heyland DK, Wade CE, et
al. Skeletal Muscle Predicts Ventilator-Free Days, Icu-Free Days, and Mortality in
Elderly Icu Patients. Crit Care. 2013;17(5):R206.

74

136. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain
VG, et al. Muscle Wasting Is Associated with Mortality in Patients with Cirrhosis.
Clin Gastroenterol Hepatol. 2012;10(2):166-73, 73.e1.
137. Kyle UG, Genton L, Pichard C. Low Phase Angle Determined by
Bioelectrical Impedance Analysis Is Associated with Malnutrition and Nutritional
Risk at Hospital Admission. Clin Nutr. 2013;32(2):294-9.
138. Lee RC, Wang ZM, Heymsfield SB. Skeletal Muscle Mass and Aging:
Regional and Whole-Body Measurement Methods. Can J Appl Physiol.
2001;26(1):102-22.
139. Heymsfield SB, McManus C, Stevens V, Smith J. Muscle Mass: Reliable
Indicator of Protein-Energy Malnutrition Severity and Outcome. Am J Clin Nutr.
1982;35(5 Suppl):1192-9.
140. Di Iorio B, Terracciano V, Bellizzi V. Total Body Water and Body Cell Mass
in Normal Weight Healthy Adults. The Nephron journals. 2000;86(4):531-3.
141. A’Beckett K, Baytieh L, Carr-Thompson A, Fox V, MacLennan P, Marriott
J, et al. Clinical Practice Guidelines Nutrition Burn Patient Management. Nsw
Statewide Burn Injury Service.2011; Version 3. Available from:
http://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0009/162639/SBIS_Nutritio
n_CPG_new_format.pdf.
142. Baxter CR, Shires T. Physiological Response to Crystalloid Resuscitation of
Severe Burns. Ann N Y Acad Sci. 1968;150(3):874-94.
143. Kyle UG, Kossovsky MP, Karsegard VL, Pichard C. Comparison of Tools
for Nutritional Assessment and Screening at Hospital Admission: A Population
Study. Clin Nutr. 2006;25(3):409-17.
144. Earthman C, Traughber D, Dobratz J, Howell W. Bioimpedance
Spectroscopy for Clinical Assessment of Fluid Distribution and Body Cell Mass.
Nutrition in clinical practice. 2007;22(4):389-405.
145. Lee Y, Kwon O, Shin CS, Lee SM. Use of Bioelectrical Impedance Analysis
for the Assessment of Nutritional Status in Critically Ill Patients. Clin Nutr Res.
2015;4(1):32-40.
146. Toso S, Piccoli A, Gusella M, Menon D, Bononi A, Crepaldi G, et al. Altered
Tissue Electric Properties in Lung Cancer Patients as Detected by Bioelectric
Impedance Vector Analysis. Nutrition. 2000;16(2):120-4.
147. Kyle UG, Genton L, Slosman DO, Pichard C. Fat-Free and Fat Mass
Percentiles in 5225 Healthy Subjects Aged 15 to 98 Years. Nutrition. 2001;17(78):534-41.
148. Norman K, Stobaus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele
R, et al. Cutoff Percentiles of Bioelectrical Phase Angle Predict Functionality,
Quality of Life, and Mortality in Patients with Cancer. Am J Clin Nutr.
2010;92(3):612-9.
149. Mika C, Herpertz-Dahlmann B, Heer M, Holtkamp K. Improvement of
Nutritional Status as Assessed by Multifrequency Bia During 15 Weeks of Refeeding
in Adolescent Girls with Anorexia Nervosa. J Nutr. 2004;134(11):3026-30.
150. Meireles MS, Wazlawik E, Bastos JL, Garcia MF. Comparison between
Nutritional Risk Tools and Parameters Derived from Bioelectrical Impedance
Analysis with Subjective Global Assessment. J Acad Nutr Diet. 2012;112(10):15439.
151. Holavanahalli RK, Helm PA, Kowalske KJ. Long-Term Outcomes in Patients
Surviving Large Burns: The Musculoskeletal System. J Burn Care Res. 2015.

75

152. Hart DW, Wolf SE, Mlcak R, Chinkes DL, Ramzy PI, Obeng MK, et al.
Persistence of Muscle Catabolism after Severe Burn. Surgery. 2000;128(2):312-9.
153. Mlcak RP, Jeschke MG, Barrow RE, Herndon DN. The Influence of Age and
Gender on Resting Energy Expenditure in Severely Burned Children. Ann Surg.
2006;244(1):121-30.
154. Roubenoff R, Grinspoon S, Skolnik PR, Tchetgen E, Abad L, Spiegelman D,
et al. Role of Cytokines and Testosterone in Regulating Lean Body Mass and Resting
Energy Expenditure in Hiv-Infected Men. American Journal of Physiology
Endocrinology and Metabolism. 2002;283(1):E138-45.
155. Roubenoff R. Sarcopenia and Its Implications for the Elderly. Eur J Clin
Nutr. 2000;54 Suppl 3:S40-7.
156. Gunn SM, Halbert JA, Giles LC, Stepien JM, Miller MD, Crotty M.
Bioelectrical Phase Angle Values in a Clinical Sample of Ambulatory Rehabilitation
Patients. Dyn Med. 2008;7:14.
157. Bartels EM, Sorensen ER, Harrison AP. Multi-Frequency Bioimpedance in
Human Muscle Assessment. Physiol Rep. 2015;3(4).
158. Weber-Lange B, Glöckl R, Winterkamp S, Behr J, K. Kenn (Schönau am
Königssee M, Germany)
editors. Bioimpedance Analysis (Bia) in Pre Lung
Transplantation (Pre-Ltx) Patients Undergoing Continuous (Ct) or Interval Training
(It). European Respiratory Society Annual Congress 2009; Vienna, Austria.
159. Ribeiro AS, Avelar A, Schoenfeld BJ, Ritti Dias RM, Altimari LR, Cyrino
ES. Resistance Training Promotes Increase in Intracellular Hydration in Men and
Women. Eur J Sport Sci. 2014;14(6):578-85.
160. Grisbrook TL, Elliott CM, Edgar DW, Wallman KE, Wood FM, Reid SL.
Burn-Injured Adults with Long Term Functional Impairments Demonstrate the Same
Response to Resistance Training as Uninjured Controls. Burns. 2013;39(4):680-6.
161. Stahn A, Terblanche E, Strobel G. Modeling Upper and Lower Limb Muscle
Volume by Bioelectrical Impedance Analysis. J Appl Physiol (1985).
2007;103(4):1428-35.
162. Birgersson U, Birgersson E, Aberg P, Nicander I, Ollmar S. Non-Invasive
Bioimpedance of Intact Skin: Mathematical Modeling and Experiments. Physiol
Meas. 2011;32(1):1-18.
163. Grisbrook TL, Kenworthy P, Phillips M, Wood FM, Edgar DW.
Nanaocrystalline Silver Dressings Influence Bioimpedance Spectroscopy
Measurements in Burns Patients. Burns. 2016.

76

Chapter 3 Addressing The Barriers To Bioimpedance
Spectroscopy Use In Major Burns:
Alternate Electrode Placement

This manuscript (Study 1) was accepted for publication in the Journal of Burn Care
and Research, in February 2017.
Kenworthy P, Grisbrook TL, Phillips M, Gibson W, Wood FM, Edgar DW.
Addressing the barriers to bioimpedance spectroscopy use in major burns: alternate
electrode placement. Journal of Burn Care and Research, 2017 Mar 15.
The PhD candidate, Pippa Kenworthy led the study and drafting of the manuscript
and completed the submission, accounting for ~85% of the intellectual property
associated with the final manuscript. Collectively the remaining authors contributed
15%.
Permission regarding copyright has been obtained from the publishers of this
manuscript (Appendix B).

Foreword

The first two studies in this thesis investigate the use of BIS in acute major burns.
They address the potential barriers to its use and the reliability and validity of BIS as
a measure of fluid shift. The following study firstly investigates potential barriers to
the use of BIS in acute major burns. Major acute burns, admitted to the BSWA, have
ActicoatTM (silver dressings) insitu and often have wounds at the site of BIS
standardised electrode placement rendering BIS unusable in this environment.
Alternative electrode positions have been investigated in healthy populations, but not
in the burns environment. Therefore, prior to determining BIS reliability and validity
in major burns and to enhance its clinical utility we investigated whether BIS
alternate electrode positions were a comparable alternative to standardised positions,
across

different

dressing

conditions,
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in

acute

major

burns.

3.1 Introduction
Bioimpedance spectroscopy (BIS) is a method of body composition analysis, which
allows the immediate assessment of the inter-compartmental fluid volumes such as
ECF, intracellular fluid (ICF) and total body fluid (TBF) and measures of cell health
and function (1). By applying a small alternating current via electrodes placed on
intact skin across a number of different frequencies, BIS measures the body’s 1)
resistance (opposition by a conductor) and 2) reactance (opposition by a capacitor) to
the flow of an electrical current (2, 3). The frequency of the alternating current
determines whether it can penetrate the cell membrane and at low frequencies it
cannot (1). The BIS instrument uses a Cole-Cole (4) model to generate Cole model
terms including, resistance at zero frequency (R0) and at infinite frequency (Rinf),
which are representative of ECF and TBF respectively and Ri (associated with
intracellular fluid) (5). Fluid volumes (litres) are determined by applying the Cole
model terms to predictive mixture theory equations incorporated into the BIS
instrument (6).
The ability of BIS to measure real time fluid shifts non-invasively has led to numerous
studies investigating its evaluation in different clinical conditions with a small number
being conducted in the burns environment (7-10). In minor burns BIS is reliable and
able to measure the direction of oedema change using localised electrode placement in
any dressing condition (11). Grisbrook et al (2016) also showed whole body BIS can
measure resistance and fluid parameters in burns with a median TBSA of 15% in the
presence of ActicoatTM (Smith & Nephew, Australia) dressings, if the BIS variables
are adjusted for using their provided ActicoatTM BIS algorithm (12).
There are numerous challenges in the assessment of fluid shifts in patients with burns,
including (but not limited to) open wounds, dressings, reduced mobility plus ‘the need
to monitor small whole body fluid shifts on the background of large fluid resuscitative
volumes(10). On average, 23% of burn injuries in the State Burns Service of Western
Australia have either their hands or feet involved, thus preventing the standardised
positioning of electrodes (13). Tetrapolar electrode placement for whole body and
limb segmental BIS measures requires one current and one sense electrode 5cm apart
to be placed on the dorsum of both the hands and feet on intact skin (14). Cornish et al
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1999 suggests, based on the theory of equi-potentials (loci of points with the same
potential and are perpendicular to the flow of current), movement of electrodes
anterior, posterior or laterally will yield the same results as standard electrode
placements (15). Whether this is practically valid is yet unknown. However, others
have reported movement of electrodes proximally by 1cm and 2 cm can result in a
change of mean resistance values by 2% and 4% respectively (16).
Dressings also need to be considered when using BIS. Moderate to large burns
patients have an ActicoatTM dressing insitu in the first 48 hours of burn care, the
standard dressing used in the Burns Service of Western Australia. The dressings are in
place at all times except when they are having a dressing change and shower. Thus, it
is necessary to understand if standard and alternate electrode positions are comparable
with dressings insitu.
The aims of this study were therefore to determine whether alternate electrode
configurations for whole body and limb segmental BIS outputs are comparable to
standardised electrode configurations in moderate to large size burns across different
dressing conditions.

3.2 Methods
3.2.1

Participants

A longitudinal, prospective, single service study was conducted between December
2014 and February 2016. Patients admitted with an acute burn requiring formal fluid
resuscitation were recruited to the study within 48 hours of injury, providing they
were over eighteen years old and were able to provide written consent. They were
excluded if they had hand and/or feet burns preventing placement of electrodes.
Manufacturer’s contraindications also excluded pregnant or breast-feeding patients,
patients with surgical implants, cardiac pacemakers and/or on electronic life support
devices.
Patients were initially recruited from the inpatient Burns Unit at Royal Perth Hospital
(RPH) and then at Fiona Stanley Hospital (FSH) after the move of the Western
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Australian state Burn Service to the new facility. There was no change to the study
protocol, patient population or equipment used in the study.

3.2.2

Equipment

The ImpediMed SFB7 (ImpediMed, Brisbane, Queensland, Australia) was used to
collect whole body and segmental BIS measures.
The equipment applies 256 discrete current frequencies (4-1000 Hz) to interpret each
measurement. BIS computes raw variables (resistance, reactance) and derived fluid
distribution values such as whole body ECF, ICF, and TBF using manufacturer’s
algorithms. Extra and intracellular fluids behave as resistive ® components and R is
inversely proportional to fluid volume and therefore swelling (ECF) (5, 17).
Readily available ECG electrodes (Kendall CA610 diagnostic tab electrodes reference code 31447793, Covidien, Mansfield, MA, USA) were utilised.

3.2.3

Data Collection

Bioimpedance triplicate measures, with one second intervals between each measure,
were taken in two dressing conditions 1) no dressing or an open wound, and 2) new
ActicoatTM dressing. BIS measures were taken within 5 minutes of the dressing being
applied. The time between the open wound and new ActicoatTM dressing was recorded
as this was unable to be standardised. The patient’s weight and height, measured prior
to the electrode placement, age and gender were input into the Impedimed instrument.
All BIS measures were taken with the patient lying supine. Electrodes were placed
over cleaned, intact skin in standard and alternate electrode whole body and limb
segmental configurations unless precluded by wounds. If precluded by wounds that
particular electrode configuration was not utilised. Due to the nature and presentation
of moderate to large burns not all participants were able to have all electrode
configurations assessed. Where feasible the measures were taken on the right side of
the body unless precluded by wounds, then the left side was utilised. Electrodes
remained in place between triplicate measures of each dressing condition. The
researcher was blinded to the BIS measurements as only a file name was viewed and
recorded.
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3.2.4

Electrode Configurations

Standardised whole body and upper and lower limb segmental tetrapolar electrode
placements were utilised as well as an alternative placement for each. Alternate
electrode placements were used as burn wounds often preclude the placement in
standardised positions and were determined based on the theory of equi-potentials (see
Cornish et al (1999) for further explanation of equipotential points)(15). The different
electrode configurations and actual placements were as follows (see Figure 3.1):
1) WBS: whole body standard tetrapolar placement
2) WBA: whole body alternate tetrapolar placement. Hand electrodes were placed on
the volar surface of the hand and wrist, reflecting the standardised positions at the
head of the third metacarpal and at the distal radio-ulnar joint. The foot electrodes
were placed on the sole of the foot at the third metatarsophalangeal joint and anterior
to the lateral aspect of the Achilles heel in line with the standard position.
3) ULS: upper limb standard tetrapolar placement. The right hand electrodes are as
per the whole body standard tetrapolar placement, at the head of the third metacarpal
and at the distal radio-ulnar joint on the dorsal surface. The left hand electrode was
placed on the dorsal aspect of the distal radio-ulnar joint. The foot electrode was
placed at the third metatarsophalangeal joint on the dorsal surface. As per Cornish,
Jacobs et al.’s (1999) protocol (18).
4) ULA: upper limb alternate tetrapolar placement. The right side hand electrode
placement was as per whole body alternate and the foot and left hand electrode
placement remained in the standard position.
5) LLS: lower limb standard tetrapolar placement. The right hand electrode was
placed at the head of the third metacarpal dorsally. The right foot electrode
placements were at the third metatarsophalangeal joint and talocrural joint on the
dorsal surface. The left foot electrode was placed at the dorsal talocrural joint. As per
Cornish, Jacobs et al.’s (1999) protocol(15)
6) LLA: lower limb alternate tetrapolar placement. The right side foot electrode
placement was as per whole body alternate and the left foot and hand electrode
placement remained in the standard position.
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Figure 3.1: Electrode placement sites used for whole body, upper limb
and lower limb BIS.

3.2.5

Ethics

This study was approved by the RPH Human Research Ethics Committee (EC
2011/028), and FSH (2014 106) Research Governance Committee and The University
of Notre Dame, Australia Human Research Ethics Committee (014139F).

3.2.6

Statistical Analysis

All results were analysed using Stata statistical software, release 14 (StataCorp LP
2014, College Station, TX). Descriptive analyses were performed and are reported
using the means and standard deviations (SD).
All BIS triplicate measures were used in the analysis. Multi-level mixed effects
(MLME) linear regression was therefore utilised to determine whether electrode
placement significantly affected the BIS variables. Whole body measurements had a
separate model fitted for each of the raw variables R0, Ri, Rinf and calculated values
(ECF, ICF, TBF). Segmental measures only had models fitted for each of the raw
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variables, as the BIS algorithm is not applicable for segmental volume calculations.
The MLME accounts for confounding variables thus limiting bias and it assumes that
each variable in the regression is approximately normally distributed. To determine
whether the whole body, upper and lower limb alternate electrode positions, in each
dressing condition, were a valid measure of BIS variables a χ2 post-estimation test was
performed. It is a comparison of the difference of means as estimated by the
regression coefficients determined by MLME linear regression. Results are reported
as χ2 statistic and a p-value of <0.05 was deemed significant for all analysis. The
percentage difference between the alternate and standard electrode position was also
calculated, in each dressing condition, whereby each BIS variable from the alternate
electrode positions were expressed as a percentage change of the value obtained from
the standard site. This assists with clinical application and meaning of the estimated
BIS values. A percentage difference of greater than five percent was deemed clinically
significant. There appears to be little consensus on an acceptable level of error in fluid
assessment and monitoring clinically. Earthmann et al (2007) suggests a five percent
error is tolerable (19).

3.3 Results
In line with the planned study timeframe and university milestones, the patient
recruitment period was between December 2014 and February 2016. Twenty one
patients were recruited on average 25 (SD = 11) hours post burn injury. There were
two patients with burns < 15% TBSA who were fluid resuscitated were burnt while
intoxicated and were considered clinically dehydrated. The final number of patients
included in each electrode placement was: WBS (n=21), WBA (n=18), ULS (n=14),
ULA (n=14), LLS (n=15), LLA (n=14). Other patient data is presented in Table 1.
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Table 3.1: Patient data. Presented as means (standard deviations) ±
range
%TBSA

Age (years)

Height (cm)

Weight (kg)

Time between open
wound & new dressing
(minutes)

24 (13)

36 (13)

172.2 (38.4)

77.4 (16.3)

66. 7 (31)

range 12-80

range 18-63

The means and confidence intervals for each of the BIS variables by electrode
placement and dressing condition and the percentage difference between the alternate
and standard electrode positions are presented in Table 3.1. The percentage difference
between the alternate and standard electrode positions show a large variation across
the variables (Table 3.2).
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Table 3.2: Estimated BIS variable values for each electrode placement
and dressing condition. Values presented as means (95%
confidence intervals).
BIS

Dressing

Variable

Condition

R0
(ohms)

Open

Electrode Placement
WBS

WBA

ULS

ULA

LLS

LLA

498.77
(467.17530.37)

483.97
(451.79516.15)
-2.97*

230.96
(196.89265.03

231.79
(197.71265.86)
0.36*

268.77
(235.22302.33)

254.69
(220.61288.77)
-5.3

351.94
(295.56408.32)

338.58
(281.33395.83)
-3.80*

197.32
(134.23260.40)

164.18
(103.24225.12)
-16.79

205.01
(145.75264.27)

194.18
(134.14254.21)
-5.30

1412.47
(1225.511599.42)

1353.01
(1164.261541.76
-4.21*
679.88
(468.59891.17)
-5.02

660.29
(465.29855.29)

644.85
(449.83839.87
-2.34*
355.05
(137.63572.46)
-19.25

791.23
(597.91984.55)

722.00
(526.99917.05)
-8.75
425.37
(209.46641.28)
-14.51

361.89
(337.57386.20)

348.61
(324.02373.20)
-4.67*

164.81
(139.28190.35)

161.28
(135.74186.81)
-2.15*

196.77
(171.49222.05)

183.76
(158.22209.29)
-6.62

226.58
(183.50269.67)

216.81
(173.16260.46)
-4.32*

128.06
(80.55175.57)

102.0139
(55.92148.10)
-20.34

135.01
(90.03179.99)

122.57
(77.08168.07)
-6.62

20.76
(17.5623.97)

21.05
(17.8024.29)
1.40*

-

-

-

-

34.77
(14.0055.54)

35.54
(13.8357.25)
2.21*
26.71
(23.0330.40)
5.74

-

-

-

-

-

-

-

-

48.47
(27.7469.21)

51.32
(29.8372.82)
5.88

-

-

-

-

46.03
(39.6752.38)

47.77
(41.3654.19)
3.78*
86.66
(44.96128.37
4.21*

-

-

-

-

-

-

-

-

%difference
ActicoatTM

%difference
Ri
(ohms)

Open

%difference
ActicoatTM

715.75
(505.83925.68)

%difference
Rinf
(ohms)

Open

%difference
ActicoatTM

%difference
ECF (L)

Open

%difference
ActicoatTM

ICF (L)

%difference
Open

25.26
(21.6228.91)

%difference
ActicoatTM

%difference
TBF (L)

Open

%difference
ActicoatTM

83.16
(43.11123.20)

%difference

439.66
(218.64660.68)

497.52
(282.90712.14)

R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf =resistance at infinite frequency, ECF = extracellular fluid, ICF =
intracellular fluid, TBF = total body fluid, open = open wound, ActicoatTM = ActicoatTM and betadine compress dressing. %
difference = % difference between alternate and standard electrode positions. * <5% in % difference. Electrode positions: WBS whole body standard, WBA – whole body alternate, ULS - upper limb standard, ULA - upper limb alternate, LLS – lower limb
standard, LLA – lower limb alternate.
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The results of the post-estimation test analysis, χ2, are shown in Table 3.3. The results
show there is no statistically significant differences in the means of the BIS variables
when comparing the standard and alternate electrode placements for the whole body,
upper limb or lower limb segments (p = 0.097-0.96). This is true for any dressing
condition.

Table 3.3: Difference in means comparison of standard and alternate
electrode placement, in different dressing conditions for
each of the BIS variables. Data presented as χ 2 (p-value).
Electrode

Dressing

placement

Condition

Whole Body

R0 (ohms)

Ri (ohms)

Rinf (ohms)

ECF (L)

ICF (L)

TBF (L)

Open

1.28 (0.258)

1.10 (0.295)

2.76 (0.097)

0.06 (0.804)

1.59 (0.208)

0.88 (0.346)

TM

Acticoat
Upper Limb

0.40 (0.526)

0.49 (0.484)

0.44 (0.511)
0.49 (0.484)
0.004 (0.95)

0.06 (0.810)

0.02 (0.885)

Open

0.00 (0.96)

0.06 (0.81)

0.15 (0.699)

-

-

-

TM

1.61 (0.20)

1.79 (0.18)

2.00 (0.16)

Open

0.91 (0.34)

1.18 (0.28)

2.10 (0.15)

-

-

-

ActicoatTM

0.21 (0.65)

1.58 (0.21)

0.55 (0.46)

Acticoat
Lower Limb

Table 3.4: BIS measures in standard and alternate electrode
placements in the healthy population.
BIS
Variable

Electrode Placement

WBS

WBA

ULS

ULA

LLS

LLA

R0 (ohms)

619.32

697.33

314.2

313.14

275.05

265.53

Ri (ohms)

1458.41

1388.82

797.35

816.89

656.60

587.72

Rinf (ohms)

428.19

416.61

220.68

221.43

191.62

180.55

ECF (L)

17.45

17.69

ICF (L)

24.27

24.84

TBF (L)

41.72

42.53

R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf =resistance at infinite frequency, ECF
= extracellular fluid, ICF = intracellular fluid, TBF = total body fluid. Electrode positions: WBS whole body standard, WBA – whole body alternate, ULS - upper limb standard, ULA - upper limb
alternate, LLS – lower limb standard, LLA – lower limb alternate.
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3.4 Discussion
The results of this study demonstrate alternate whole body electrode placements
(WBA) measure all resistances and generate ECF and TBF BIS variables comparable
to whole body standardised placements (WBS) in burns greater than 12% TBSA
within dressing conditions. Upper limb alternate segmental electrode placement also
provides comparable BIS variable outputs with an open wound but not with an
ActicoatTM dressing.
Even though no statistical significant difference was found between standard and
alternate electrode placements for all BIS variables, suggesting they are not different,
consideration needs to be given to i) the percentage change between the two
conditions and ii) the difference between the measured resistances and fluid volumes
to determine clinically, if these differences are important. Each of these values needs
to be considered in conjunction with one another, as there is the potential for volume
over or understatement of up to 3.50L for TBF. A five percent difference was
considered a clinically appropriate range for resistance and fluid volumes in the burns
resuscitation environment. This could be in the order of ±1.25 L in an individual with
25 L of ICF, for example. This level was determined after considering the available
literature and the need for maintenance of the intravascular volume with limited
expansion of the extracellular volume in the burn resuscitation period. A volume
change greater than 200 ml or a bioimpedance resistance ratio percentage change of
greater than 10% is a suggested cut-off to identify secondary upper limb
lymphoedema (20). In surgical gynaecological patients postoperative fluid overload
was defined as being greater than 15% change in extracellular fluid (ECF) volume
(determined by bioimpedance) from peri operative volumes (21).
Whole body electrode placements have a percentage change from WBS to WBA
electrode placement for all BIS variables, except ICF, less than 5.02% in both
dressing conditions. For R0 and ECF (representative of oedema) the percentage
difference between WBS and WBA electrode placement is ≤ 2.97% with an open
wound and ≤ 3.80% with an ActicoatTM dressing. These percentage differences are
consistent with typical daily biological, intra-individual, within session variations,
with multifrequency BIS, which ranges from 0.3-3% (as per manufacturers
specifications) and up to 4% as reported by Kushner et al (22). Recently Pichonnaz et

87

al (2015) reported variations in some BIS variables below 5.6 %, may be considered
measurement error (23). The actual estimated difference in R0 and ECF between WBS
and WBA electrode placements was -14.48 ohms and 245 ml in an open wound and 13.36 ohms and 770 ml in the ActicoatTM dressing condition. Clinically, these may be
considered acceptable changes in the acute burns resuscitation environment where
rapid fluid shifts are occurring on the background of large resuscitation volumes e.g
13 354 ml (± 7386 ml) over 24 hours (24). This is in the realm of 500 ml of
resuscitation fluid per hour. In gynaecological surgical cases an administered
preoperative IV fluid volume of 1.9 L over 154 minutes resulted in an increase in ECF
of 0.8 L (± 0.8 L), TBF of 1 L (± 1.4 L) and a stable ICF as measured by BIS (21). For
TBF the volume difference between WBS and WBA were 1.74 L and 3.50 L for an
open wound (no dressing) and ActicoatTM dressing condition respectively. These
values are less than a five percent difference, however a change from 1.74 L to 3.50 L
between standard and alternate electrode placement in the ActicoatTM condition is too
large to be acceptable, potentially causing a patient to be under-resuscitated if
alternate electrode positions were used. This suggests alternate electrode positions
cannot be relied upon in the ActicoatTM condition to monitor TBF volumes. In
contrast, Rinf the equivalent raw variable of TBF, mean difference is 13.28 ohms in an
open wound and 9.77 ohms in an ActicoatTM dressing. These are considered
acceptable when the mean Rinf is 348-361 ohms and 216-226 ohms in the respective
dressing conditions.
Although there was no statistically significant difference between whole body
standard and alternate electrode placement for ICF the percentage difference was
5.74% and 5.88%, with the greatest change in the ActicoatTM dressing condition. This
is above the normal biological variation range, accepted 5 percent error and in the
order of 1.45 L and 2.85 L difference in volume between WBS and WBA for the open
wound and ActicoatTM dressing condition respectively. This variation is considered
too great to be used clinically, as it could lead to under or over resuscitation of a
patient. Yet the corresponding resistance (Ri) percentage difference was 57.66 ohms
and 34.51 ohms respectively. These values are less than 5.02% difference and also
considered insignificant on the background of whole body Ri values of 1350-1412
ohms (open wound) and 680-715 ohms (ActicoatTM). The WBA electrode placement
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was the same utilised in Grisbrook et al’s (2015) study (25). However, they found all
BIS fluid volumes to be significantly overestimated in healthy individuals.
Whole body alternate electrode positions are comparable to that of the standard
positioning for measuring BIS resistance variables, ECF and TBF (within the
specified dressing conditions) but not ICF. Clinically, whole body BIS resistance
values can be used to monitor changes in inter-compartmental fluid volumes and this
is supported in the literature. Ward et al (2006) reported raw resistance values could
be used as a surrogate index of volume due to their inverse relationship (26). It has
also been suggested in the literature that raw BIS data may prove to be more clinically
useful as it removes the need for predictive equations (27). Further support for the use
of whole body BIS in daily monitoring of fluid volumes is the comparison of our BIS
measures to normative values (Figure 3.4) (25). This study utilised the same alternate
electrode placement as Grisbrook et al (2015). Considering the average time post burn
was 25 hours, with a potential fluid resuscitation volume of up to ~ four litres over
this period the results of the BIS measures seem reasonable. i.e the difference in
standard BIS fluid volume measures between burns and healthy populations are ECF
3.31 L, ICF 0.99 L, TBF 4.31 L (Table 3.4). The validity of BIS in its ability to
measure fluid inter-compartmental volumes in major burns however is yet to be
determined. Future research should therefore explore this.
In the upper limb electrode positions however, there were large percentage differences
(range 16.79-20.34%) in the ActicoatTM dressing condition compared to an open
wound (range 0.36-2.34%). There was however no statistical significance difference
found between ULS and ULA electrode placements in χ2 test (p = 0.16-0.2) of the
mean BIS values for each dressing condition. Upper limb alternate electrode
placement can be utilised if wounds preclude the use of standard placements in the
open wound as they give comparable measures. However, the large mean percentage
change between ULS and ULA with ActicoatTM insitu does not support the use of
ULA in this dressing condition. Grisbrook et al (2015) found placement of electrodes
on the ventral surface of the hand and wrist for upper limb segmental measures were
valid alternatives to the standard placement in the healthy population (no dressings
insitu) (25).
No statistically significant differences were found between the LLS and LLA
electrode placements, but they too also had higher than accepted intra-individual
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biological variations in their mean percentage differences of the resistance variables
(range 5.3 – 14.56%). Resistance at zero frequency had the lowest values (5.30% for
both an open wound and ActicoatTM dressing) with Ri having the greatest values. Such
large percentage differences render LLA electrode placement unsuitable to be used if
wounds preclude the placement of standardised lower limb electrode placements. This
again, is consistent with the findings of Grisbrook et al (2015) in terms of potential
clinical utility, although they found a statistical difference between LLS and LLA
electrode placements (25). Limb segmental BIS measures provide only raw resistance
variables, as they require a separate algorithm to calculate fluid volumes. The
segmental measures were included in this research to determine whether they are a
potential alternative to whole body BIS but further research is required for clinically
meaningful application.
A statistical significant difference was not found between any of the standard and
alternate electrode placements however the percentage difference was deemed
clinically significant for the aforementioned whole body fluid variables ICF, TBF and
all lower limb resistances with and without ActicoatTM, and all upper limb resistances
with ActicoatTM. This could be explained by the potential risk of type two error in the
study due to the relative small sample size in each electrode placement group (n=1418) i.e. failing to reject the null hypothesis that there is a difference between standard
and alternate electrode placement. Another possible reason for the larger differences
in the BIS variables, between standard and alternate positions in the ActicoatTM
dressing condition, is the age of the electrodes. The electrodes were kept in place
between the open and new dressing condition to reduce the risk of electrode mismatch
placement measurement error, which can be in the order of 4% (14). However, the
electrochemical properties of the electrodes change with time (28) and resistivity
decreases with moisture thus decreasing the resistance, however the magnitude of
influence is unknown (29, 30). Burns patients stress levels and skin temperature will
often increase during a dressing change and with dressings in place. The palms and
soles of the feet (location of alternate electrode positions) have the highest density of
sweat glands in the body (31). Therefore the resistance measured in the alternate
electrode placements, especially of the hand, may be further decreased, increasing the
percentage difference between BIS resistance values in the ActicoatTM dressing
compared to the open wound.
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3.4.1

Future Research

To make progress in the field new alternative electrode placements need to be
investigated to ascertain whether they are comparable to standardised placement for
all BIS variable outputs. It is evident the ActicoatTM exaggerates the differences
between the standard and alternate electrode positions but also between the open
wound and ActicoatTM dressing condition. Future studies should therefore examine
alternate electrode placements in the ActicoatTM condition. An ActicoatTM BIS
calculator to adjust for the ActicoatTM effect in moderate to large burns (unpublished
data) is currently being developed. To further enhance the clinical applicability of BIS
in burns, studies investigating alternate electrode placements in other dressing
conditions are also warranted.

3.5 Conclusion
This study determined whole body alternate electrode placements are a feasible
alternative when wounds preclude the use of standardised placement for monitoring
R0, Ri, Rinf and ECF within dressing conditions in burns >12% TBSA. Further
research is required to establish the best alternate electrode placements to measure all
BIS variables in moderate to large burns.
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Foreword

The preceding study determined whole body and upper limb segmental resistance
variables and whole body ECF and TBF volumes only in alternate electrode
positions were interchangeable with standardised positions in specified dressing
conditions. Hence providing a substitute when wounds preclude standardised
electrode placement to enable monitoring of fluid volume change in acute major
burns. Following on, applying these findings, the next study investigated the
reliability and validity of BIS as a measure of fluid shifts in acute major burns, and
the impact of dressings on BIS measures. Bioimpedance spectroscopy has been
shown to be sensitive measure of oedema volume change in large burns. It is reliable
in burns less than 30% TBSA across different dressing conditions but it is yet to be
validated as a method of fluid shift over time in moderate to large burns. ActicoatTM,
a nanocrystalline silver dressing used in the first 48 hours of care in the BSWA, has
been demonstrated to effect BIS measures in burns not receiving fluid resuscitation
however the effect on those receiving fluid resuscitation is not known.
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4.1 Introduction
Large fluid shifts and local and distant tissue swelling are features of burn injuries.
Swelling hampers burn wound healing and the volume created is directly related to
the size and depth of the burn (1). Major burns greater than 15-20% total body
surface area (TBSA) with a depth of partial to full thickness result in both a local and
systemic inflammatory response (2, 3). This can be a life threatening scenario which
requires formal fluid resuscitation. Acute burn fluid resuscitation is vital in
decreasing patient morbidity and mortality in the first 24-48 hours of injury but can
contribute to already large amounts of oedema (4).
Despite the importance of fluid resuscitation in the early management of traumatic
burn injuries, there is currently no single, simple, non-invasive and accurate outcome
measure which can assist clinicians to titrate fluid volumes in acute burns or monitor
the effect of treatments on swelling. Thus, the objective, timely adjustment of fluid
resuscitation is challenging, particularly when patients are not supported by critical
care and invasive monitoring. This research investigates the accuracy of
bioimpedance spectroscopy (BIS) in monitoring whole body fluid volume and
oedema change in moderate to large acute burns.
There has been little advancement in the area of burn fluid resuscitation over the last
30 years (4) and in recent times there has been a trend to over resuscitate patients (5,
6), necessitating a descriptor known as fluid creep. Excess fluid can contribute to
burn wound progression, lead to complications such as peripheral and abdominal
compartment syndromes, pulmonary oedema and peripheral tissue oedema. Any one
or a combination of these will affect patient recovery, increase medical costs and is
likely to increase patient length of stay (3, 7-10).
Fluid resuscitation formulas such as the Parkland and Brookes are used to instigate
intravenous (IV) fluid rates but are guidelines only and fluid must then be titrated
according to particular endpoints of resuscitation (11-13). The most commonly used
outcome measure for fluid therapy is urine output, with the aim to maintain a rate of
30-50ml per hour for an average sized man while preserving haemodynamic
properties such as oxygen saturation and blood pressure (5, 14). There are other
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objective measures to guide volume titration however they are invasive and not
without limitations (6, 14, 15). oedema
Bioimpedance spectroscopy has historically been used in healthy populations to
measure body composition. However in the last 20 years it has gained increasing
popularity in clinical populations and is now commonly used to measure arm
lymphoedema post breast surgery (16) and dry weight in haemodialysis patients (17,
18). Bioimpedance spectroscopy has demonstrated sensitivity, high reliability
(repeatability) of measures in a number of clinical areas (19). The method has also
been validated (determined credible) in both healthy and clinical populations against
MRI and bromide and potassium dilution techniques, which are considered gold
standard in the assessment of fluid compartment volumes and lean body mass (LBM)
(20-23). It can investigate the body’s physiological parameters such as extracellular
fluid (ECF), intracellular fluid (ICF) and total body fluid (TBF). It achieves this by
passing a small alternating current, over a number of frequencies (4-1000 kHz),
through the tissues and fluid compartments of the body via electrodes on intact skin.
It provides instantaneous measures of resistance (R) and reactance (capacitive
resistance (Xc)). Resistance is the opposition to flow of an electric current, is
reflective of the body’s water compartments and is inversely proportional to fluid
volume and therefore oedema (24, 25). Capacitance is the delay in the passage of
current through the cell membranes and tissue interfaces (25). The current flow is
frequency (Hz) dependent and varies according to the composition of the body (26).
Resistances at zero and infinite frequencies (considered ideal measurement
frequencies) are estimated utilising the Cole-Cole plot embedded in the BIS
software, due the constraints of using a direct or very high frequency alternating
current in humans (27). The resistance at zero (R0) and infinite (Rinf) frequencies (25)
are representative of extracellular fluid (ECF) and total body fluid (TBF)
respectively. Resistance (Ri) of the intracellular fluid (ICF) is extrapolated using the
other raw variable data. At low frequencies the current can penetrate the ECF only
and at high frequencies it passes through both the ECF and ICF measuring TBF.
The ability of BIS to quantify individual body fluid compartments, the ease of use
and non-invasive nature has led to a small number of papers examining its use in the
burn population. Miller et al (1999) and Zdolsek et al (1998) were able to determine
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the development of oedema post burn injury but each study lacked power and neither
was able to provide statistical conclusions regarding the reliability of BIS in the
burns populace. In 2009 Edgar et al demonstrated whole body bioimpedance
spectroscopy was a reliable means of quantifying real time oedema shifts in patients
with burns less than 30% TBSA across numerous dressing conditions (28). However
the study only had 6 participants with burns greater than 15% TBSA and was
therefore inconclusive in this subset of patients. Further each study utilised standard
whole body electrode positions only and it is unknown whether alternate electrode
positions, for both whole body and limb segmental BIS, are reliable in this particular
population. Grisbrook et al (2015) investigated whether alternate electrode
configuration BIS measurements were interchangeable with standard electrode
configurations in the healthy population but reliability was not determined (29). In
Edgar et al’s (2009) study it was also apparent the dressing condition affected the
sensitivity of the BIS results. Bioimpedance measures were found to be less sensitive
in older dressings (> 8 hours old) than in an open wound or new dressing condition.
Dressing-type may pose a further challenge in the assessment of fluid shifts by BIS.
ActicoatTM (Smith & Nephew) is an antimicrobial dressing, composed of
nanocrystalline silver particles (30). It is the standard dressing used in the first 48
hours of burn care, and as indicated after, in the Burn Service of Western Australia
(BSWA). Understanding that BIS measures the resistance of the body’s tissues and
inter-compartmental fluid volumes by introducing a low amplitude electrical current
into the body, it would not be unexpected that ActicoatTM may affect the BIS
measures. Silver is a highly conductive material, and such dressings release ionic
silver species and are applied in a wet condition. Both the silver ions and wet
condition would therefore be expected to reduce the BIS resistance measured, thus
potentially limiting the use of monitoring fluid shifts with BIS in acute burns
patients.
To extend Edgar et al’s (2009) reliability study and on the premise that BIS can
reliably quantify tissue fluid, it was hypothesized BIS would provide a method for
real time accurate measures of fluid shifts in the acute major burn. The study aimed
to a) examine the reliability with respect to dressing condition and electrode position,
b) investigate the influence of ActicoatTM on BIS variable outputs and c) determine
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the validity of whole body BIS to assess net fluid shift in the presence of moderate to
major burns, greater than 15% TBSA.

4.2 Methods
4.2.1

Participants

An observational longitudinal cohort study was conducted from December 2014 to
February 2016. Patients were recruited into the study if they were: over eighteen
years old, receiving formal fluid resuscitation had a flame and/or scald burn and the
injury was less than 48 hours old. The BSWA medical team instigates fluid
resuscitation for partial to deep thickness burns greater than 15% TBSA (modified
however based on each individuals clinical presentation and nutritional status at
admission) and uses Ringer’s Lactate (crystalloid) solution with volumes initially
determined by the modified Parkland’s formula. Fluid volumes were titrated to
maintain an adequate urine output of 0.5-1.0ml/kg/hr for the first 36-48 hours after
burn injury. Participants were excluded from the research if they had: hand and/or
feet burns precluding placement of standard whole body electrode placement, body
mass index (BMI) ≤ 15 and ≥ 40 kg/m2 (manufacturer’s guidelines) and if they met
Impedimed SFB7 (ImpediMed, Brisbane, Queensland, Australia) manufacturer’s
contraindications which includes pregnant or breast-feeding patients, patients with
surgical implants, cardiac pacemakers and/or are on electronic life support devices
(ventilated patients).
Burn inpatients were recruited initially from the Burn Unit at Royal Perth Hospital
(RPH) and then at Fiona Stanley Hospital (FSH) due to the transition of the adult
care of the BSWA to the new Fiona Stanley Hospital. There was no change to the
study protocol or equipment used in the study.

4.2.2

Equipment

The ImpediMed SFB7 was used to collect whole body and segmental BIS measures
(Figure 4.1). The calculated fluid volumes are stable when the subject’s BMI is > 15
kg/m2 (as per the manufacturer).
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The BIS equipment measures both raw resistance variables and derived fluid
distribution values such as whole body ECF, ICF, and TBF using manufacturer’s
algorithms. It achieves this by applying 256 discrete current frequencies (4-1000 Hz)
through the body. Extra and intracellular fluids behave as resistive (R) components
and R is inversely proportional to fluid volume (26, 31).
Diagnostic tab electrodes, Kendall CA610 (reference code 31447793, Covidien,
Mansfield, MA, USA), were utilised.

Figure 4.1: Bioimpedance spectroscopy: standard whole body
electrode positions

4.2.3

Procedures

Firstly, the patient’s weight and height was measured and input into the Impedimed
instrument along with their age and gender. All BIS measures were taken using
manufacturer’s recommended and standardised positions with the patient lying
supine and with arms and legs abducted away from the body. BIS electrodes were
placed over intact, cleaned skin (using alcohol swabs).
4.2.3.1

Electrode Configurations

Standardised tetrapolar electrode placements (EP) were utilised (25, 32) and alternate
electrode configurations were placed based on the theory of equi-potentials (see
Cornish et al (1999) for further details of equipotential points) (32) and were placed
as per Grisbrook et al (2015). Electrodes were placed on intact skin only. Participants
with bilateral hand or foot injuries which precluded the application of standardised
electrode placements were excluded. Bioimpedance measures were taken on the right
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side of the body unless precluded by wounds, then the left side was utilised. The
location of their wounds determined whether all other electrode placements
(segmental) could be used and measured.
BIS measures were taken in triplicate in an open wound (time point 0 (T0)) and in
the new ActicoatTM dressing condition at five (5) half hour intervals (T1-5) after the
baseline measure i.e. five measures in total (Figure 4.2). The time between T0 and
T1 was recorded, as this was unable to be standardised. Standard and alternate whole
body, upper limb segmental and lower limb segmental BIS measures were taken at at
T0-T1. Standard whole body EP’s only were utilised at T2-T5 (Figure 4.2). Burn
wounds often prevent electrodes being applied in the standard position, therefore
alternative whole body and limb segment electrode positions were utilised as able at
T0-T1 and their reliability investigated. The data to determine the validity of
alternate electrode placement has been analysed separately (33). The segmental
measures were included in the reliability analysis only. The effect of ActicoatTM on
whole body BIS results was determined from T0-T1 BIS readings. Electrodes
remained in situ between triplicate measures where possible, unless prohibited by
dressing changes or adhesive loss.
Net fluid shift was recorded between each time point (T1-5), in conjunction with the
BIS measures. Net fluid shift was calculated by subtracting urine output and other
bodily fluid output recorded (e.g. emesis) from fluid intake (IV and oral fluids and
food).
The researcher was blinded to all BIS measurements as only a file name was viewed
and recorded, not the actual BIS values.
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Excluded
n = 10
(n = 9 in ICU, n = 1 went
to surgery)

Screened
for eligibility
n = 31

Consented and included
n = 21

Time point 2-5
(30 min intervals)
ActicoatTM Dressing

Time point 1
New ActicoatTM
Dressing

Time point 0
No Dressing

BIS: standard and
alternate electrode
montage
Fluid Balance

BIS: standard and
alternate electrode
montage
Net fluid shift

BIS: standard whole body
electrode montage only
Net fluid shift

Figure 4.2: Consort Diagram-Flow diagram of data collection process

4.2.4

Ethics

This study was approved by RPH Ethics Committee (EC 2011/028), FSH Research
Governance Committee (2014 106) and The University of Notre Dame, Australia
Human Research Ethics Committee (014139F).

4.2.5

Data Analysis

Stata statistical software, release 14 (StataCorp LP 2014, College Station, TX), was
utilised to analyse all results. Descriptive analyses were performed and are reported
using the means and standard deviations (SD).
4.2.5.1

Reliability

A three level nested mixed effects linear regression was performed to examine the
reliability of the BIS triplicate measures, taking into account random effects of
confounders of electrode position, time and dressing condition. The multilevel mixed
effects (MLME) linear regression also explored whether there was a significant
within-session difference between the triplicate measures for each of the BIS
variables. Reliability is presented as the intra-class correlation coefficient (ICC)
(acceptable, 0.75-0.89, excellent ≥ 0.9) (34), variance indicated by 95% confidence
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intervals (CI) and systematic bias between within session trial measures (p < 0.05
considered significant). All BIS triplicate measures were used in the analysis.
Analysis was completed using the MLME model as it can account for random effects
from individuals and responses within individuals (35). It is a robust method
providing hierarchical analysis, adjusting for nested observations of measures for
each individual and gives the most precise and least biased estimates of treatment
effects. Prior to interpreting the results of the MLME, several assumptions were
evaluated, confirming that each variable in the regression was approximately
normally distributed.
4.2.5.2

Factors influencing BIS readings

The effect of dressing condition, %TBSA and initial TBF on the BIS whole body
variables only was determined by MLME linear regression. A separate model was
performed for each BIS variable. The interaction between ActicoatTM and %TBSA
and their influence on the BIS variables was also examined. The whole body
standard and alternate electrode placement BIS variable outputs were grouped
together for use in the analysis for the effect of ActicoatTM and %TBSA. Time point
0 (open wound) and TP1 (new ActicoatTM dressing) were used only.
4.2.5.3

Validity

Validity was determined using a series of MLME linear regression models including
the data with the ActicoatTM dressing condition only, and whole body standard
electrode placement (T1-T5) and alternate electrode placement (T1) only. The final
model was produced by completing step-wise, backward elimination of predictor
variables on each of the dependent BIS variables. The final model included %TBSA,
time, net fluid shift and initial TBF volume. Initial TBF volume was derived from the
mean of the TBF measured with an open wound using standard tetrapolar whole
body electrode placement as single frequency BIA has been shown to measure TBF
accurately in burns patients with no dressings (36). This provided a baseline total
body volume (L). A correlation matrix was performed to determine the relationship
between initial TBF, weight and height and the skewness-kurtosis test demonstrated
that they were each normally distributed.
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Change scores or calculated difference of the BIS variables between time points (e.g.
R0 at T2 - R0 at T1) were not used in the validity analysis, as the calculation of a
change score requires measurement of the outcome twice and in practice it is
proposed that it is more efficient to use a (single) change from baseline measurement
to derive outcomes. In addition by not analysing change (difference) data, the
additive effect of the random errors is potentially reduced (37).
4.2.5.4

Calculator

A calculator was developed to estimate the net fluid shift between consecutive BIS
measures, when an ActicoatTM dressing is in place. Algorithms, for calculation of
estimated fluid volumes were developed incorporating the significant and influential
variables (on BIS variables) from the MLME models.

4.3 Results
Twenty one patients, 7 females and 14 males, were recruited post burn injury. One
patient had an incomplete set of fluid recordings and 2 patients only had repeated
measures completed 4 times in the new ActicoatTM dressing condition. The mean net
fluid shift (SD) at each time point, separated by ~30 minutes for T1-T5, were as
follows, T1 174.72 ml (533.18), T2 189.15 ml (164.23), T3 204.00 ml (135.37), T4
141.48 (253.25) and T5 123.20 (114.33). The average time between T0 –T1 (SD)
was 67 minutes (31). The mean TBF (SD) of patients on initial assessment was 46.06
L (9.71). Other patient data are presented in Table 4.1.
Table 4.1: Patient data (n=21).
%TBSA

24 (13)

Age (years)

Recruitment
post burn
injury (hrs)

Height (cm)

Weight (kg)

36.4 (13.5)

25 (11)

172.2

77.4 (16.3)

Range 12-80
Values presented as means (SD) ± range
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4.3.1

Reliability

BIS triplicate measures were reliable within any electrode position, dressing
condition and over time. Table 4.2 presents that BIS was a reliable measure in all
circumstances, as confirmed by the ICC’s. There were no significant differences
between the estimated means of within session triplicate trial measures for each of
the BIS variables (ie no systematic bias) (Table 4.2). Final numbers included in each
EP analysis were WBS (n=21), WBA (n=18), ULS (n=14), ULA (n=14), LLS
(n=15), LLA (n=14).
Table 4.2: BIS Reliability
BIS
Variable

ICC (95% CI)

BIS trial
number*

BIS measure
p-value
Coefficient (95%
CI)
0.999 (0.999-0.999)
2
-0.07 (-0.68-0.54)
0.83
R0
3
-0.06 (-0.68-0.55)
0.84
0.999 (0.998-0.999)
2
0.41 (-1.90-2.71)
0.73
Ri
3
2.06 (-0.24-4.37)
0.80
0.9996(0.999-0.999)
2
0.01 (-0.30-0.32)
0.94
Rinf
3
0.07 (-0.24-0.38)
0.66
0.999 (0.998-0.999)
2
0.03 (-0.17-0.22)
0.78
ECF
3
0.12 (-0.07-0.32)
0.22
0.997 (0.996-0.998)
2
-0.12 (-0.46-0.22)
0.49
ICF
3
-0.26 (-0.61-0.08)
0.13
0.999 (0.999-0.999)
2
-0.09 (-0.38-0.20)
0.53
TBF
3
-0.14 (-0.43-0.15)
0.33
ICC = intraclass correlation coefficient, R0 = resistance at zero frequency, Ri = intracellular resistance,
Rinf =resistance at infinite frequency, ECF = extracellular fluid, ICF = intracellular fluid,
TBF = total body fluid. *Each BIS measure coefficient is in reference to measure 1 of the triplicate
measures.

The means and CI for each of the BIS variables for the standard whole body
electrode placement and time point are presented in Table 4.3.
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Table 4.3: BIS variable values for the standard whole body electrode
placement and time point. Values presented as means
(confidence intervals).
BIS
Variable
At WBS
R0 (ohms)

Time Point
T0

T1

T2

T3

T4

T5

498.77

351.94

366.70

371.18

371.76

401.01

(467.17-

(295.56-

(314.94-

(319.50-

(322.20-

(348.18-

530.37)

408.32)

418.45)

422.86)

422.33)

45384)

1412.47

715.75

715.51

721.81

713.41

798.52

(1225.51-

(505.83-

(536.09

(546.31-

(541.38-

(611.02-

1599.42)

925.68)

894.93)

897.31)

885.44)

986.02)

Rinf

361.89

226.58

234.35

237.45

238.65

261.95

(ohms)

(337.57-

(183.50-

(195.19-

(198.23-

(200.24-

(220.50-

386.20)

269.67)

273.52)

276.67)

277.06)

303.40)

20.76 (17.56-

34.77 (14.00-

32.50 (13.22-

31.93 (14.21-

31.50 (15.07-

24.84 (10.44-

23.97)

55.54)

51.78)

49.66)

47.92)

39.25)

25.26 (21.62-

48.47 (27.74-

46.97 (27.11-

46.71 (27.15-

46.18 (27.20-

37.80 (21.38-

28.91)

69.21)

66.83)

66.27)

65.16)

54.23)

46.03 (39.67-

83.16 (43.11-

79.48 (41.84-

78.53 (42.85-

77.65 (43.18-

62.65 (33.67-

52.38)

123.20)

117.12)

114.20)

112.11)

91.63)

Ri (ohms)

ECF (L)

ICF (L)

TBF (L)

WBS = standard whole body electrode position, R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf =resistance at
infinite frequency, ECF = extracellular fluid, ICF = intracellular fluid, TBF = total body fluid. T0 = initial BIS measurement
with no dressing, TBSA = total body surface area, T1= first BIS measure with new ActicoatTM dressing, T2-5= BIS measures
taken at half hourly intervals. intervals. Values presented as means (confidence intervals).

4.3.2

Factors influencing BIS readings

The regression analysis demonstrated ActicoatTM had a significant effect on the raw
variables Ri and Rinf (but not R0) and on all the calculated variables (ECF, ICF, TBF)
in whole body BIS (Table 4.4). The resistance variables reduced between 182.22 and
23.87 ohms for Ri and Rinf and the calculated volumes were increased by 31.00 –
67.23 L when an ActicoatTM dressing was in place, compared to the open wound
condition.
There was no evidence of an effect of TBSA on any of the BIS variables (Table 4.4).
However there was a statistically significant interaction (p <0.01) between TBSA
and ActicoatTM for all BIS variables, raw and calculated. When an ActicoatTM
dressing was in place and for every 1% increase in TBSA R0 decreased by 4.68
ohms, Ri by 17.98 ohms and Rinf by 3.96 ohms. This results in a divergence away
from the open wound R values as TBSA% increases. Extracellular fluid, ICF and

105

TBF volumes all increased with greater TBSA when an Acticoat TM dressing was in
place also resulting in divergence away from the open wound fluid volumes as TBSA
increased (Table 4.4).
As expected, there was a strong positive correlation between initial TBF and weight,
with a correlation coefficient (r) of 0.83 (p <0.01). There was also a moderate
positive correlation between initial TBF and height, r = 0.67 (p <0.01). Initial TBF
was therefore included in the model, and height omitted, to reduce collinearity. Initial
TBF was included in preference to BMI as it was determined to be a more robust
indicator of a person’s size as the random error was reduced when compared to BMI
(as it is one variable compared to two (height and weight)). Initial TBF is
significantly associated with all BIS variables. For every 1 L increase in initial TBF
R0 decreased by 5.71 ohms (p <0.01), Ri decreased by 32.52 ohms (p <0.01) and Rinf
decreased by 5.30 ohms (p <0.01). All estimated fluid volumes increased (ECF 0.93
L, ICF 1.08 L, TBF 2.02 L) with every 1 L increase in initial TBF.
Algorithms were developed to correct for the effect of ActicoatTM for the BIS
variables. They are as follows:
Corrected ECF = measured ECF with Acticoat dressing – (-59.02 + (time since
dressing applied*1.38) + (initial measured ECF*2.69))
Corrected ICF = measured ICF with Acticoat dressing – (-79.26 + (time since
dressing applied*-0.0006) + (%TBSA*1.85) + (initial measured ICF*3.088918))
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Table 4.4: Predictor variable effects on whole body BIS variables for
determining the effect of Acticoat TM
BIS
variable
R0

Covariate
Acticoat

TM

% TBSA
Acticoat

TM

#% TBSA

Initial TBF (L)
Ri

Acticoat

TM

% TBSA
Acticoat

TM

#% TBSA

Initial TBF (L)
Rinf

Acticoat

TM

% TBSA
Acticoat

TM

#% TBSA

Initial TBF (L)
ECF

Acticoat

TM

% TBSA
Acticoat

TM

#% TBSA

Initial TBF (L)
ICF

Acticoat

TM

% TBSA
Acticoat

TM

#% TBSA

Initial TBF (L)
TBF

Acticoat

TM

% TBSA
Acticoat

-17.42

Confidence intervals
Lower
Upper
-39.35
4.52

-1.07

-2.75

0.61

0.21

-4.68

-5.37

-3.98

<0.01*

-5.71

-8.32

-3.09

<0.01*

-182.22

-265.27

-99.16

<0.01*

6.50

-3.45

16.46

0.20

-17.98

-20.61

-15.36

<0.01*

-32.52

-48.16

-16.87

<0.01*

-23.87

-38.57

-9.17

<0.01*

-0.01

-1.33

1.32

0.99

-3.96

-4.42

-3.49

<0.01*

-5.30

-7.37

-3.23

<0.01*

-36.23

-41.91

-30.55

<0.01*

-0.04

-0.31

0.23

0.76

1.86

1.68

2.04

<0.01*

0.93

0.53

1.33

<0.01*

-31.00

-36.07

-25.92

<0.01*

-0.15

-0.36

0.07

0.18

2.01

1.85

2.17

<0.01*

1.08

0.77

1.40

<0.01*

-67.23

-77.13

-57.32

<0.01*

-0.19

-0.63

0.25

0.40

3.87

3.55

4.18

<0.01*

2.02

1.36

2.67

<0.01*

Co-efficient

TM

#% TBSA

Initial TBF (L)

p-value
0.12

R0 = resistance at zero frequency (ohms), Ri = intracellular resistance (ohms), Rinf = resistance at infinite frequency (ohms),
ECF = extracellular fluid (L), ICF = intracellular fluid (L), TBF = total body fluid (L), TBSA = total body surface area, # =
interaction term, *p= <0.05. ActicoatTM is in reference to an open wound

4.3.3

Validity

BIS resistance and fluid volume variables were analysed to determine BIS validity.
The MLME linear regression univariate analysis, in the ActicoatTM dressing
condition only, showed R0, Ri and Rinf significantly changed with time (Table 4.5).
Compared to T1 (new ActicoatTM dressing), for every minute increase in time, R0
decreased 0.40 ohms (p <0.01), Ri decreased 2.51 ohms (p <0.01) and Rinf decreased
0.40 ohms (p <0.01). The BIS calculated fluid volumes ICF and TBF were also
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significantly associated with time, increasing by 60 ml and 20 ml for every minute
increase in time (p < 0.01). ECF was not significantly associated with time.
The regression analyses demonstrated all resistance values significantly decreased
with increasing net fluid volume in a linear relationship (Table 4.5, Figure 4.3 A).
Net fluid volume was significantly associated with ICF and TBF BIS fluid volume
change, increasing with increasing net fluid shift (Figure 4.3 B). All BIS variables
were significantly associated with % TBSA. For every 1% increase in TBSA R0
decreased 5.09 ohms, Ri decreased 8.85 ohms and Rinf decreased 3.25 ohms. Fluid
volumes increased between 1.20 – 2.77 L with every 1% increase in TBSA (p <
0.01) (Table 4.5).
Two individuals who had large negative fluid shifts >850 ml across a single time
point were removed from the analysis after step wise analysis found they
significantly altered the results of the final model Leaving these patients in the
analysis would have resulted in a non-homogenous sample. It appears a large loss of
fluid volume compromises the interpretation of BIS measures. Both patients suffered
loss of large volumes of ionic fluid due to emesis which likely altered the measured
BIS resistance (27).
When a patient’s initial TBF increased by 1 L R 0 decreased 5.78 ohms (p <0.01), Ri
decreased 28.79 ohms (p <0.01) and Rinf decreased 5.31 ohms (p <0.01).
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Table 4.5: Univariate analysis of variable correlation on whole body
BIS measures
Confidence intervals

BIS
variable

Covariate

R0

Time (minutes)

Ri

Rinf

ECF

ICF

TBF

Co-efficient

p-value
Lower

Upper

-0.40

-0.54

-0.27

<0.01*

% TBSA

-5.09

-7.08

-3.10

<0.01*

Net fluid shift (ml)

-0.05

-0.07

-0.02

<0.01*

Initial TBF (L)

-5.78

-8.95

-2.61

<0.01*

Time (minutes)

-2.51

-3.09

-1.92

<0.01*

% TBSA

-8.85

-16.98

-0.74

0.03*

Net fluid shift (ml)

-0.25

-0.36

-0.15

<0.01*

Initial TBF (L)

-28.79

-41.74

-15.84

<0.01*

Time (minutes)

-0.40

-0.51

-0.28

<0.01*

% TBSA

-3.25

-4.69

-1.81

<0.01*

Net fluid shift (ml)

-0.05

-0.07

-0.03

<0.01*

Initial TBF (L)

-5.38

-7.68

-3.07

<0.01*

Time (minutes)

0.02

-0.01

0.05

0.15

% TBSA

1.40

0.99

1.80

<0.01*

Net fluid shift (ml)

0.01

-0.001

0.01

0.09

Initial TBF (L)

1.20

0.56

1.85

<0.01*

Time (minutes)

0.06

0.03

0.10

<0.01*

% TBSA

1.52

1.17

1.88

<0.01*

Net fluid shift (ml)

0.01

0.01

0.02

<0.01*

Initial TBF (L)

1.56

0.99

2.13

<0.01*

Time (minutes)

0.08

0.02

0.14

<0.01*

% TBSA

2.92

2.18

3.65

<0.01*

Net fluid shift (ml)

0.02

0.01

0.03

<0.01*

Initial TBF (L)
2.77
1.59
3.94
<0.01*
R0 = resistance at zero frequency (ohms), Ri = intracellular resistance (ohms), Rinf = resistance at
infinite frequency (ohms), ECF = extracellular fluid (L), ICF= intracellular fluid (L), TBF = total body
fluid. *p= <0.05.
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Figure 4.3: Predicted margin plots of BIS variable (Ri, ICF) and net
fluid shift relationship
* The predicted margin plots of R0 and Rinf, and ECF and TBF have a similar linear
relationships to net fluid shift as Ri and ICF above. Ri = resistance of intracellular fluid, ICF
= intracellular fluid
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4.3.4

Calculator

A calculator was developed to estimate the net fluid shift between consecutive BIS
measures, accounting for dressing condition, %TBSA and time since dressing
(Appendix C). The significant and influential variables from the MLME models
(Table 4.5) were incorporated into the newly developed algorithms (for calculation
of fluid volumes), which were then embedded in an excel calculator to allow
clinicians access to them. The variables required for input into the calculator by the
clinician include dressing condition, %TBSA, time since application of Acticoat TM
dressing (minutes) and the measured BIS variables. The calculator does not require
the clinician to monitor or include net fluid shift, namely urine output and fluid input.
The validity analysis utilised the measured BIS fluid volumes and did not correct for
the ActicoatTM effect, as it was not considered necessary for this preliminary study.

4.4 Discussion
The principal novel finding of this study show bioimpedance spectroscopy was a
reliable method for monitoring fluid change in moderate to large burn patients.
Bioimpedance resistance measures can be interpreted in the presence of ActicoatTM
to monitor changes in fluid volume over time, if corrected for using the provided
calculator. Thus, the study also established BIS as a valid indicator of fluid change
over time during burns resuscitation while ActicoatTM dressings are in situ.
Bioimpedance spectroscopy at the bedside has the potential to improve fluid
management in an acute major burn by providing real time measures of fluid shifts
thus reducing the risk of over resuscitation and associated adverse outcomes.

4.4.1

Reliability

The results of the study demonstrate BIS produces reliable raw and predicted
measures in patients with >12% TBSA burns, regardless of dressing condition (open
wound or ActicoatTM) and electrode placement (Table 4.5). This data suggests BIS is
a reliable method for assessing oedema change over time in moderate to large area
burns. This concurs with and adds to the findings of Edgar et al’s (2009) study which
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found BIS reliability applicable to burns with <30% TBSA across different dressing
conditions (28).

4.4.2

Factors influencing BIS readings

Bioimpedance whole body calculated fluid volumes were grossly and significantly
overestimated and resistance of the ICF and TBF underestimated when an ActicoatTM
dressing was in place. The under or overestimation of BIS variables increased with
increasing TBSA. Grisbrook et al (2016) and Kenworthy et al (2017) also found the
effect of silver dressings on BIS variable measures increased with increasing size of
the burn.
Body mass index is also well known to be associated with BIS variable output as
larger people have a greater amount of body fluid (38). This has been demonstrated
in the present results where a larger initial TBF (indication of the bulk of the person
and collinear with BMI) significantly decreased BIS resistance and therefore
increased calculated fluid volumes.
It can be concluded that BIS was appropriate for use in a moderate to large burns
population when an ActicoatTM dressing was in place only with adjustment, as
resistance measures and fluid volumes are significantly under and overestimated with
significantly different values to those in an open wound. The SFB7 impedimed
embedded algorithms are not appropriate for use in burns with ActicoatTM insitu.
This is consistent with the findings of Grisbrook et al (2016) (39) though the burns
population sample in that study did differ from those recruited in this study sample
with respect to %TBSA (range 5.5-28.5% compared to our 12-80%) and fluid
resuscitation requirements. Therefore, to monitor fluid shifts it is recommended the
resistance and fluid volume variables measured when an Acticoat TM dressing is
insitu, be corrected using the provided calculator.

4.4.3

Validity

The present results show BIS is a valid indicator of fluid volume change over time in
moderate to large burn resuscitation with TBSA, time, net fluid shift and initial TBF
all significantly associated with BIS resistance and calculated fluid volumes. For
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clinically interpretable resultsthe measured BIS variables need to be adjusted using
the provided calculator if ActicoatTM is in place.
Time was significantly associated with resistance variables, with an increase in time
decreasing all estimated resistances and increasing ICF and TBF volumes. This may
be explained by a combination of factors including the time since dressing
application, the effect of ActicoatTM and the amount of fluid resuscitation
administered. Firstly, over time the ActicoatTM dressing deposits more silver ions
into the wound, therefore decreasing the raw resistance values and in turn increasing
the ‘equivalent’ fluid volumes as calculated by BIS embedded algorithms (40).
Secondly, the total mean volume of fluid resuscitation over time increased, thus
increasing all inter-compartmental fluid volumes and consequentially decreasing the
associated estimated resistance values. Although ECF was not associated with time,
the p-value (0.15) is arguably low enough to accept that a clinical relationship may
exist despite a small sample. In contrast, the embedded algorithm of analysis may
explain why ECF is not associated with time in this population (each algorithm has
different constants for estimating the individual fluid compartments (41)). However,
R0 the equivalent resistance of ECF significantly changed with time, suggesting fluid
volume change in the extra cellular compartment is associated with time.
It is known BIS resistance is inversely proportional to fluid volume (22, 24). The
results of this study support this. Bioimpedance variables and net fluid shift were
found to have a negative inverse linear relationship with resistance and as expected,
calculated fluid volumes a positive linear relationship (Figure 4.3) providing the net
fluid shift (at each half hour measure) was greater than 100 ml. There were two
patients who had a large (> 850 ml) negative fluid shift, both noted to have emesis
during the single measurement period, and thus these data were excluded from the
analysis, as they were assumed to have an altered, uncorrected physiological (ionic)
state at the time of measurement and thus, significantly differed from others in the
sample. It appears a large loss of fluid consequentially affects the following repeated
BIS measures (within at least the following two hours). It is proposed that not only
was the volume change a contributor to the difficulty in interpretation of the BIS
measures but also the loss of electrolytes from the gut following emesis. The emesis
could have altered the whole body fluid ionic state for a short period until it was
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corrected by the body systems. Bioimpedance resistance is inversely proportional to
fluid volume and electrolyte concentration. Therefore significant changes in the ionic
status of the fluid or tissues measured will alter the BIS raw variables and render the
machine embedded algorithms for calculated volumes, invalid. Clinicians are advised
not to use BIS measures in the period after an episode of emesis (42). Further, the
results suggest the BIS measure is only sensitive to fluid losses ≤ 100ml per half hour
in the burns resuscitation period. The sensitivity of the BIS measure for fluid losses
greater than 100 ml and less than 850 ml cannot be predicted as the patient cohort did
not experience losses in this range.

4.4.4

Calculator

On the basis of the results a calculator was developed to improve the clinical utility
of BIS in burns resuscitation patients at the bedside. It adjusts for the ActicoatTM
effect and provides an estimated change in BIS resistance and fluid volumes between
consecutive BIS measurements, hence allowing fluids to be titrated accordingly. It
has been established however that BIS is reliable and valid in the open wound
condition. Therefore BIS can be utilised without variable adjustment when no
dressings are in place.

4.4.5

Clinical Practice Recommendations

Optimum fluid resuscitation requires maintenance of the intracellular volume with
minimal expansion (extravasation) of the extracellular volume. The results of this
study indicate that using the relationship or pattern between R0 or ECF and Ri or ICF
is a non-invasive, interpretable method of monitoring or titrating fluid resuscitation.
A stabilised Ri or ICF volume, over time, equal to or greater than the normal range
(ICF 22.9-25 L) (24) represents a fluid resuscitation target. Fluid volumes should
then be titrated to maintain R0 or ECF at a steady state whilst continuing to preserve
Ri or ICF at the target volume. Ideally ECF volumes would be maintained as close to
normal (or the average for a healthy person) as possible (13.2-15.3 L). However due
to the body’s systemic “leaky vessel” inflammatory response to a major burn injury,
with extravasation of fluid into the extracellular space, volumes within 5-10% of
these norms would be a suggested acceptable target range (43, 44). In postoperative
surgical patients fluid overload has been defined as >15% of preoperative fluid
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volume (43) and in haemodialysis patients reaching ECF volumes within one to two
litres of normal values is deemed acceptable (45). An example of how to titrate
fluids: If Ri or ICF is stable and the change values of R0 or ECF continue to increase,
the fluid administered is adding to the extracellular compartment (swelling) rather
than preferentially maintaining the intracellular compartment. Infused fluid volumes
therefore need to be reduced if Ri (ICF) is stable and R0 (ECF) is trending upward.
However, in a recent study, intracellular volume actually decreased (~0.8L over 70
minutes) upon rapid infusion of intravenous fluid (~2L in ~ 60 minutes) into healthy
male volunteers (46). It was suggested the infusion of fluid was responsible for the
increase in extracellular fluid. The fluid administered in this study was <500ml/hr
therefore difficult to conclude whether this may have the same effect. It however
does suggest potentially accepting an ICF volume of ~ 1L less than average volumes
when considering titrating fluid as above. For greater sensitivity to change, at this
time this study suggests it is more advantageous to use the change in BIS raw
resistance values (adjusted in the presence of ActicoatTM) rather than the calculated
volumes as it removes the need for specific predictive equations and eliminates the
need for height and weight measures measures (47). There are a growing number of
studies suggesting raw BIS variables may be more useful in predicting clinical
outcomes (48, 49). BIS raw variables may also be able to indicate changes associated
with cell membrane damage and cell wall integrity (49).
Further work is required to increase the confidence and promote greater utility of this
sensitive measure over standard haemodynamic monitoring. In contrast urine output,
a ‘quasi’ measure of fluid shifts and whole body perfusion (8) has been suggested to
lag behind the actual events of hypoperfusion by up to two hours (50, 51).
Bioimpedance also removes the need to rely heavily on initial fluid volume
calculations such as the Parkland or Brooke’s. This could prove highly useful out in
the field with paramedics and in isolated country hospitals where clinician’s burns
experience may be limited and where Western Australia’s vastness means it is not
uncommon for people to travel greater than eight hours to be admitted to a tertiary
hospital.
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4.4.6

Future Research

Additional research is warranted in evaluating the effect of other silver and nonsilver dressings such as sulfadiazine and hydrocolloids, in moderate to large burns to
increase the utility of BIS across burns services.
Further, consideration may need to be given of the type of resuscitation fluid (e.g.
crystalloids versus colloids) in future studies as BIS electrical conductivity is
affected by electrolyte concentration. This may therefore influence BIS variable
measurements. Electrical and chemical burn injuries may also influence or change
the ionic state of the tissue. Thus future research should include these modes of
injury.
Ideally BIS would be able to be used on burns patients on life support or mechanical
ventilation however further study needs to be done to determine whether electronic
equipment interferes with the BIS instrument. Several studies have been conducted
in intensive care units however they did not stipulate whether ventilated patients
were included (52, 53).

4.5 Conclusion
In moderate to large burn patients, BIS is a reliable and valid method of oedema
change. The ActicoatTM dressings significantly alter the BIS raw outputs. To allow
clinical interpretation of BIS, measures must be adjusted for silver dressings.
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Foreword

The first two studies presented in this thesis demonstrated BIS is a reliable method in
the assessment of fluid shifts in acute burns >12%TBSA receiving fluid
resuscitation, across different dressing conditions and electrode positions. Validity of
BIS as a measure of fluid shift over time, with the use of the provided calculator to
adjust for the presence of an ActicoatTM dressing, was also established. Solutions to
particular barriers in the use of BIS were also established. For broad clinical
applicability across the spectrum of burns, BIS reliability and validity as a measure
of oedema change needed to be determined in localised minor limb burns.
Minor burns experience localised wound oedema, not a systemic inflammatory
response like major burns, and are also managed with both non-silver and silver
dressings in the acute period. It is unknown whether whole body BIS is a sensitive
measure of oedema change in minor burns, less than five percent TBSA. Therefore
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standardised electrode placements and a novel localised electrode placement were
investigated as well as the influence of dressing conditions on the BIS measures.

5.1

Introduction

Oedema as a result of inflammation is the body’s normal response to injury (1). In
burns, this process is exaggerated, causing an excessive volume of fluid in the tissues
(2, 3). Oedema contributes to burn wound progression, slows healing and can
increase risk of infection (4-7). Burn wound healing time is directly related to scar
outcome (7, 8). Oedema can alter the severity of the wound by increasing the oxygen
diffusion distance within the wound, exacerbating hypoperfusion thus forming a
physical barrier to healing (9, 10). Limb oedema can also impact an individual’s
immediate physical function by limiting the range of motion of joints, causing pain
with movement and mobilisation and increasing the effort required to move (11).
Proactive, early management of oedema is therefore an integral part of a
multidisciplinary intervention program to minimise the negative impact of swelling
and optimise patient recovery (12). However, there is little high level evidence to
support traditional oedema management regimes, nor is there emergent interventions
for more proactive oedema removal (2). Thus, to guide improvements in oedema
management in the burn population, a non-invasive, easy to use accurate assessment
of swelling is required (13).
At present, the widely accepted methods for clinical monitoring of peripheral
swelling are volume displacement and circumferential measures (14, 15).
Circumferential measures are prone to subjective bias and lack sensitivity while
volumetry is cumbersome to perform and rarely used in clinical practice (16). In the
burns population both methods may pose an increased risk of infection, increased
pain and can only be used when dressings are removed. Clinical examination of the
burn wound such as visual analysis of depth, healing (re-epithelialisation) and signs
of infection can also indicate presence of oedema (as a wound heals oedema
decreases), however these are largely subjective (4, 17).
Techniques designed for the serial measurement of wound oedema would ideally be
sensitive, reliable, user independent and minimally or non-invasive. Bioimpedance
spectroscopy (BIS) is a technique, which may provide such a solution (18, 19). It is a
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technique used frequently in healthy populations and more recently in clinical
populations to measure an individual’s body composition, including intercompartmental fluid volumes, fat free mass (FFM) and cell (membrane) mass and
function (20-22). By applying a small alternating current into the body via adhesive
electrodes placed on intact skin, assessment of tissue resistance (R) and reactance
(Xc) is possible. The R and Xc values are measured over a range of frequencies (51000hz). Bioimpedance spectroscopy software then utilises the Cole – Cole model
applying non-linear curve fitting to estimate the resistance at zero frequency (R0,
extracellular fluid (ECF) equivalent), infinite frequency (Rinf, total body fluid (TBF)
equivalent) (23). The intracellular fluid (ICF) resistance (Ri,) is extrapolated using
the other raw variable data (24). Extra and intracellular fluids behave as resistive
components and resistance is inversely proportional to fluid volume and therefore
swelling (20, 25). The pathway the current takes is dependent on the frequency. At
low frequency (5 Hz), currents travel through ECF only and at higher frequencies
(>50 Hz) it travels through both ICF and ECF (26), thus providing the potential to
develop a correlate measure of oedema volume (ECF).
Traditionally BIS technology measures fluid flux at a whole body level with
electrodes placed in standardised locations on the hands and feet (23). However,
segmental BIS, the measurement of the body in segments, brings the electrodedependent field of measurement closer to the site of interest and is more sensitive to
fluid volume changes of single limbs compared to whole body measures (25).
Grimnes and Martinsen (2007) state as the distance between electrodes decreases, the
deeper layers of tissue contribute less to the BIS result, therefore increasing
sensitivity of the measured signal and oedema volumes (27). Codognotto et al (2008)
used segmental electrode placement to assess single limb oedema as whole body
electrode placement was shown to be insensitive to decreases in volumetric measures
during the treatment of lymphedema (25, 28). Also in muscle injures, localised
bioimpedance analysis (BIA) was able to detect changes in swelling and cellular
injury consistent with MRI imaging over time (29). Localised BIA is not
standardised and electrode placement differs depending on the site of injury or
swelling. Electrodes are normally placed longitudinally and parallel to the axis of the
limb. However, in a in a proof of concept study in uninjured adults, Ward et al
(2013), demonstrated localised BIS to be a highly sensitive measure of fluid volumes
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and highly reproducible data was obtained from electrodes located at different
(localised) positions around the region of interest (19).
A challenge to measuring oedema in the acute burn environment with traditional
methods is the presence of dressings and wounds. It is yet to be established if this
invalidates, or is also a potential barrier to, the use of BIS. Acute burn wounds in the
Western Australian context are dressed with a number of different products including
hydrocolloid and ionic silver anti-microbials. Bioimpedance technology is based on
the flow of an electrical current delivered at different frequencies through the body
and is directly related to the amount of electrolyte rich (ionic) fluid in the field of
measure. Therefore, silver (a conductive material) and hydrocolloid (water based)
dressings have the potential to influence BIS variable outputs, independently of the
oedema volumes in the tissues.
The ability to objectively assess local changes in fluid composition and fluid
accumulation around the site of a wound would be helpful in determining the
efficacy of the interventions currently aimed at reducing peripheral or limb oedema.
Thus, the current study aims to examine the reliability and validity of the BIS
technique for the measurement of localized burn wound oedema with respect to
electrode position and dressing condition. It is hypothesised that bioimpedance
resistance variables, R0, Ri, Rinf will increase as limb volumes decrease.

5.2
5.2.1

Methods
Participants

A longitudinal, prospective, single service study was conducted between December
2014 and December 2016. Participants were included in the study if they were: over
18 years old, had a minor burn wound less than five percent TBSA, the injury was
less than four days old and involved the limbs only and had a body mass index of
between 15-40 kg/m2. Patients were excluded if they were unable to lie supine for the
duration of the testing. Manufacturer’s requirements were adhered to thereby
preventing inclusion of the following patients: pregnant or breast-feeding patients,
patients with surgical implants and/or cardiac pacemakers.
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Patients were initially recruited from Royal Perth Hospital (RPH) burns outpatient
clinics or as inpatients on the RPH Burns Unit. Recruitment was then completed at
Fiona Stanley Hospital (FSH) burns inpatient and outpatient areas due to the Western
Australian State Burns Service moving in February 2015. The change of State Burns
Service location did not alter the study protocol, patient population sampled or the
equipment used.

5.2.2

Data Collection

Upon recruitment, participant’s height, body mass, age and gender were recorded
and input into the BIS device (SFB7 ImpediMed, Brisbane, Queensland, Australia).
BIS measures were taken with participants in a supine position, limbs abducted away
from the body and electrodes placed over cleaned, intact skin. The flow of the data
collection process can be seen in Figure 5.1.

Assessed for eligibility
n = 42

Excluded or declined n=10
Withdrawn
n=2

Included
n=30

Height and *weight taken
and input into SFB7

*NoDressing

CLM (affected limb),
*scaled photo
*BIS: WB, Segmental
affected limb, localised

*New wound dressing
(dressing type recorded)

*BIS: WB, Segmental
affected limb, localised

Patient lies supine with
legs abducted

Figure 5.1: Flow diagram of data collection process. * Occurs at time
point 1 and 2.
5.2.2.1

Reliability

Circumference limb measures (CLM) of the 1) affected limb were measured to
determine localised limb volume and 2) unaffected limb were measured to determine
our raters’ CLM reliability. Measurements were taken at three points. On initial
assessment they were taken 3cm proximally and distally to the wound and at the mid
point (across the wound) between these two measures. The proximal and distal
measurement points were also measured in reference to specific anatomical
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landmarks, with the patient supine in the anatomical position, so they could be
replicated on the unaffected side and at follow up. This has been shown to increase
the accuracy and reliability of circumference limb measures (30). The tape measure
was cleaned with alcohol wipes to adhere to infection control protocols.
The localised sense electrodes were placed at the same measurement points as the
proximal and distal CLM’s, on initial assessment (Figure 5.2), making sure there was
3cm between the wound edge and the edge of the electrode. The distance between
the two electrodes was also measured and recorded to 1) minimise electrode
placement error at follow up and 2) to calculate localised limb segment volume. This
inter electrode distance was termed the ‘localised inter-electrode distance’.

Figure 5.2: Position of distal localised electrode on a thigh, 3 cm from
wound edge. Day 4 post burn.
Within each assessment session, triplicate BIS measures were taken for each
electrode configuration (Figure 5.2 and Figure 5.3) and in both dressing conditions
(no dressing and new dressing). Bioimpedance spectroscopy has been found to be
reliable and valid in healthy and clinical populations (16, 31-33). In 2009, Edgar et al
demonstrated the use of whole body BIS measurements of acute oedema shifts in
human burn survivors, with injuries less than 30% total body surface area (TBSA)
(mean 10.45% TBSA), with excellent reliability across different dressing conditions
(16).
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Electrode Montage Electrode placement
Sense

Drive

Whole Body

1,3

2,4

Right Upper Limb

1,5

2,4

Right Lower Limb

3,6

2,4

Figure 5.3: Schematic representation of the BIS whole body and limb
segment electrode positioning: measurement (sense) electrode
sites (solid circles) and drive (current injecting) electrode sites
(open circles).

5.2.2.2

Validity

BIS measures were taken in three different electrode positions to determine which is
most sensitive to oedema change. They were 1) whole body BIS using standard tetrapolar whole body electrode placement (electrode position (EPWB) (34); 2) whole limb
segmental measures of the affected (EPlimb) limb (electrode placement as per
Cornish, Jacobs et al 1999) (35) (Figure 5.3); and 3) localised BIS (EPlocal) with the
sense electrodes placed 3cm adjacent to the burn wound along the longitudinal axis
of the limb (localised inter-electrode distance) and drive electrodes in the standard
position (dorsum of the foot and hand) (Figure 5.3). This allowed a dressing to be
accommodated where needed during the assessments. All measures were taken with
1) an open wound or no dressing and 2) with a new dressing (less than 2 minutes
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old). The dressing type were categorised as either a non silver dressing or a silver
dressing.
The volume of the novel limb segment was calculated using the truncated cone
volume formula (36). Two truncated cone volumes were calculated for each localised
limb segment and then added together (volume between mid and proximal, and mid
and distal CLM).
V = [h (CP2 + CPCM + CM2)]/ 12 𝜋 + [h (CD2 + CDCM + CM2)]/ 12 𝜋
Where:
C P,M,D = circumference limb measures (P = proximal, M = mid, D = distal)
h = height of each segment = localised inter-electrode distance /2
Participants had initial measures taken within 96 hours of injury (time point 1 (T1))
and follow up measures at a second time point (time point two (T2)), within fourteen
days, after initial assessment to enable comparison of acute outcomes (BIS raw
variables; localised limb segment volume) over time. It is known that in burns not
requiring fluid resuscitation, oedema peaks on about day one post injury and by day
four post- burn, the rate of volume change over time tapers to clinically insignificant
levels (37). Therefore the method planned was to capture individuals within this
initial time period to increase the likelihood of detecting changes in swelling over
time.
Researchers (data analysers) were blinded to circumferential limb and BIS measures
between time point one and two by using separate data collection sheets and only a
BIS file name was recorded, not the actual variable values.

5.2.3

Equipment

The ImpediMed SFB7 was used to collect whole body, segmental and localised BIS
measures. The equipment applies a small AC current across 256 discrete current
frequencies (4-1000 Hz) to interpret each measurement. BIS computes both raw
impedance values and derived fluid distribution values such as whole body ECF,
ICF, and TBF using manufacturer’s algorithms (23) and are stable when the subject’s
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body mass index is > 15 kg/m2 (as per the manufacturer). Only raw BIS variables are
used in this study, as the algorithm is not applicable to localised or segmental BIS.
Kendall CA610 diagnostic tab electrodes (reference code 31447793, Covidien,
Mansfield, MA, USA) were utilised.
A thin 150cm tape measure was used for circumference limb measures.

5.2.4

Ethics

Approval for the study was granted by the RPH Human Research Ethics Committee
(EC 2011/028), FSH governance committee (2014-106) and The University of Notre
Dame Australia Human Research Ethics Committee (014139F).

5.2.5

Statistical Analysis

Stata Statistical Software, release 14 (StataCorp LP 2014, College Station, TX) was
utilised to complete all data analysis. The Shapiro-Wilk test was used to assess the
normality of the data. Normally distributed variables were described as means and
standard deviations (SD). Where the data was not normally distributed, as for BIS
measures, CLM and other co-variates, non-parametric statistics were performed.
Where the variable was skewed it was transformed using the log function and the
geometric mean and confidence intervals (CI) were reported, as for BIS resistances,
localised inter-electrode distance, TBSA and CLM. A p value of less than 0.05 was
considered statistically significant for all analysis.
5.2.5.1

Reliability

Two sample Wilcoxon rank sum (Mann-Whitney) tests were applied to determine if
there were any significant differences between CLM of the unaffected limb between
the two time points. As the patients were not undergoing resuscitation, it was
assumed there would be no change in the size of the unaffected limb between
sessions.
Reliability of the within session triplicate BIS resistance measures was determined
by concordance (intra-class correlation coefficients (ICC)) (acceptable, 0.75-0.89;
excellent, ≥ 0.9) (38), acceptable variance estimated by 95% confidence intervals
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(95% CI) and systematic bias between trials (considered significant at P < 0.05) (38).
The ICC’s were obtained using a three level nested mixed-effects linear regression
model. Multilevel mixed-effects (MLME) linear regression analysis was also utilised
to determine if there was a significant change in BIS mean resistance values between
triplicate measures. Initial and follow up triplicate BIS measures were included in the
analysis.
5.2.5.2

Validity

A series of multilevel mixed effects (MLME) linear regression analyses were used to
determine the effect of the measurement, patient and time characteristics on the
dependent BIS variables (R0, Ri, Rinf). Step-wise, backward elimination of the
variables was completed, to produce the final model. A MLME linear regression
analysis was also used to determine the effect of time on mean localised segment
volume. The regression coefficients, with 95% confidence intervals were reported. A
p value of less than 0.05 was considered statistically significant for all analysis.
The MLME model is a robust method allowing for nested observations of measures
for each individual and provides a hierarchical analysis with generalisations for nonnormalised data. The method can account for random effects from individuals and
responses within individuals (39).

5.3
5.3.1

Results
Demographics

Thirty burn patients (20 males and 10 females) with a mean age of 37 (SD=10.57)
years and a mean TBSA of 1.39% (SD=0.96) were included in the analysis. An
additional two patients were excluded from the analysis. One was lost to follow up
and the second due to equipment malfunction. The mean days post burn at initial
recruitment (T1) was 2.35 days (SD 1.18,) and at follow up (T2) was 7.05 days (SD
3.98). The burns were located on upper limbs (n=16, 53%) and lower limbs (n=14,
47%) only. The localised inter-electrode distance mean was 18.19cm (CI 15.6121.19). The total percentage of dressing by type in the final analysis was no dressing
53.23%, non-silver 30.07% and silver 16.70%. The median limb localised segment
volume was 1861.94 ml (inter quartile range 850.63 ml– 3010.36 ml).
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5.3.2

Reliability

The mean CLM scores of the unaffected limb at T1 and T2 for each point of measure
are displayed in Table 5.1
Table 5.1: Geometric means of unaffected CLM (cm) at time point 1 and
time point 2
Unaffected CLM point of

Mean CLM (cm) (CI)

Mean CLM (cm) (CI)

measure

Time point 1

Time point 2

Proximal

33.19 (32.29-34.12)

33.52 (32.54-34.53)

Mid

29.27 (28.43-30.08)

29.66 (28.77-30.58)

Distal

23.98 (23.23-24.75)

24.69 (23.86-25.54)

CLM = circumference limb measures

A two sample Wilcoxon rank-sum test determined there was no significant difference
between the medians (p value range 0.19-0.86) of the unaffected CLM (proximal,
mid, distal) between repeated measures at the first and second time point. This
indicates consistency of CLM’s over time and between raters.
Table 5.2 presents the analysis of the within session triplicate BIS measurements
reliability. There is a high correlation (level 3 intra class correlation) of the within
session BIS triplicate resistance measures within the same electrode position, time
point and dressing condition (BIS resistance is reliable in any circumstance) as
determined by the ICC’s which are as follows. R0 0.9999 (CI (0.9999 - 0.9999); Ri
0.9999 (CI 0.9999 - 0.9999); Rinf 0.9999 (0.9999 - 0.9999). There were no significant
differences between the estimated means of the within session triplicate measures for
each of the BIS variables (p = 0.11-0.72).
Table 5.2: BIS reliability results
BIS Variable

Triplicate BIS
within session
measure

Co-efficient (CI)

p-value

R0

2

-0.06 (-0.17 - 0.04)

0.257

3

-0.02 (-0.12 - 0.09)

0.72

2

1.65 (-0.38 - 3.68)

0.110

3

1.12 (-0.90 - 3.15)

0.278

2

0.02 (-0.08 - 0.11)

0.721

Ri

Rinf

3
0.02 (-0.07 - 0.12)
0.602
*Triplicate BIS measures are in reference to the first triplicate measure

130

5.3.3

Validity

The series of MLME regression analysis conducted and univariate analyses
established there was no significant effect of gender, age, weight, surgery, burn agent
or burn depth on the BIS variables. Further associations and interactions between the
independent variables and BIS resistance variables are reported below.

5.3.4

Effect of electrode position on BIS variables

Table 5.3 demonstrates the interaction between electrode position and time point.
The BIS variables at localised EP (EPlocal) had the biggest percentage change from
T1 to T2 compared to the whole body (EPWB) and affected limb (EPlimb) EP’s as
shown with the electrode position and time point interaction, however not significant.
From T1 to T2 for EPlocal: R0 increased by 12% (p= 0.121); Ri increased by 12%
(p=0.288); and Rinf by 11% (p= 0.241) whereas EPlimb had a percentage change less
than 9% (p = 0.410-0.850) for all resistance variables, compared to EPWB. Although
none of the electrode positions and time point interactions was significant (p≤0.05),
EPlocal demonstrated the greatest power to detect change over time and was therefore
the EP used for further MLME analysis.
Table 5.3: Change in BIS resistance variables with the interactions
between time point and electrode position (in reference to time point
1 and EP1)
BIS
Variable

Covariate
Interactions

Coefficient

R0

95% Confidence
Interval
Lower
Upper
0.87
1.18

pvalue

Time point 2#Electrode
1.02
0.85
position 2
Time point 2#Electrode
1.13
0.97
1.32
0.12
position 3
Ri
Time point 2#Electrode
1.09
0.89
1.35
0.41
position 2
Time point 2#Electrode
1.13
0.90
1.39
0.29
position 3
Rinf
Time point 2#Electrode
1.03
0.85
1.26
0.73
position 2
Time point 2#Electrode
1.11
0.92
1.36
0.24
position 3
# = Interaction term. Time point#Electrode position interaction is in reference to time point 1
and electrode position 1 (whole body). Electrode position (EP) 2 = affected segment,
Electrode position (EP) 3 = localised.
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5.3.5

Effect and interactions of burn size, localised limb
segment volume and dressings on BIS variables

Univariate analysis of time point determined R0 and Rinf significantly decreased over
time (p = 0.04 and 0.04 respectively). Ri did not change significantly over time (p =
0.07) (Table 5.4). When time, as indicated by assessment points (T1, T2) was
included in the regression it did not significantly improve the prediction of any of the
BIS variables using the MLME model. Time point was therefore not needed in the
following analysis and results from the MLME regression analysis included EPlocal
from T 1 only.
Localised inter-electrode distance had a significant association with R0 and Rinf only
and TBSA had a significant association with R0 only (p=0.05) (Table 5.4). As
localised inter-electrode distance increased by 1cm, R0 increased by 2.38 ohms (p=
<0.01) and Rinf by 2.24 ohms (p=<0.01).
The mean volume of the burnt limb segment was significantly associated with each
of the BIS resistance variables. A 1 ml increase in calculated volume reduced R0 by
0.68 ohms (p = <0.01), Ri by 0.53 ohms (p = <0.01) and Rinf by 0.63 ohms (p=
<0.01), indicating an inverse relationship between resistance and fluid volumes.
Mean localised segment volume also changed significantly over time. From time
point 1 to time point 2, mean volume had a mean decrease of 0.98 ml (CI 0.96-1.00)
(p=0.05). There was no significant interaction between time point and mean localised
segment volume for any of the resistance variables, suggesting the relationship
between mean localised segment volume and resistance is consistent over time.
Regression analysis of the effect of dressing condition on BIS resistance values
indicated there was a significant difference between no dressing and silver dressings
at EPlocal and T 1 for R0 and Rinf measured. R0 increases by 4.98 ohms (p = <0.01)
and Rinf by 8.25 ohms (p = <0.01) with a silver dressing in place compared to no
dressing (Table 5.4). A non-silver dressing also significantly increased resistance
values in all measured BIS variables (p = <0.01) (Table 5.4) when compared to no
dressing condition.
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Table 5.4: BIS resistance measures relationships with covariates at
electrode position ‘local’ only
BIS
Variable

Covariate

Coefficient

R0 (ohms)

Time point 2
Localised inter-electrode
distance (cm)
TBSA (%)
Non silver dressing
Silver dressing
Mean volume of localised
limb segment
Non silver dressing#mean
volume
Silver dressing#mean
volume
Non silver dressing#
Localised inter-electrode
distance
Silver dressing# Localised
inter-electrode distance
Time point 2
Localised inter-electrode
distance (cm)
TBSA (%)
Non silver dressing
Silver dressing
Mean volume of localised
limb segment
Non silver dressing#mean
volume
Silver dressing#mean
volume
Non silver dressing#
Localised inter-electrode
distance
Silver dressing# Localised
inter-electrode distance
Time point 2

1.13
2.38

Ri (ohms)

Rinf (ohms)

Localised inter-electrode
distance (cm)
TBSA (%)
Non silver dressing
Silver dressing
Mean volume of localised
limb segment
Non silver dressing#mean
volume
Silver dressing#mean
volume
Non silver dressing#
Localised inter-electrode
distance
Silver dressing# Localised
inter-electrode distance

95% Confidence
Interval
Lower
Upper
1.01
1.28
1.28
4.45

pvalue
0.04*
<0.01*

1.43
6.75
4.98
0.68

1.00
3.75
2.57
0.52

2.16
12.12
9.65
0.87

0.17
<0.01*
<0.01*
<0.01*

0.90

0.81

1.00

0.05*

0.84

0.73

0.96

0.01*

0.55

0.45

0.67

<0.01*

0.53

0.43

0.66

<0.01*

1.17
1.81

0.99
0.77

1.40
4.27

0.07
0.17

1.42
6.86
18.66
0.53

0.84
3.33
8.26
0.39

2.41
14.11
42.16
0.71

0.19
<0.01*
<0.01*
<0.01*

0.81

0.71

0.93

<0.01*

0.81

0.68

0.97

0.02*

0.55

0.43

0.71

<0.01*

0.32

0.24

0.42

<0.01*

1.17

1.01

1.36

0.04*

2.24

4.14

16.44

<0.01*

1.48
6.78
8.25
0.63

0.97
3.68
4.14
0.48

2.25
12.48
16.44
0.81

0.07
<0.01*
<0.01*
<0.01*

0.88

0.79

0.99

0.03*

0.81

0.70

0.94

<0.01*

0.55

0.44

0.68

<0.01*

0.44

0.35

0.55

<0.01*

R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf = resistance at infinite frequency;
# = interactions between 2 variables; *p= <0.05. Values for non silver and silver dressings are in
reference to no dressing condition.
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There was a significant interaction (p <0.01-0.012) between silver dressings and the
mean volume of the localised burnt limb segment for all resistance values (Figure
5.4). When a silver dressing was in place R0, Ri and Rinf decreased with increasing

volume, resulting in divergence away from no dressing R values as the limb segment
volume increased (Figure 5.4 A,B,C). A significant interaction also existed between
non-silver dressings and the mean volume of the localised burnt limb segment for all
resistance values. When a non-silver dressing was in insitu R0, Ri and Rinf decreased
with increasing volume but resulted in a convergence toward the no dressing R value
with increasing volume (Figure 5.4 A,B,C).
Significant interactions existed between the localised inter-electrode distance and
each of the dressing conditions for all BIS R values at EPlocal and T 1 (Table 5.4,
Figure 5.5). A 1cm increase in the inter-electrode distance increased R0 by 0.53 ohms

(P <0.01) when a silver dressing was insitu and the difference between silver
dressing and no dressing R0 increased as the inter-electrode distance increased
(Figure 5.5 A). This relationship was opposite for Ri and Rinf, where Ri and Rinf
decreased significantly (p <0.001) with increasing inter-electrode distance with a
silver dressing in place and resulted in divergence away from the no dressing R value
with increasing inter-electrode distance (Figure 5.5 B,C).
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148.4
90
54.6
33.1

R0 (ohms)

492.7

812.4
1339.4
Localised segment volume (ml)
No Dressing
Silver Dressing

2208.3

Non-silver Dressing

244.7
148.4
90.0

Ri (ohms)

403.4

665.1

A

492.7

812.4
1339.4
Localised segment volume (ml)
No Dressing
Silver Dressing

2208.3

Non-silver Dressing

54.6
33.1
20.1

Rinf (ohms)

90.0

148.4

B

492.7

812.4
1339.4
Localised segment volume (ml)
No Dressing
Silver Dressing

2208.3

Non-silver Dressing

C

Figure 5.4: The interaction between dressing condition and mean
localised segment volume (logarithmic scale) for R 0 (A), R i (B)
and R inf (C).
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121.5
99.5
81.4
66.7
44.7

54.6

R0 (ohms)

12.2

20.1
Localised inter-electrode distance (cm)
No Dressing
Silver Dressing

33.1

Non-silver Dressing

148.4
90.0

Ri (ohms)

244.7

A

12.2

20.1
Localised inter-electrode distance (cm)
No Dressing
Silver Dressing

33.1

Non-silver Dressing

54.6
44.7
36.6

Rinf (ohms)

66.7

81.4

B

12.2

20.1
Localised inter-electrode distance (cm)
No Dressing
Silver Dressing

33.1

Non-silver Dressing

C

Figure 5.5: The interaction between dressing condition and localised
inter-electrode distance (logarithmic scale) for R 0 (A), R i (B)
and R inf (C).
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There was a significant interaction (p <0.01) between non-silver dressings and the
inter-electrode distance for all resistance values (Figure 5.5). When a silver dressing
was in place R0, and Rinf increased with increasing inter-electrode distance, with the
difference in R values between the no dressing and non-silver dressing conditions
decreasing with increasing inter-electrode distance (Figure 5.5 A,C). Ri also had a
significant and similar interaction but with minimal increase with increasing interelectrode distance (Figure 5.5 B).
Algorithms were therefore developed to adjust R0 when a dressing is in situ. They are
as follows:
Adjusted (Ag) R0 = R0 (Ag) / (10.47 + 0.53* inter-electrode distance + 2.38* interelectrode distance)
Adjusted (non Ag) R0 = R0 (Non-Ag) /(12.24 + 0.55* inter-electrode distance + 2.38*
inter-electrode distance)
Where:
R0 (Ag) = measured BIS R0 when a silver dressing is in place
R0 (Non-Ag) = measured BIS R0 when a non-silver dressing is in place
Inter-electrode distance = the measured inter-electrode distance
The above equations can be used to adjust R0 when BIS is used in the presence of
any dressings, thus providing a measure of oedema change.

5.4

Discussion

In patients with minor limb burns, resistance as measured by BIS is a reliable and
valid index of oedema change. In patients with an acute wound, this study
demonstrated that localised BIS was sensitive and accurate for use with and without
a dressing in situ. Further, to improve the clinical application in burns, the
interpretation of the BIS resistance variables is enhanced by adjusting for the
presence of a silver impregnated and non-silver dressings. From the results of this
study, adjustment of BIS resistance is now possible due to the development of an
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algorithm, which can be embedded as formulae in readily available spread sheet
software.
The SFB7 instrument provided reliable BIS resistance output regardless of dressing
condition and type, and electrode position. The data demonstrated high intra-class
coefficients (>0.999) with minimal variance (95% confidence interval range 0.9960.999) and no indication of significant systematic bias. This suggests BIS is a reliable
tool for monitoring changes in BIS R values in minor limb burns. These results are
consistent with the literature (40). Edgar et al (2009) found BIS to be a reliable
method for assessment of oedema shifts in burns (%TBSA < 30%) regardless of
dressing condition and dressing age (16). Circumferential limb measures of the
unaffected limb were also found to be reliable with no significant difference in
measures found over time. This indicates the CLM’s and thus truncated cone volume
estimates of the affected limb in this study were reliable, as the unaffected limb
volume was not expected to change appreciably between time points. This is due to
minor burns causing a localised inflammatory response (not systemic) with swelling
concentrated around the burn wound (2, 3, 41).
A primary aim of this study was to establish whether BIS is a valid measure of
oedema volume change in minor limb burns (<5% TBSA) with respect to electrode
position and dressing condition. A localised (EPlocal) electrode montage was found to
be the most sensitive arrangement when compared to the calculated truncated cone
measurement and when compared to whole body and segmental electrode positions.
Localised BIS electrode placement was best option to detect and measure oedema
volume change over time. The change in resistance values detected over time ranged
from 0.11- 0.12% at electrode position 3 and 0.2 - 0.9% at electrode positions 1 and
2. This compares similarly with other studies where localised electrode positions
were superior at detecting change in fluid volumes (42, 43). It has been demonstrated
that narrowing the field of measurement closer to the site of interest increases the
sensitivity of bioimpedance measures (44). As localised electrode positioning is not
standardised to manufacturer’s specifications, it is recommended strict measurement
and placement protocols be adhered to, to ensure consistency (comparability) of BIS
assessments and minimisation of the introduction of type two measurement error, on
the same individual.
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The MLME regression analysis allowed us to accept our hypothesis, bioimpedance
resistance variables, R0, Ri, Rinf increase as limb volume decreases (Figure 4 A,B,C).
Additionally, all BIS resistance values, R0 and Rinf, at EPlocal had significantly
increasing mean values (1.13-1.17 ohms) over time and the burnt limb segment
volume significantly reduced over time. It is known BIS resistance is inversely
proportional to fluid volumes and therefore swelling (33, 45). Burn wound healing
clinically manifests as reduced oedema, in the acute phase (3, 46). This suggests BIS
resistance variables can monitor changes in minor acute burn wound oedema over
time and is supported by Ward et al (2006) (47). They reported raw resistance values
can be used as a surrogate index of volume due to the inverse relationship between
the two. Further, there was a greater percentage change in BIS resistance variables
(R0 5.27%, Ri 7.68%, Rinf 8.80%) over time than with burnt limb segment volume
(0.13%), indicating BIS is more sensitive to fluid volume change than calculated
truncated cone volume measures from CLM. This concurs with Cornish et al 2001
who found BIA was 100% sensitive at detecting those at risk of lymphoedema and
CLM had a sensitivity of only 5% (43). The study demonstrated that BIS has a
superior ability to detect small oedema volume changes in a clinical setting,
compared to CLM, and thus could be better placed to help guide early decisions and
oedema management practices.
After establishing the reliability and validity of BIS in patients with a wound, the
focus of this study following on was to examine the influence of silver impregnated
and non-silver dressings in assessment of limb oedema in the clinical context.
Dressings certainly render other common assessment techniques such as WDV and
CLM, uninterpretable. In this study we found regularly used silver impregnated
burns dressings significantly affected BIS resistant values. As expected, due to the
delivery of ionic silver from dressings, BIS resistance values decreased compared to
the no dressing conditions, measured in the same session. In addition, the difference
increased as the 1) localised inter-electrode distance increased and 2) limb segment
volume increased. This is consistent with the findings of Grisbrook et al (2016), who
documented that silver dressings interacted similarly with TBSA in burns with a
median TBSA of 15%, where an increasing %TBSA had a measurable decrease in
BIS resistance variables when a silver dressing was in situ (48). As the localised
inter-electrode distance increases, the greater the depth of the BIS current and
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therefore the greater amount of tissue it passes through. This explains the significant
relationship of increasing R0 and Rinf values with increasing localised inter-electrode
distance (44, 49).
Non-silver dressings also significantly affected within session BIS resistance
variables compared to no dressing conditions. However the measured resistance
values were increased in comparison to no dressing conditions and the difference
decreased with increasing 1) localised inter-electrode distance and 2) limb segment
volume. Hydrocolloid dressings, the main non-silver dressings used in this patient
sample, contain gelatin and cellulose and are adhesive (50). Gelatin is a highly
viscous protein and coupled with the adhesive properties may act like a cell
membrane or skin, thus resulting in a measured increase in BIS resistance (51).
To increase the clinical utility of BIS at the bedside the provided algorithm can
provide adjusted R values when a dressing is in situ. Resistance at zero frequency,
equivalent to ECW and therefore oedema, would be the most clinically useful BIS
variable to track changes in oedema volume. The localised inter-electrode distance,
significantly associated with BIS R values, is a measure that can be taken clinically
with or without a dressing insitu and with relative ease and accuracy, unlike CLM. In
minor burns it can be used as quasi measure of percent TBSA, as TBSA estimation
can be highly variable and inaccurate (52). Localised inter-electrode distance was
therefore included in the final MLME regression analysis, instead of limb segment
volume, to estimate BIS R values and formulate the algorithm to adjust the BIS R
variables when a dressing is insitu.
It is recommended localised BIS be utilised to improve responsiveness of the BIS
measures. As long as the localised inter-electrode distance and the measured BIS R
(with dressings) is entered into the provided algorithm BIS can be used in a clinical
setting to assess oedema change over time and the effectiveness of treatment
interventions.
Bioimpedance spectroscopy was demonstrated to be more sensitive in the assessment
of oedema volume change, than traditional methods. It is simple and rapid to use.
Anecdotally, during this study it took ~two minutes to complete measures from set
up to finish, This concurs with other authors who have quoted one minute for BIS
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measures versus seven minutes for tape measurements in the assessment of limb
lymphoedema (53). They also reported BIS is better accepted by clinicians,
therapists, and patients than serial CLM or WDV methods. It is non-invasive and can
be used accurately with dressings in place or an open wound (54). Further, it is more
sensitive to oedema volume changes over time than truncated volume measures.
Therefore, the BIS methodology can provide the earliest possible objective data
regarding oedema volume and guide management interventions in the same
timeframe. Thus, BIS has the potential to assist in limiting the impact of adverse
outcomes associated with burn wound oedema.

5.4.1

Future Studies

This study examined the use of BIS in minor limb burns and the effect of electrode
position and new dressings on the measured resistance variables. To enhance clinical
utility however, investigation of the effect of dressing age is necessary as the
properties of common dressings change with time. Silver dressings deposit silver
ions over a particular amount of time and hydrocolloid dressings absorb fluid and
wound exudate forming a gel. Both conditions are likely to affect the electrical
conductivity based on the principles that resistance is proportional to the amount of
electrolyte rich fluid (23). Clinically this is relevant as minor burns often have
dressings left in place for up to five days with physical rehabilitation and oedema
management strategies occurring within this time period, thus necessitating oedema
monitoring in these timeframes. Further studies may also include quantifying limb
and whole body oedema with BIS, so a true magnitude of oedema change over time
can be measured. The magnitude of change in research is relevant to determine the
best intervention however further research is required to determine this. This was
beyond the scope of this study. In addition, investigation of BIS in the assessment of
oedema shifts in major burns and the effect of regularly used silver dressings on BIS
variables would further enhance the clinical applicability of BIS in the burns
population.

5.5

Conclusion

Localised bioimpedance spectroscopy is a reliable, valid and non invasive technique
for the assessment of oedema after minor limb burns with and without dressings in
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situ. BIS provides an interpretable measure of oedema change in minor limb burns
when dressing condition is accounted for using the provided algorithm.
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Foreword

The first 3 studies have demonstrated the reliability of BIS across different electrode
positions and dressing conditions and have established the validity of BIS, after
adjusting for dressing condition, as a measure of fluid change across the spectrum of
burn severity. As a result of these previous studies, it is possible to recommend BIS
as an adjunctive objective measure of oedema and fluid shifts in burn injured
patients, major and minor, which will i) assist in improving clinical assessment and
treatment of oedema and ii) aid oedema management intervention studies aimed at
reducing the overall impact of burn severity.
The final study of this thesis explores BIS, as an objective measure of monitoring
burn wound healing. Localised BIS is able to monitor wound healing in traumatic
and surgical wounds and has been shown to be more sensitive at detecting wound
infections than regular laboratory tests. It is not known however, if BIS can monitor
wound healing in acute minor burns.
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6.1 Introduction
Wound healing, re-epithelisation, is a complex but well described physiological
process. Erythema, heat, pain and swelling are classic symptoms of both acute and
chronic wounds, which are caused by a vascular and cellular inflammatory response
of the body to injury (1). Timely treatment of the wound and associated symptoms is
crucial for providing the best possible environment for healing. Acute burn wounds
are unique in their degree of swelling. After a burn the body responds with an influx
of chemical and inflammatory mediators resulting in excess swelling (2).
Immediate management of a burn wound should include optimum first aid,
management of swelling and medical attention with appropriate dressings (3, 4).
Improvements in dressings, surgical intervention and the advent of antibiotics over
the decades has improved aspects of burn wound care, yet oedema remains an issue.
It is known that in the first 3-5 days post burn when assessed according to Jackson’s
three zones of tissue injury (5), the burn wound can progress, thus increasing the
wound depth and time to healing and increasing the risk of a worse scar and
functional outcome (6). Time to healing is directly related to severity of scarring (2).
Oedema is considered a primary impediment to the healing process and burn wound
conversion (7). The specific mechanism by which oedema interferes with healing is
unknown but is theorised to be related to compromised vascular and tissue diffusion
dynamics (8). Peri-wound oedema is thought to impair the clearance of cellular
debris and waste; to prevent the migration of inflammatory cells impairing defence
from infection and antigens; and impeding nutrient transport from the capillary bed
to the cell (9). Other factors affecting healing are an individual’s pre-morbid health
and age. Systemic factors such as diabetes, peripheral vascular disease and obesity
are associated with slowed wound healing (10).
It is essential to monitor wound healing closely to ensure the most appropriate
intervention to promote healing is carried out. In clinical practice the assessment of a
burn wound must include the wound size (total body surface area (TBSA)), depth,
agent and days post burn. Each of these factors helps guide the best and optimal
medical management of the patient (11). Other signs such as wound oedema volume
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and chemical changes in the wound surface are essential assessment points and may
indicate infection (1).
The most common measures used to assess a burn wound are: visual evaluation;
photos, TBSA and depth (determined by colour, skin elasticity, hairs left) (12, 13).
These are influenced by a certain degree of subjectivity and clinician specialisation
and training. Clinician assessment of a burn wound has been shown to be accurate
only 60–75% of the time (14). The use of computer software, planimetry, wound
biopsy, laser Doppler and ultrasound can be used to objectively assess the structure
of the wound but these can be expensive, require specialist training and don’t
necessarily provide immediate results (15). In the burns wound environment,
dressings may remain in place for 2-5 days, limiting wound assessment unless
dressings are removed. Having the capability to monitor wound healing with a
dressing in place would limit dressing cost, decrease patient burden and pain and
potentially detect infection and delayed or poor healing in wounds earlier.
Kenworthy et al (2017) (the authors of this study) found bioimpedance raw
resistance measures, can monitor localised changes in acute burn oedema with
dressings in place (16). In addition, the ability to monitor wound healing in real time,
non-invasively and without subjectivity would be advantageous and minimise error.
Bioimpedance spectroscopy (BIS) is an instrument with this potential. It can measure
the body’s inter-compartmental fluid volumes, indicate metabolic state and cell
health through passing a small electrical current, over a number of frequencies, via
electrodes placed on the skin and measuring the voltage drop between them (17). The
current flows depending on the body’s composition. The body offers two types of
resistance to an electrical current. They are resistive R (resistance) and capacitive R
(reactance) (18). Resistance is the opposition to flow of an electric current and
capacitance is the delay in the passage of current through the cell membranes and
tissue interfaces. The BIS instrument measures real time raw variables (resistance
(R), reactance (Xc) and phase angle (PA)) using current frequencies of 4-1000 kHz.
Mathematical formulas embedded in the BIS instrument then utilise these raw
variables to estimate the inter-compartmental fluid volumes (19).
Resistance has an inverse relationship to fluid volume due to alterations in electrolyte
concentration, so as the fluid volume increases R decreases. Resistance at zero (R0)
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frequency theoretically indicates extracellular fluid ((ECF) oedema), as the current
does not traverse the cell membrane. Higher frequency currents pass through the cell
membrane and ionic extracellular environment, therefore R at infinity frequency
(Rinf) indicates total body fluid (TBF) (20). Practical limitations prevent the use of
zero frequency (direct currents) and low high frequency alternating currents,
therefore values of R0 and Rinf are predicted by the BIS instrument using a Cole-Cole
plot (21). Resistance of the intracellular fluid (ICF) (Ri) is extrapolated using the
other raw variable data. Reactance represents cell membrane mass and function.
Phase angle, calculated as the arc tangent of Xc/R and expressed in degrees (18). The
capacitance of the cell membrane causes the current to lag behind the voltage as it
traverses the cell, creating a phase shift of the waveform as measured by BIS (22). If
the health of the tissue is disturbed in any way (e.g. inflammation, disease) the
electrical properties of those tissues (cell membranes) are altered. Phase angle is
therefore promoted as a measure of cell membrane health and a prognostic indicator
of malnutrition and disease (23). As the health of the cell improves, the transit of the
BIS current and voltage is delayed, thus resulting in greater PA’s. In experimental
case studies, BIS R and PA measures have been, shown to be associated with wound
healing in acute and chronic wounds (24-26). Resistance measures were also
positively associated with histological measures of healing in surgically induced
wounds in rats (26). The following study therefore aims to examine whether the BIS
technique is a valid measure of wound healing.. Based on the evidence from the
literature it is hypothesised R and PA will increase with burn wound healing.

6.2 Methods
6.2.1

Participants

Participants were recruited from the Western Australian State Burns Service,
outpatient clinic between December 2014 and December 2016.
Participants, who were over 18 years of age, had a minor limb burn (less than five
percent TBSA) which was less than four days old were eligible for inclusion in the
study. Participants were able to be included if they also had minor burns to other
non-assessed body locations and, or if they had surgical intervention to the burn
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wound of interest. They were excluded if they had a body mass index (BMI) < 15
kg/m2 and were unable to lie supine. Manufacturer’s contradictions also excluded
pregnant or breast-feeding individuals, participants with surgical implants and
cardiac pacemakers.
This was a longitudinal study, with participants having BIS, circumference limb
measures (CLM) and photos taken on two different days. Patients were initially
recruited within four days of injury and followed up in a second measurement
session within 14 days of initial assessment.

6.2.2
6.2.2.1

Data Collection
Wound Healing

Digital photos (in colour), were standardised by inclusion of a measurement scale in
each image, and were taken of the individual’s burn at initial recruitment and follow
up to visually monitor wound healing area. A Burns Attending Surgeon reviewed the
scaled photographs and determined whether there was healing of the burn wound
over time. Indicators such as epithelialisation (assessed by wound hue and wound
surface moisture), presence of erythema and wound area were used to assess the
wound. A combination of these factors were utilised to categorise the wound. The
wound healing categories and relevant descriptors are as follows: 1) worse –
increased area, worsening erythema, wound hue changes indicating burn wound
conversion or increased wound ooze, signs of infection; 2) no change – no clear
difference in the wound, in any stated parameter as per category 1, could be seen on
visual assessment and 3) healing – re- epithelialisation, decreased wound area,
wound contraction, increasing red/pink hue of the wound. The parameters of wound
healing were assessed at follow up to provide a category of wound healing in
comparison to the initial assessment.
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6.2.2.2

Bioimpedance Spectroscopy

The subject’s height, body mass, age and gender were recorded and entered into the
BIS instrument (SFB7 ImpediMed, Brisbane, Queensland, Australia). Participants
were positioned in supine with limbs abducted away from the body. Electrodes were
placed over cleaned, intact skin with the measurement (sense) electrodes placed 3cm
longitudinally either side of the burn wound (Figure 1). Drive (current applying)
electrodes were placed in the standardised position, at the head of the third
metacarpal dorsally and the base of the third metatarsophalangeal joint dorsally. To
minimise inter- and intra-rater error, bony anatomical landmarks were used as
measurement reference points for placement of the two sense electrodes, with the
patient in supine and the distance between the sense electrodes was also measured
(27). Within each assessment session localised BIS (R0, Ri, Rinf and PA) measures
were taken in triplicate with an open wound. Phase angle measured at 50 kHz (PA50)
was utilised as it has been suggested to be the most appropriate frequency to monitor
changes in bioimpedance variables in humans (28).

Figure 6.1: Burn of volar forearm two days after surgery. Sense
electrodes in place either side of wound
6.2.2.3

Localised limb segment volume (oedema)

The localised limb segment volume was calculated using the truncated cone method,
as a method of oedema assessment. In minor burns, oedema peaks on day one (1)
post injury and then reduces to clinically insignificant levels by day four (4). Wound
healing clinically manifests itself as reduced oedema (29). Therefore limb segment
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oedema volume was determined to support and strengthen the statistical analysis and
primary aim .Limb circumference measures were taken at the site of the sense
electrodes (distal edge) and at their mid point with the patient in the anatomical
position. These CLM were then utilised to calculate limb segment volume using the
truncated cone method (27). Reliability of our CLM has been determined in a
previous study (16). The tape measure was cleaned with medi-wipes to adhere to
infection control protocols.
Truncated volume measures of the localised segment were determined using the
below formula.
V = [h (CP2 + CPCM + CM2)]/ 12 𝜋 + [h (CD2 + CDCM + CM2)]/ 12 𝜋
Where:
C P,M,D = circumference limb measures (P = proximal, M = mid, D = distal)
h = height of each segment = inter electrode distance /2
Researchers were blinded to the CLM and BIS measures between recruitment and
follow up. The Burns Attending Surgeon was also blinded to both the BIS and CLM
results.

6.2.3

Equipment

Localised BIS measures were collected using the ImpediMed SFB7 instrument
(ImpediMed, Brisbane, Queensland, Australia) (Figure 6.2).
The portable BIS instrument applies a small AC current across 256 discrete current
frequencies (4-1000 kHz) via electrodes placed on intact skin. Electrical leads
connect the electrodes (via alligator clips) and the BIS instrument together. Patient’s
details are entered via a touch screen. BIS measures raw R and Xc values and then
computes PA (at the varying BIS frequencies) as the arc tangent of Xc/R.
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Figure 6.2: ImpediMed SFB7 instrument (ImpediMed, Brisbane,
Queensland, Australia)
Kendall CA610 diagnostic tab electrodes (reference code 31447793, Covidien,
Mansfield, MA, USA) were utilised.
A tape measure was used for circumference limb measures (CLM) to calculate
truncated limb volume and Fiona Stanley Hospital (FSH) medical illustrations
department photographed the wounds with a standardised technique.

6.2.4

Ethics

Approval for the study was granted by the Royal Perth Hospital (RPH) Human
Research Ethics Committee (EC 2011/028), and subsequently Fiona Stanley Hospital
(FSH) Governance Committee (2014-106) (upon transfer of the Burn Service to the
new hospital during the study period) and The University of Notre Dame Australia
Human Research Ethics Committee (014139F).

6.2.5

Data Analysis

Statistical analysis of the results was completed using Stata statistical software,
release 14 (StataCorp LP 2014, College Station, TX). Normality of the data was
assessed using skewness – kurtosis tests. Descriptive statistics (mean ± standard
deviation) were utilised to portray normally distributed patient characteristics and
appropriate predictor variables.
Non-parametric statistics were performed where the data was not normally
distributed. A Spearman’s rank-order correlation was performed to determine the
relationship between a healing wound and the mean limb segmental volume. The
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results are presented as the correlation co-efficient (rho) (weak, 0-0.39; moderate,
0.40-0.59; strong, > 0.6) (30). Kruskal-Wallis equality of populations test was
applied to determine if limb segment volume was different for the three groups of
wound healing (worse, no change, healing). The results of the Kruskal-Wallis test
were reported as χ2. A p value of less than 0.05 was considered statistically
significant for all analysis.
A series of proportional-odds ordered logistic regression (POLR) analyses, were used
to determine the effect of BIS variables R0, Ri, Rinf, PA50 and limb segmental
volume on the dependent categorical variable, wound healing. Wound healing as
confirmed by epithelialisation and area. The odds ratios, with 95% confidence
intervals were reported. Statistical significance was determined if the p value was
less than 0.05. Prior to interpreting the results of the OLR models; 1) several
assumptions were evaluated, confirming the response variable healing is ordinal and,
healing is linearly related to each BIS variable and 2) Step-wise, backward
elimination of the variables was completed, to produce the final model.

6.3 Results
A total of 30 patients with minor limbs burns <5% TBSA were recruited and a final
28 (20 male, 10 female) were included in the analysis. Two patients were excluded,
one due to equipment malfunction and one lost to follow up (did not return for
second assessment). Patient injury details are presented in Table 6.1.
Table 6.1: Patient injury details (n=28). Values presented as means
and (standard deviations) or number, where appropriate.
Days post burn

TBSA of
Ax
wound

Burn Location

Wound Healing

Surgery

Categories
Initial Ax

1.39%
(0.96)

Follow

Upper

Lower

up Ax

limb

limb

2.35

7.05

(1.18)

(3.98)

16

14

Worse

No

Better

Yes

21

6

Change
5

2

Ax = assessed

Within this patient sample, burn wound depths included superficial partial thickness
(n=9), mid dermal (n= 11), deep partial thickness (n=6) and full thickness (n=2). The
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surgical intervention included dermabrasion and ReCell® (Visiomed group ltd)
(n=3) and split skin graft and ReCell® (n=3). The median limb localised segment
volume was 1861.94 ml (inter quartile range (IQR) 850.63 ml – 3010.36 ml). The
median limb localised segment volumes by wound category were ‘worse’ 3010.48
ml (IQR 1587.64 – 3231.84 ml), ‘no change’ 1221.15 ml (IQR 1081.52 – 1360.78
ml) and ‘healing’ 969.57 ml (IQR 509.86 – 1810.44 ml).
Spearman’s correlation determined there was a significant but weak negative
association between a healing wound and limb segment volume (ml), rho -0.30, p
<0.01.
Kruskal-Wallis tests determined that there was a statistically significant difference in
limb segment volume between the three wound healing groups, χ2 = 9.62, p = 0.008.
However, the non-healing wound response category sample sizes were small (worse,
n = 5; no change, n = 2) and the results should be interpreted with caution. An
analysis of variables with sample size less than five (5) per category cannot be
considered a robust result (31).
Proportional-odds ordered logistic regression analysis determined surgery was a
significant predictor variable of healing. Once surgery was adjusted for, R0 and Rinf
were significantly associated with healing. A one ohm increase in R0 and Rinf will
increase the odds of wound healing by 6% and 5% respectively (Table 6.2). Phase
angle and Ri were not significantly associated with healing of the wound. Whilst
limb segment volume was correlated with wound healing (spearman’s analysis),
when added to the POLR analysis it was not significantly associated with the wound
healing categories i.e.it did not enhance prediction of wound healing outcome
compared to BIS variables, and thus was not warranted in the final POLR model.
Burn wound depth was not significantly associated with wound healing category (p =
0.85).
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Table 6.2: Relationship of wound healing with localised BIS variables
Wound
Healed

Covariate

Odds Ratio

95% Confidence Interval
Lower

Upper

p-value

R0 (ohms)

1.05

1.02

1.08

<0.01*

Ri (ohms)

1.01

1.00

1.03

0.07

Rinf (ohms)

1.06

1.02

1.11

<0.01*

PA50 (degrees)

0.94

0.67

1.32

0.74

R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf = resistance at infinite
frequency; PA50 = phase at 50Hz; *p= <0.05. BIS = bioimpedance spectroscopy

6.4 Discussion
In patients with minor limb burns, localised BIS resistance measures, at zero and
infinite frequencies, are able to monitor wound healing. BIS demonstrated a
significant association with a healing wound and the subsequent decrease in oedema
volume which supports this result.
The POLR analysis allowed us to confirm part of the hypothesis that bioimpedance
resistance variables (R0, Ri, Rinf) will increase as the wound heals. The results
determined R0 and Rinf significantly increased with wound healing, but Ri and PA did
not. These results are supported by rodent and human studies where epithelialisation
of a wound was associated with an increase in resistance measured at a variety of
frequencies (24, 26, 32). Lukaski and Moore (2012) suggest R is a specific
biomarker of cell growth where increases reflect healing and decreases is suggestive
of a lack of healing.
Resistance at zero frequency increasing with wound healing may also be explained
by the reduction in limb oedema with healing. At low frequencies the BIS current
cannot penetrate the cell membrane and is therefore a measure of ECF. In the acute
phase, one element of burn wound healing is a reduction in oedema (7, 33). This is
further supported by the significant negative spearman’s correlation between a
healing wound and limb segment volume (ml), and the difference in limb volumes in
each of the three wound healing categories (worse, no change and healing) as
determined by Kruskal-Wallis analysis. The spearman’s correlation and KruskalWallis analysis results also indicate that reduction of edema volume is a measureable
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symptom of progression of acute wound healing. The Kruskal-Wallis analysis result
though, needs to be interpreted as a preliminary finding due to the low sample
numbers in two of the wound healing categories. Segmental limb volume however,
was not a significant independent predictor of wound healing in the multivariable
POLR analysis. Measurement of resistance at high frequencies, Rinf, is reflective of
molecules inside and outside the cells (TBF). Resistance at infinite frequency would
therefore increase as a result of decreased oedema and cell proliferation (34).
Changes in Ri are not reflective of wound healing and may be due to the intracellular
fluid compartment remaining stable in an acute minor burn wound.
In this study, the PA measured by BIS at a frequency of 50 kHz was not significantly
associated with healing of a minor limb burn for this cohort. Therefore, using the
markers of wound healing defined for this study, there is no evidence in this sample
that PA50 measurements are related to wound healing. Phase angle indicates the
distribution of water between intracellular and extracellular space and reflects the
electrical integrity of vital cell membranes (35). Wagner et al (1996) found localised
PA measures taken at two different sites were significantly different between those at
high risk of pressure ulcers compared to a control group. There was however no
difference in PA within the high risk or control groups between the two sites (36). It
is therefore possible, in minor limb burn injuries, that the relationship between Xc
and R is consistent independent of the extent of tissue injury. In contrast however,
localised PA50 has been demonstrated in a series of case studies using serial
measures of wounds with varying aetiologies, to reflect wound healing and
breakdown (23). An alternative explanation for the inconclusive findings regarding
phase angle as an indicator of wound healing from this analysis may be due to the
lack of sensitivity of the wound healing markers used in this study i.e. visual
assessment and, or the limitation of a small sample size in the wound healing
categories, worse (n = 5) and no change (n = 2). A second explanation of the PA
results measured at 50 kHz may not be the optimum frequency that is sensitive
enough to measure cellular proliferation in acute burn wounds. Tornuev et al (2014)
demonstrated that a PA at higher frequencies (100 or 200 kHz) is best to distinguish
a change in the level of cellular healing and thus is more sensitive in detecting wound
healing and inflammatory diseases in mammary glands after surgery (37). In
contrast, Kekonen et al (2012) found healing of a single superficial acute wound
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could be first detected with BIS at frequencies between 1 - 100 kHz within the first
four days of injury. Frequencies lower than 1 kHz did not indicate any significant
change in the wound. It appears optimal PA frequency for measuring healing may
differ for different wound aetiologies.
This study demonstrates the capability of BIS as a quantitative non-invasive index of
wound healing. The BIS measures are sensitive which allows some confidence in the
generalisation of our results. A limitation of the study however is the small overall
sample size, which is not a representative sample of the burns population and does
not allow conclusive results to be drawn with respect to PA as a wound healing
measure.
To further enhance the clinical applicability of BIS in burns, studies investigating the
association of PA at various frequencies with burn wound healing using enhanced
wound healing markers and larger sample sizes are warranted. In addition assessment
of bioimpedance until wound healing would provide a greater understanding of the
relationship between BIS variables and the wound healing process.

6.5 Conclusion
Bioimpedance spectroscopy resistance variables, R0 and Rinf, can be used to monitor
wound healing in minor limb burns as an adjunct to standard practice. Further
research is required however to investigate if phase angle is of value as an indicator
of the wound healing process.
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Chapter 7 Synthesis Of Results And Conclusions

7.1 Introduction
The oedema that occurs after an acute burn has a significant negative impact on
wound healing and in severe cases, patient survival (1). The rate of wound healing is
directly related to the severity of the scar, which consequentially can significantly
affect the functional and psychological well-being of the patient (2-4). There is
therefore an urgency to reduce acute burn oedema. Whilst considerable gains have
been made in many areas of burn care, few advances have been made in the
treatment and measurement of acute burn oedema in both minor and major burns.
Advancements in acute burn oedema management have been stunted by the ability to
measure the efficacy of interventions (5, 6).
Following a burn injury, significant oedema is present in measurable amounts for up
to 5 days, as fluid leaks (fluid shift) into the tissue from the inflamed blood vessels
(6). The management of this fluid shift in major burns involves formal fluid
resuscitation. Adjustment of the patient’s fluid requirements is a dynamic process
and close monitoring is recommended, in order to prevent under or over resuscitation
in the first 24 - 48 hours after burn the burn injury. When treating a burn this way,
the clinician treads a fine line between excess tissue oedema, which slows wound
healing and increases the risk of scar; and the prevention of hypovolaemic shock,
renal failure and possibly death. The current most widely utilised measures of
oedema and fluid shift include CLM, urine output monitoring and WDV. However
they either lack precision, are invasive and/or lack utility in the acute burn unit.
Urine output is a ‘quasi’ measure of fluid shifts and whole body perfusion and is
suggested to lag behind actual hypoperfusion events (7). These limitations and the
challenges of oedema volume change assessment in burns was the driving force
behind this series of studies. A rapid, real time, reliable method of oedema
assessment is required to help reduce the negative sequelae of acute burn oedema.
Bioimpedance spectroscopy, is emergent in the literature as a method to evaluate
oedema change in burns. It has advantages of other competing technologies of
oedema change assessment such as near-infrared spectroscopy (NIR), perometry and
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ultrasound as it has demonstrated reliability, sensitivity in detecting fluid volume
change, is practical and user friendly (1, 8, 9). Also, after initial purchase BIS is low
cost and likely a sustainable method of oedema monitoring in comparison to other
technologies.
Bioimpedance spectroscopy is a non-invasive tool, which is based on the principle
that the resistance to the flow of an electric current through the body is directly
related to the composition of the body. By measuring the resistance of the whole
body and the limbs it is possible to calculate the inter-compartmental fluid volumes
of the body (and other tissues) and hence obtain an index measure of oedema. The
utility of BIS, as a non-invasive measure of fluid shifts in burn patients has been
previously demonstrated, however the studies lacked power to determine BIS as a
valid measure of fluid shift (1, 10, 11). The use of the BIS method in acute burns is
also hindered by the presence of open wounds at the sites of standard electrode
placement, i.e. the hands and the feet and by the presence of dressings. The dressings
routinely used in the first 24-48 hours of injury, in the BSWA, incorporate silver
compounds and dressings after this period are commonly hydrocolloid or similar.
Since bioimpedance is based on the flow of an electrical current through the body, it
raises the question as to whether the accuracy of the BIS measures is altered in the
presence of various dressings.
This research therefore aimed to investigate an alternative method, which is easy and
rapid to use, for monitoring fluid shifts in the acute burn environment. Hence, the
primary aim was establishing whether BIS was a reliable and valid instrument for
measuring fluid shifts in acute burns, across the spectrum of burn severity. Secondly,
to address the potential barriers to the clinical application of the BIS instrument in
this environment and thirdly to examine whether BIS could monitor minor burn
wound healing.
The outlined research problems were addressed using four integrated studies. This
chapter: 1) summarises the outcomes of each of the studies, 2) discusses the clinical
limitations of BIS, 3) considers the future path of research and 4) concludes with the
significance, recommendations and clinical implications of the research.
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7.1.1

Study 1: Addressing The Barriers To Bioimpedance
Spectroscopy In Major Burns: Alternate Electrode
Placements

The first study in the study series addressed potential barriers to the use of BIS in
burns receiving fluid resuscitation to enable greater clinical utility by investigating
alternate electrode placements when wounds hinder the use of standardised
placement. The literature reports movement of electrodes circumferentially around
the limb, theoretically, will not affect BIS measures (12). However Grisbrook et al
(2015) found BIS measures were significantly different when electrodes were moved
circumferentially on the lower limb in healthy populations. In contrast, movement of
electrodes proximally 1cm and 2 cm has been reported to result in a change of mean
BIS resistance values by 2% and 4% respectively (13). The use of alternate electrode
placements in the burns patient population has not been described in the literature.
The single service study therefore specifically aimed to contribute to the body of
knowledge and determine whether alternate electrode configurations for whole body
and limb segmental BIS outputs were comparable to standardised electrode
configurations in moderate to large size burns across different dressing conditions
(an open wound and ActicoatTM dressing).
The first study demonstrated that whole body bioimpedance spectroscopy resistance
variables (R0, Ri, Rinf indicative of extracellular, intracellular and total body fluid
respectively) and extracellular fluid (ECF) volumes were interchangeable in an open
wound and the ActicoatTM dressing condition. All upper limb segmental measures
were interchangeable in an open wound only but not in an ActicoatTM dressing. The
differences between measurements of other BIS variables (namely intracellular fluid
(ICF) and total body fluid (TBF) whole body measures and all lower limb measures)
across the dressing conditions were not clinically acceptable. It was also evident that
the ActicoatTM dressing condition amplified the differences between the standard and
alternate electrode positions but also between the open wound and ActicoatTM
dressing condition for each BIS variable. The study however was not designed to
explore this effect further. Additionally, it was shown that the standardised whole
body BIS fluid volumes measured in the open wound environment were comparable
to those expected when fluid resuscitation volumes were taken into consideration
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(14) i.e. the ECF, ICF and TBF volumes were within 4 L (maximum resuscitation
volumes) of normal values. This further supports the establishment of BIS as a valid
measure of fluid volume change in the burns environment. Also, the fact that
resistance variables were more stable than fluid volumes between the two electrode
configurations (standard and alternate) may suggest that resistance measures are
more clinically useful as it removes the need for predictive equations (15).
The results of the study therefore demonstrates whole body alternate electrode
placements are a feasible alternative when wounds preclude the use of standardised
placement for monitoring R0, Ri, Rinf and ECF within dressing conditions in burns
>12% TBSA. This result hence partly ameliorates the potential difficulties to the use
of BIS in the burn population, improving its practical application in this clinical
environment. Further research is required to establish the best alternate electrode
placements to measure all BIS variables in moderate to large burns and to therefore
enhance its clinical utility.

7.1.2

Study 2: An Objective Measure For The Assessment And
Management Of Fluid Shifts In Acute Major Burns

The second study, in the study series, expands on addressing the barriers to BIS
application in burns and explores its reliability and validity as a measure of fluid shift
(using both raw resistance variables and calculated fluid volumes). The reliability
and applicability of BIS in the measurement of fluid volumes in the burns
environment has been demonstrated yet it has not been validated as a method of fluid
shift assessment (10, 12). The second observational longitudinal study therefore
aimed to contribute to the understanding of a) the reliability of BIS with respect to
dressing condition and electrode position, b) the influence of ActicoatTM on BIS
variable outputs and c) the validity of whole body BIS to assess net fluid shift in the
presence of moderate to major burns.
This study demonstrated the reliability of BIS under any dressing conditions and
electrode position. All BIS measures were reliable within any electrode position
(standard and alternate whole body and limb segmental), across dressing conditions
(open wound and ActicoatTM) and over time. We therefore propose that
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bioimpedance spectroscopy is a reliable method for monitoring fluid change in
moderate to large burns patients.
Further, this study supported the hypothesis that “Acticoat dressing used in the first
48 hours of burn injury in the BSWA reduced BIS variable outputs”. ActicoatTM, an
antimicrobial silver impregnated dressing significantly reduced BIS resistance
variables as expected, and led to increased calculated fluid volumes. There was also
a significant ActicoatTM TBSA interaction where the ActicoatTM effect on BIS
measures was magnified with increasing TBSA. These results concur with those
found by Grisbrook et al (2015). Therefore, in order to maximise clinical utility of
BIS in the measurement of oedema at the bedside, this PhD project has included the
production of algorithms embedded in a calculator to adjust for the effect of
ActicoatTM on BIS fluid volume measures.
The final hypothesis that ‘BIS raw resistance variables will decrease and predicted
fluid volumes will increase with increasing fluid shift’ was also accepted.
Bioimpedance variables and net fluid shift were found to have a negative inverse
linear relationship for resistance and calculated fluid volumes a positive linear
relationship providing the net fluid shift, between consecutive measures, was greater
than -100 ml. Other factors influencing BIS measures were: initial TBF volumes,
with increasing initial TBF increasing measured fluid volumes and decreasing
measured resistance and; time, where increasing time decreased resistance variables
and increased fluid volumes measured.
This study confirmed that BIS is a reliable and valid indicator of fluid volume
change in moderate to large burns, if BIS measures are corrected for using the
provided calculator and the fluid shift is not larger than -100 ml i.e. the patient can’t
have a loss of fluid >100ml within the consecutive time periods. The calculator is
able to adjust for the effect of ActicoatTM and can provide an estimated change in
BIS fluid volumes between consecutive BIS measurements (e.g. half hourly or
hourly intervals), hence providing the potential for fluids to be titrated accordingly.
This finding is important as BIS provides immediate, non-invasive assessment of
fluid volume, thus having the potential to reduce the risk of over or under
resuscitation and associated adverse outcomes. Other methods of fluid shift
monitoring in the acute burn resuscitation period involve invasive monitoring or
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delayed results from laboratories (16, 17). And the most widely used outcome
measure, urine output has been suggested to lag behind the actual events of
hypoperfusion by up to two hours questioning its accuracy (18, 19). Further work is
required though, to increase confidence and allow greater reliance on this sensitive
measure in fluid resuscitation management, over standard haemodynamic
monitoring. Figure 7.1 shows a summary flow chart for the use of BIS in major
burns.
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Figure 7.1: Summary flow chart for the use of BIS in major acute burns
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7.1.3

Study 3: Bioimpedance Spectroscopy: A Technique
To Monitor Interventions For Swelling In Minor
Burns

The first two studies in the series demonstrated BIS is a reliable and valid measure of
whole body fluid volume change if measures are corrected for the presence of
dressings by using the using the developed calculator. These studies attempted to
address barriers to the use of BIS in the acute burns resuscitation environment by
investigating alternative electrode placements and the effect of routinely used
dressings in the BSWA. The third study continues in the same vein, exploring BIS as
a reliable and valid measure of oedema change in minor burns with respect to
dressing condition and electrode placement. Limb segmental and localised BIS has
been shown to be a reliable and sensitive measure of lymphoedema and oedema
change in muscle injuries (9, 20) but whole body BIS has not (21). Yet, it is
unknown if this is true in minor burns less than five percent TBSA. Therefore, the
third study examined the reliability and validity of the BIS technique for the
measurement of localised burn wound oedema with respect to electrode position and
dressing condition.
This study supported the hypothesis that BIS variables R0 (resistance of extracellular
fluid), Ri (resistance of intracellular fluid), Rinf (resistance of total body fluid)
increased as limb volume decreased. This finding is supported by Ward et al (2006)
who reported raw resistance values could be used as a surrogate index of volume due
to the inverse relationship between the two. It was also determined that localised BIS
was the most sensitive electrode positioning to detect oedema change (R0), was
reliable and the BIS raw resistance measures provided a valid index of oedema
change in minor burns. Additionally, BIS was found to be more sensitive to fluid
volume change than calculated truncated cone volume measures from CLM.
As with the major burn study (second study) dressings were found to influence the
BIS measures and they had a significant interaction with TBSA. It was found
hydrocolloid dressings increased and silver impregnated dressings decreased the
measured BIS resistance. An algorithm was therefore developed to adjust resistance
values when dressings are in use. This improves the clinical utility of BIS to monitor
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localised changes in burn wound oedema. These findings expand the usefulness of
BIS in the burns population. There is now a rapid, reliable and valid objective
measure of peripheral oedema that can be utilised in the presence of dressings and
wounds. Unlike CLM and WDV, the most widely accepted methods of peripheral
oedema assessment, where their use is limited to open wounds, and they pose an
infection risk if cleaning procedures are not thorough. Bioimpedance spectroscopy’s
utility in the monitoring of peripheral oedema change is valuable as being able to
determine the effectiveness of oedema management interventions easily, can guide
best patient care and help improve functional and scar outcomes post burn.

7.1.4

Study 4: Monitoring Wound Healing In Minor Burns – A
Novel Approach

The final study explores BIS as a method of monitoring wound healing. As with
assessing oedema changes, usual assessment of wound healing involves an undressed
wound. The most common current assessment tools are computer software packages,
which assess the area and depth of wound, and subjective assessment by specialised
clinicians (22). Bioimpedance spectroscopy is emerging as a tool for wound healing
assessment both in rodent and human studies (23, 24). It has been investigated in
chronic non-healing wounds of differing aetiologies (e.g. traumatic, surgical) and in
surgical mammary gland wounds (25, 26). All BIS variables appear to be associated
with healing, however the totality of studies performed in this area seem to primarily
investigate resistance and phase angle as indicators of wound status.
The fourth and final study determined the BIS technique is a valid measure of wound
healing and examined whether a healing wound is associated with oedema volume
change.
The hypothesis that ‘BIS resistance increased with burn wound healing’ was partly
confirmed. It was determined that the resistance of the extracellular and total body
fluid (R0 and Rinf respectively) were associated with a healing wound, each
increasing as the burn wound heals. An increase in both of these resistance values is
related to a reduction in oedema with a healing wound. This was further supported
by the significant negative correlation between a healing wound and limb segment
volume (ml). Kekonen et al (2015) found resistance, measured at varying
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frequencies, increased with epithelialisation of an acute wound (27). The results
however found phase angle (PA and promoted as a measure of cell membrane
health) at 50 kHz was not significantly associated with healing of a minor burn for
this cohort. Therefore, using the markers of wound healing as per this study, there is
no evidence in this sample that measurements of PA at 50 kHz are related to wound
healing. Further research is warranted to explore the capability of BIS as a noninvasive tool for quantitative evaluation of wound health with PA’s at different
frequencies. It has been demonstrated that BIS frequencies of 100-200 Hz are more
sensitive to early changes in indicating wound healing and is worth investigation in
burn patients (26).
It can be concluded that BIS resistance values at zero (indicative of oedema) and
infinite frequencies can be used, in conjunction with standard practice, to monitor the
status of minor burn wounds. Figure 7.2 provides a summary of how localised BIS is
utilised in minor burns.
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Localised BIS
in
Minor limb Burns
<5% TBSA
Place electrodes 3cm
longitudinally from
wound edge

Measure inter-electrode
distance + electrode distance
from anatomical landmarks

Measure BIS
resistance variables

Open wound (no
dressing)

Measured resistance at zero frequency
(R0) = index oedema change
R0 = oedema

Monitoring wound
healing

Measure BIS
resistance variables

Monitoring oedema

Resistance at zero (R0) and
infinite (Rinf) frequency are
associated with healing

Dressing insitu
Measured R0 , if corrected using
appropriate algorithm (for the
dressing type), is a valid index
of oedema change

BIS can monitor oedema
change where R0 = index
of oedema volume change

Figure 7.2: Summary flow chart for the use of BIS in minor acute burns
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Localised BIS may be used in
conjunction with standard practice to
monitor the status of a minor burn
wound

7.2 Limitations
Even though the individual studies presented in Chapters three to six discuss their
limitations, these were guided by the journal requirements. Further limitations
relevant to the individual studies are detailed below.

7.2.1

General Limitations

This study was limited in terms of the population involved. It was a single service
study including adults only and results may not able applicable to paediatrics. This is
due to the different developmental stages of children and varying body composition
throughout these stages, which significantly influence BIS measures (28).
Furthermore, being a single service study allowed only dressings routinely used in
the BSWA within the specified timeframes to be investigated. This may limit the
generalizability of the results to other services, which use different dressings,
especially silver impregnated ones, in the acute period. The population was also
limited to acute burns, potentially decreasing the application and generalisation of
results to subacute and chronic burn oedematous states.

7.2.2

Study 1: Addressing The Barriers To Bioimpedance
Spectroscopy In Major Burns: Alternate Electrode
Placements

A limitation of this study was the use of the same alternate lower limb electrode
positions utilised in the healthy population by Grisbrook et al (2015). Due to the time
constraints of the research and schedule of the researchers we were unable to await
the results of their study. We had to move forward with the proposed alternate
electrode placements, based on the theory of equi-potentials from the literature (12).
Grisbrook et al (2015) demonstrated the lower limb alternate electrode placements
did not provide interchangeable BIS measures with the standardised positions.
Knowing this, we could have investigated other alternate electrode placements but
were unable to. This is therefore considered in the future research. The standard and
alternate electrode positions were only measured in a new ActicoatTM dressing
condition so results may not be generalizable to measures in older dressings.
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ActicoatTM works by depositing silver ions into the wound over time thus likely
increasing the conductivity of the BIS electrical current, in turn affecting BIS
measures.

7.2.3

Study 2: An Objective Measure For The Assessment And
Management Of Fluid Shifts In Acute Major Burns

The results from this study are not generalizable to major burns with dressings other
than an open wound or ActicoatTM. Study Three demonstrated that non-silver
impregnated dressings alter BIS measures. Due to other research projects being
conducted at the BSWA site, time constraints were put on the research and the
project was limited to collection of data within the first 48 hours of injury only.
Hence other dressing conditions were unable to be included in this study, as
ActicoatTM is the dressing used in this timeframe in the BSWA. Investigating the
relationship between BIS measures and total body weight changes (a gross measure
of oedema change) was also limited. Burn dressings and retention of fluid from
formal resuscitation in large burns pose a barrier to regular reliable weights in the
acute period.

7.2.4

Study 3: Bioimpedance Spectroscopy: A Technique To
Monitor Interventions For Swelling In Minor Burns

Confirmation of localised BIS as a measure of localised wound oedema ideally
should have been compared to WDV rather than CLM, however in collusion with the
supervisors of this candidature it was not considered viable during this project.
Firstly, to be able to include limb burns at any location (upper or lower limb) large
containers of water would be required which are cumbersome, heavy and pose a risk
to the researcher. Secondly, it is another burden to the patient as they potentially
have to undress and must be functionally able to get a limb in and out of the water
container (especially if it is on the upper thigh). In contrast, we could have tightened
the inclusion criteria to burns on the forearm or lower leg but this was not considered
feasible due to the timeframe of the research.
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7.2.5

Study 4: Monitoring Wound Healing In Minor Burns – A
Novel Approach

The comparative measure for wound healing over time was visual assessment via
photographs by a Specialist Burns Consultant. Ideally a wound area measurement
would have been included as another objective outcome measure. Wound area was
calculated for each series of photographs using Image J, a free software package able
to calculate wound area but it was not used in the final analysis (29). The wound area
measure was excluded because frequently, at early follow ups, the wound margins
had extended. Therefore wound area increased even though the wound was clearly
healing on visual assessment. This is the nature of burn wounds and may have been
due to further debridement of dead tissue with a healing wound presenting itself
underneath the removed tissue. Patients who had surgery were also included in the
patient cohort. If surgery was completed after recruitment the wound area had
increased, due to debridement, but the wound was healing or healed. This inherently
goes against a healing wound where the area decreases as it heals (30). The image J
area measurement was therefore not appropriate for inclusion in the analysis.
Additionally, it was difficult to account for the curve of the limb in the bigger minor
limb burns, which led to large discrepancies between the two photo areas calculated.
It was therefore decided to omit the image J area calculations from the analysis.
Further, we were unable to examine whether there is a quantifiable volume of
oedema that impacts significantly on wound healing. A degree of oedema is essential
in an acute wound injury and is a normal part of the healing process (31). However,
it is not certain how much oedema is detrimental to healing. It was not possible to
investigate the rate of, or time to healing associated with a quantifiable volume of
oedema due to the available instrumentation and equipment and the time constraints
of the study.

7.3 Conclusions
The novel findings of this study demonstrate a single instrument, BIS, is capable of
monitoring fluid shifts easily, in real time and in the presence of dressings in the
burns population. The first study of this study series determined whole body BIS
alternate electrode placement measures can be utilised in burns > 12% TBSA,
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without adjustment, for the assessment of i) all resistance variables and extracellular
fluid (ECF) volumes in an open wound and ActicoatTM dressing, ii) total body fluid
(TBF) in an open wound only. Total body fluid volumes in an ActicoatTM dressing
and intracellular fluid volumes in an open wound and ActicoatTM dressing need to be
used with caution as there is the potential for them to be over or underestimated.
The second and third studies showed BIS is a reliable method for monitoring fluid
volume change across the spectrum of burns severity in any dressing condition and
electrode position. Both whole body and localised BIS are accurate in the assessment
of fluid shifts in major and minor burns, respectively. Silver and non-silver
impregnated dressings alter BIS measures. Therefore, in the presence of dressings,
BIS measures have to be corrected using the appropriate algorithms or calculator.
The final study established BIS resistance values, (R0 ECF equivalent and Rinf, TBF
equivalent) are able to monitor the status of minor limb burn wounds and are a useful
adjunct to standard practice. However, further research is required to investigate
phase angle as an indicator of the wound healing process.

7.4 Future Research
There is a plethora of opportunity to extend the use of BIS in burns as mentioned in
the literature review, but in keeping with the overarching theme of this research the
future recommendations will concentrate its application in the assessment of fluid
volume change.
This research has demonstrated that BIS is able to monitor fluid volume change
across the spectrum of burn severity with use of the developed algorithms or
calculator. To make further progress and to enhance the clinical utility of BIS in the
burns population, development of one workable calculator for burns greater than 5%
TBSA would help achieve this. It is recommended the results of this research (Study
Two) and Grisbrook et al’s (2016) be pooled together to accomplish this. As touched
on in Study Two, additional work is required to improve confidence in the use of BIS
over standard haemodynamic monitoring in major burns for titration of resuscitation
fluids. A greater understanding of the effect of large negative fluid shifts (> 100 ml)
on BIS measures is also required as negative volumes of such amplitude clinically
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exist. Future research design should therefore include repeated BIS measures (e.g.
hourly, over seven-eight hours) over the initial 48-72 hours of burn injury, in order to
capture the ebbs and flows of fluid shift in major acute burns. Study Two in this
series only included five consecutive half hourly BIS measures (with dressings
intact), over a two-three hour period. Ideally multi centred trials would be conducted
to increase major burn patient numbers, thus providing the best representative burn
population sample and generalisability of results. This would also allow for
comparison of burn centre’s fluid resuscitation regimes and the effects on acute burn
fluid shifts. To extend BIS’s ability to measure oedema change, studies need to be
conducted in subacute and chronic burns to explore its reliability and validity in
these sub groups.
With respect to wounds posing a potential barrier to BIS utility, further exploration
into optimal alternate electrode placements is required (as discussed in Study One).
A greater understanding of limb segmental measures in measuring whole body fluid
volumes is also warranted. It has been suggested whole body impedance and
composition may be predicted by the measurement of one extremity’s (or segment of
extremity) impedance (32). Bioimpedance measurement of a calf segment in dialysis
patients has been shown to reflect whole body fluid shifts (33). Therefore if upper
limb burns prevent the placement of hand electrodes then is it possible lower limb
segmental BIS measures alone provide an option of whole body fluid volume
assessment? Segmental upper and lower limb BIS measurements, in healthy
individuals, were collected as a part of Grisbrook et al’s study thus providing
normative data (34). Limb segmental BIS measurements were also measured in study
one of this series (major burns) but investigation of the results in monitoring fluid
shifts were considered out of scope of the study. This data may therefore be utilised
in a pilot study exploring limb segmental BIS measures in monitoring whole body
fluid volume change.
An option to combine a BIS instrument with intravenous fluid pumps would enhance
the utility of this non-invasive tool in not only burns, but other clinical areas where
fluid resuscitation is required e.g. major trauma, severe sepsis. Combining BIS with
intravenous fluid pumps would allow continuous monitoring of fluid shifts and
automatic, real time titration of fluid volumes to set targets. In burns receiving fluid
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resuscitation, fluid volumes delivered could be automatically titrated to maintain ICF
fluid volumes within a normal average range (for given height, weight and gender)
and ECF volumes within five percent of average.
Another possibility to address open wounds hindering oedema assessment by BIS is
putting electrodes directly on the wound. Kekonen et al (2012) demonstrated a two
electrode configuration, where one electrode was placed on the wound, was able to
evaluate the status of a superficial acute wound (35). Investigation of within wound
electrode configurations is worth pursuing. It eliminates the impedance of the skin
and would reduce the barriers to BIS use in the burns population. Handheld
microelectric, direct current generators with electrodes embedded in wound dressings
have been developed to facilitate wound healing (36). These could be considered as
another alternative to increase the clinical utility of BIS in populations where wounds
preclude the placement of electrodes.
Furthermore, it may be more advantageous to use the change in BIS resistance values
(between consecutive measures) rather than calculated volumes as it removes the
need for specific predictive equations and may eliminate the need for height and
weight measures (15). There are a growing number of studies, which suggest raw
variables may be more useful than calculated measures in predicting clinical
outcomes (15, 37). Additionally, removing the use of predictive equations has been
proposed to increase the sensitivity of BIS measures to detect change (38). However,
further investigation in the burns population is needed to clarify this. Future studies
are also required to determine what resistance change equates to a real volume
change i.e. 1 ohm = x ml, so an absolute volume measure can be determined without
the need for predictive equations.
Following on from Study Three, research quantifying absolute volumes of oedema
change over time with BIS in minor burns is also indicated. This is pertinent in
oedema management interventional studies to help determine best practice. To
achieve an absolute volume measure in minor burns a comparative objective measure
of oedema volume change with greater sensitivity than circumference limb measures
(CLM) is recommended. If funding and time allowed MRI should be considered.
Water displacement volumetry (WDV) may be an option if patients with burns above
the elbow and knee are excluded from the studies. If this was established the
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applications of BIS wound expand considerably. With an valid technique to quantify
oedema further examination of the association between oedema volume (through BIS
variables) and wound healing is warranted. Improving knowledge of the effects of
oedema would allow for advances in the development of treatment options to
decrease and, or control oedema, of both large resuscitation and minor burns
Thus further enhancing clinical decision making in the management of the patient
and the burn.
Further study investigating the effect of the age of dressings on BIS measures in both
localised and whole body burn wound oedema is also warranted. Dressings in acute
major burns are changed every 24 - 48 hours and in minor burns they can be left in
place for up to four to five days. Over time, wound exudate is absorbed by the
dressing, which may potentially alter BIS measures. Therefore longitudinal studies
should be conducted with BIS measures taken prior to removal of the intact dressing.
A portable, mini size BIS instrument (strapped to the limb) which could monitor
limb segment oedema change continuously, would allow patients to independently
monitor and respond appropriately to changes in resistance measures (an index of
oedema change). If resistance values significantly decreased, the patient could then
instigate oedema management principles (e.g. elevation and/or movement) to reduce
the oedema. A portable, real time oedema management device such as this would
guide Specialist Consultant decision making and reduce the negative impact of
oedema on wound healing and patient function.
The final study has demonstrated BIS as an auspicious tool in the assessment of
minor burn wound healing. Additional research is indicated to examine whether PA
measured at other frequencies, other than 50 KHz, are associated with minor burn
wound healing. It is recommended future studies continue wound healing assessment
and BIS measures until complete epithelialisation of the burn wound, rather than just
an initial and follow up assessment (as per Study Four). For the purposes of research
improved markers of wound healing, such as tissue sample collection for histological
assessment and laser Doppler imaging, are also indicated for exploration of BIS as a
wound monitoring tool. However, taking tissue samples introduce ethical issues and
increase the risk of adverse outcomes for the patients (39). Another question is
whether BIS variables, in major burns, are associated with the status of the wound.
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Confidence in the application of BIS as method of monitoring fluid volume change
in the burns environment will increase as further research is conducted and questions
answered. As a result it will guide best practice in oedema management strategies
and reduce the burden of burn wound injury on the individual and society.

7.5 Significance of This Research
The results of this research have demonstrated the clinical and research utility of
BIS, across the spectrum of burn severity. The novel findings show BIS possesses
advantages over the widely accepted and current methods of oedema measurement
and wound assessment, as it is user friendly, safe, rapid and non invasive. The
current findings demonstrate that bioimpedance spectroscopy can provide an
immediate measure of oedema volume change, estimate resuscitation requirements
and monitor wound status. It can be utilised with dressings intact, a capability WDV,
CLM and wound monitoring methods do not possess. Development of algorithms
(from the results of studies two and three), to adjust for the presence of dressings,
further enhances the application of the instrument in this arena. The new findings
from the study series may also be useful and translational to other clinical
populations, such as the critically ill, traumatic limb injuries and chronic ulcers
where large or minor oedema changes pose a barrier to optimal recovery and patient
treatment.
Progress in optimising acute burn oedema removal has been limited by the ability to
measure the efficacies of interventions. Oedema may contribute to burn wound
conversion and other negative sequelae of the burn injury if urgent treatment to
reduce oedema is not implemented. The results of the study series show BIS, a single
instrument, has the potential to positively impact patient outcome and recovery
following a burn. This will be achieved through implementation of its use
immediately in patient care as tool for monitoring oedema change and through
guiding future interventional studies to improve proactive oedema management and
assessment of wound healing status.
“Every intervention from the point of injury influences the outcome after burn” (6).
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